Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.0905519447770885,0.00337187184821719,0.0839430759545828,0.0971608135995942,8.0719396817556e-155
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.0676724940294519,0.00352924032221036,0.0607551829979196,0.0745898050609842,7.01829447106126e-81
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0697812693956261,0.00392090471460468,0.062096296155001,0.0774662426362513,6.61554934546095e-70
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,0.093949059858391,0.00542952041101574,0.0833071998528001,0.104590919863982,2.28332340619353e-66
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,42267,-0.0662733597381026,0.00402776381596118,-0.0741677768173865,-0.0583789426588187,2.97126813905528e-60
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,-0.0838295806546384,0.00540316866957948,-0.0944197912470142,-0.0732393700622627,1.01378393581987e-53
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,-0.0856929071290604,0.00605267451557757,-0.0975561491795924,-0.0738296650785284,4.04988418373227e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.191338462948033,0.0135441320289013,0.164791964171386,0.217884961724679,5.35822016612762e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0432599356683,0.00316981949599349,0.0370470894561528,0.0494727818804472,3.94002764258975e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.0453132986830049,0.00332740106252108,0.0387915926004635,0.0518350047655462,5.8917101248516e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,42137,0.0407943958781224,0.0030055472259411,0.0349035233152778,0.046685268440967,1.08440468162821e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,41843,-0.179463239474417,0.0132642230231819,-0.205461116599853,-0.15346536234898,1.96376685400568e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.0849518822299557,0.00636908960961017,0.0724684665951198,0.0974352978647916,2.48169548841179e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PYY,Peptide YY,39575,-0.14251912201077,0.0107101209529502,-0.163510959078553,-0.121527284942988,4.30957880770652e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.062561688462145,0.00476194860525695,0.0532282691958414,0.0718951077284486,3.46664698280903e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,42129,0.0433963563415783,0.00335403139540166,0.0368224548065911,0.0499702578765656,4.58534388751878e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,39735,0.0429521666284634,0.00332368475781064,0.0364377445031545,0.0494665887537722,6.24797901362099e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0335185714061839,0.00262176173904978,0.0283799183976464,0.0386572244147215,3.59358465877313e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,42145,0.0468766477540163,0.0037476280580129,0.039531296760311,0.0542219987477216,1.05830092327353e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,42070,-0.115316237142712,0.00940019357533321,-0.133740616550366,-0.0968918577350594,2.06768443875043e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,39736,0.0648633121129618,0.00560181742267033,0.053883749964528,0.0758428742613956,7.90725080212002e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.0473664671550096,0.0040937687229071,0.0393426804581117,0.0553902538519075,8.12010457896736e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFH,Complement factor H,39418,0.0289227404712303,0.0025178482164592,0.0239877579669703,0.0338577229754903,2.29720484996132e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,42137,-0.055478964500359,0.00485333074653027,-0.0649914927635583,-0.0459664362371596,4.01831473214111e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFP,Properdin,39979,0.0289530507037397,0.00253792689436061,0.0239787139907929,0.0339273874166865,5.5396581729431e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,0.0529925142457879,0.00465929256594537,0.043860300816535,0.0621247276750408,8.2733402301491e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.0305199914030658,0.00269262499636088,0.0252424464101984,0.0357975363959331,1.19741187156562e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C9,Complement component C9,39990,0.0697604936098973,0.00618410649791846,0.0576396448739771,0.0818813423458175,2.34112938149041e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.0876328260304671,0.00784088312856938,0.0722646950984711,0.103000956962463,7.52605903305183e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,42262,0.0552033140432469,0.0049627360107858,0.0454763514621068,0.0649302766243871,1.27854801019292e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FST,Follistatin,42166,0.0577034611827352,0.00521189869730162,0.047488139736024,0.0679187826294464,2.28197296675984e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,39870,0.0385768065815346,0.00349388179633301,0.031728798260722,0.0454248149023473,3.37042440910887e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0296868024922966,0.00273267035358968,0.0243307685992608,0.0350428363853323,2.2206283823442e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.0669010442382036,0.00623053554496092,-0.079112893906327,-0.0546891945700802,8.70779264450141e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,42113,0.0337888513966906,0.00315585305525314,0.0276033794083944,0.0399743233849867,1.21043875283564e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,0.0471082706678828,0.00441527546617003,0.0384543307541895,0.0557622105815761,1.81016779898908e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.0471510246736006,0.00448123326334843,0.0383678074774377,0.0559342418697636,9.01796980677689e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASN,Vasorin,41975,0.0307150913022613,0.00293298674112107,0.024966437289664,0.0364637453148586,1.45411150747395e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,0.0450014363862532,0.00435423791838963,0.0364671300662095,0.0535357427062969,6.05981036481558e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,41991,0.0567844073268362,0.00554737128497695,0.0459115596082813,0.067657255045391,1.67888985312883e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.037971743015856,0.0037268019531125,0.0306672111877555,0.0452762748439565,2.72143177044573e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,42145,0.0422796629180774,0.00415200936534858,0.0341417245619942,0.0504176012741606,2.88989544559336e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,-0.134718653527245,0.0134552636139005,-0.16109097021049,-0.108346336844,1.69383558543764e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,0.0413878662205749,0.00413689912705336,0.0332795439315503,0.0494961885095995,1.75402511318602e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0382955081777243,0.00383530737198517,0.0307783057286334,0.0458127106268152,2.1363566359739e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,0.0448149484285387,0.00449303040252542,0.0360086088395889,0.0536212880174885,2.47333332778633e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0406609384461052,0.00409624986841071,0.0326322887040202,0.0486895881881902,3.83442707564839e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,42181,0.0324555813965451,0.00329417994014667,0.0259989887138577,0.0389121740792326,7.9818691678433e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,0.0351192095501677,0.00358372343644357,0.0280951116147383,0.0421433074855971,1.34358727191663e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,41638,0.024795887574453,0.0025365223849825,0.0198243036998873,0.0297674714490187,1.71299417416235e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0965720102002055,0.0098876601289375,0.077192196347488,0.115951824052923,1.92451366634777e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0919753699836212,0.00949530837848634,0.073364565561788,0.110586174405454,4.19573727776855e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,-0.114858234194953,0.0118882569560574,-0.138159217828825,-0.0915572505610801,5.40552470793217e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,42089,-0.1065691334238,0.0110475423392499,-0.12822231640873,-0.0849159504388704,5.99285263795391e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,42073,0.0398394331623408,0.00414327869903741,0.0317186069122275,0.0479602594124541,8.08622317594971e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGRN,Agrin,42185,0.0364945622116249,0.00383795346139216,0.0289721734272963,0.0440169509959535,2.24651290105868e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,39979,0.0215424785501239,0.00226541269855691,0.0171022696609523,0.0259826874392954,2.30423822832863e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C3,Complement C3,39445,0.0470612178076353,0.00495200028634747,0.0373552972463943,0.0567671383688764,2.45751016926791e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,0.0268591339587499,0.00283426137857258,0.0213039816567476,0.0324142862607521,3.05728310169229e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,0.0409855750945459,0.00432608810317123,0.0325064424123303,0.0494647077767616,3.13634630483362e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0942691414374743,0.00995884244993153,0.0747498102356085,0.11378847263934,3.48559886151133e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",42262,0.0734435051434338,0.00779635613803124,0.0581626471128925,0.088724363173975,5.21197426489811e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.0162843702469345,0.00173020058021886,0.0128931771097056,0.0196755633841635,5.63984090531931e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,0.0282315934758195,0.00300482384338111,0.0223421387427926,0.0341210482088465,6.78515615712253e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0506377067751417,0.00539526756099203,0.0400629823555973,0.0612124311946861,7.22691858540523e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,-0.052936619247726,0.00568542283160263,-0.0640800479976671,-0.0417931904977848,1.45978817438026e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,0.0267572169936129,0.00290084051046651,0.0210715695930986,0.0324428643941273,3.36747766092041e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0237618892617954,0.00258307477760934,0.0186990626976811,0.0288247158259097,4.13159610406191e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,42249,0.0369802300967659,0.00402147844482934,0.0290981323449004,0.0448623278486314,4.25850156244033e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,39979,-0.0270359282946762,0.00294597419968032,-0.0328100377260496,-0.0212618188633028,5.18345101470599e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0327768961047755,0.00357387312235867,0.0257721047849525,0.0397816874245985,5.3427040998146e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,-0.0359730723083267,0.00394319680224091,-0.0437017380407189,-0.0282444065759345,8.32943946794371e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0325737377007716,0.00357118383785243,0.0255742173785808,0.0395732580229623,8.45794228230921e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.074405541586337,0.00822628358570243,0.0582820257583603,0.0905290574143138,1.7490449452733e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2,Complement C2,42199,0.0217422022923869,0.00242245162984235,0.0169941970978959,0.0264902074868779,3.19204482568186e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.100193412979533,0.0111794548375208,0.0782816814979919,0.122105144461074,3.67730407044283e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,42232,0.0401715730645193,0.00448387664430882,0.031383174841674,0.0489599712873646,3.69243589273909e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,42070,0.0745807136718324,0.00835676356795833,0.058201457078634,0.0909599702650307,5.04481214368659e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,0.0765815168140261,0.00858708793874198,0.0597508244540918,0.0934122091739603,5.33846558820809e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELL,L-selectin,39979,0.0222203703322001,0.00250176345190455,0.0173169139664672,0.027123826697933,7.5581360425064e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,42119,0.0430421438538733,0.00485154064959662,0.0335331241806639,0.0525511635270827,8.08700954136861e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,0.0327582856169333,0.00369769570507997,0.0255108020349766,0.0400057691988901,9.05951670497748e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,0.0434151850596389,0.00491943402584406,0.0337730943689845,0.0530572757502933,1.22461695550334e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0680542862118606,0.00773469693037429,0.052894280228327,0.0832142921953942,1.55454466498104e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,0.0140512861409015,0.00159798341822529,0.0109192386411799,0.0171833336406231,1.66371513578884e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,42145,0.0381904797447557,0.00434691694689536,0.0296705225288408,0.0467104369606706,1.7395629726855e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,0.0185997232587448,0.00211870250814737,0.014447066342776,0.0227523801747137,1.88781479261293e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,0.0507351045769131,0.0057901748662747,0.0393863618390147,0.0620838473148115,2.14230081222759e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,42137,0.0713764874564336,0.00815273665242657,0.0553971236176775,0.0873558512951896,2.28219877297346e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,42158,0.0179895046129196,0.00205792845750922,0.0139559648362015,0.0220230443896376,2.56663673704422e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,0.0124750078618523,0.00144167401400689,0.00964932679439875,0.0153006889293058,5.69462618609765e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,42310,0.0235297807076889,0.00272415309423466,0.018190440642989,0.0288691207723888,6.37613926882431e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.0448804140578242,0.00520431339955747,0.0346799597946915,0.0550808683209568,7.19781786633546e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.0962421158995999,0.0111845560380494,0.074320386065023,0.118163845734177,8.64313939349885e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,42146,0.0504199887400686,0.00586381378787518,0.0389269137158332,0.0619130637643039,8.9548829093199e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFB,Complement factor B,39794,0.0301971209120791,0.0035179014912658,0.0233020339891982,0.0370922078349601,1.03864581106741e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,39736,0.108091708819867,0.0126854822526705,0.0832281636046329,0.132955254035101,1.78695154229869e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0254347367597537,0.0029904562218897,0.0195734425648499,0.0312960309546575,1.9973150812733e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,42137,0.0226186953260074,0.00266799501075474,0.0173894251049281,0.0278479655470867,2.53070575751374e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,42145,0.0232411151652836,0.00277539494483733,0.0178013410734025,0.0286808892571648,6.11314892694311e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,0.0237696577698935,0.00284422595220735,0.0181949749035671,0.0293443406362199,7.16913249404172e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,39958,0.0416400902004847,0.00499134784701903,0.0318570484203274,0.051423131980642,8.11615962363978e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,42070,0.0256206279747093,0.00308531912061841,0.0195734024982972,0.0316678534511214,1.10156030436977e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,39966,0.02263415457056,0.00274344468827347,0.017257002981544,0.028011306159576,1.75442636908286e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,42119,0.0305248466759807,0.00370177590523136,0.0232693659017273,0.0377803274502342,1.78797472997088e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0266846588184476,0.00323854183362066,0.0203371168245511,0.0330322008123441,1.88375265900122e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,0.0517360604116304,0.00628616564122772,0.0394151757548241,0.0640569450684368,2.0386374409649e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0331833411347875,0.00403501119628192,0.0252747191900749,0.0410919630795,2.15000465241092e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFD,Complement factor D,39979,0.0178532049127864,0.00217578139865023,0.0135886733714319,0.0221177364541408,2.54491029664963e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,42181,0.0242309991613312,0.00295703937866227,0.0184352019791532,0.0300267963435093,2.74363878752408e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,42296,0.0760081317837345,0.00928206116379822,0.05781529190269,0.094200971664779,2.87239194934709e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,0.0212415396908075,0.00259592877190277,0.0161535192978781,0.0263295600837369,3.02456966739462e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0546300705686717,0.00667810782841994,0.0415409792249687,0.0677191619123748,3.0754453287096e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0287066978858624,0.00351772093649643,0.0218119648503294,0.0356014309213954,3.62767955147936e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,0.032166369952013,0.00394235599499851,0.0244393522018159,0.0398933877022101,3.6704031102863e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0307023750866736,0.00377182838670201,-0.0380951587246095,-0.0233095914487376,4.29762586551952e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,42181,-0.0352036778020887,0.00433110542385613,-0.0436926444328468,-0.0267147111713307,4.73553494679281e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,0.0766209090626775,0.00944224215159874,0.058114114445544,0.095127703679811,5.38643323680012e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.0279009956231489,0.00344070210398154,0.0211572194993451,0.0346447717469527,5.53325362944986e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),39775,0.158225031029271,0.019588361065403,0.119831843341081,0.196618218717461,7.28956748762162e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,0.0402836834565932,0.00500380337625705,0.0304762288391294,0.050091138074057,8.9157019140334e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,42249,0.0250472654737365,0.00312031790006405,0.0189314423896109,0.031163088557862,1.07870458869675e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0231059521830571,0.0028790381205164,0.017463037466845,0.0287488668992692,1.0933871650226e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0596060366263414,0.00742766369140136,0.0450478157911947,0.074164257461488,1.09998470129309e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,0.0349773692770911,0.00437162817060652,0.0264089780627023,0.0435457604914799,1.33476699834622e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,0.040571447973172,0.00507896804354155,0.0306166706078306,0.0505262253385134,1.47919154742918e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,-0.0310816517018631,0.0038917805542145,-0.0387095415881235,-0.0234537618156027,1.52622828127869e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,42145,0.0405330027433837,0.00508633285653573,0.0305637903445737,0.0505022151421938,1.72680853352688e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,41881,0.0485255726336063,0.00610751222303566,0.0365548486764564,0.0604962965907562,2.09377270257688e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,0.0173527307460049,0.00218418429384602,0.0130717295300667,0.0216337319619431,2.09871881477731e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,42016,0.0289255274153982,0.00365608135085737,0.0217596079677178,0.0360914468630787,2.7387327815969e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,39966,0.0272679102329087,0.00345409148928058,0.0204978909139188,0.0340379295518986,3.18547603846085e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,42262,0.0310957446420818,0.00394123519494141,0.0233709236599966,0.0388205656241669,3.25452800261915e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,0.0379345172241389,0.00482241845034955,0.0284825770614537,0.047386457386824,3.92667219707828e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,41976,0.0471379255896807,0.0059933450331188,0.0353909693247679,0.0588848818545936,3.97142105587088e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,0.0311758386149806,0.00396402123783281,0.0234063569888283,0.038945320241133,3.97883673017309e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,42310,0.026027385728741,0.00331704837951627,0.0195259709048891,0.0325288005525929,4.59169067640073e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,42216,0.0505689840777631,0.00645006242157966,0.037926861731467,0.0632111064240592,4.83595164397085e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,0.023196540502796,0.00296712516142106,0.0173809751864107,0.0290121058191812,5.84888046128724e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.0251608489764705,0.00321930462070655,0.0188510119198856,0.0314706860330553,5.96172449027541e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,0.055103335003618,0.0070635795405398,0.04125871910416,0.068947950903076,6.58571088062239e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,42069,0.0370112668443402,0.00475003090738955,0.0277012062658567,0.0463213274228237,7.08854470848957e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,0.0556447965540763,0.00714946266219917,0.0416318497361659,0.0696577433719867,7.58676646759039e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,0.0301539671005088,0.003904147829569,0.0225018373545535,0.037806096846464,1.21111924356647e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,0.0704130174766375,0.00913567674433843,0.0525070910577342,0.0883189438955408,1.3728929158864e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0442100406646021,0.00573804775577892,0.0329634670632754,0.0554566142659288,1.42365521627719e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,42249,0.0248539048588541,0.0032310335766987,0.0185210790485246,0.0311867306691835,1.54452220383432e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,39990,0.038666254641765,0.00504403265227128,0.0287799506433133,0.0485525586402167,1.92240266553823e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0945419653391424,0.0123357811443108,0.0703638342962932,0.118720096381992,1.94868417448735e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,0.0296660323370333,0.00387253297841085,0.0220758676993481,0.0372561969747186,1.97564930158807e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,42193,-0.0271225436255978,0.00354169737249244,-0.034064270475683,-0.0201808167755127,2.01476702084317e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0678933681534821,0.00887207003237322,0.0505041108900306,0.0852826254169336,2.10453824490559e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,42070,0.0245237664340103,0.00321610283395829,0.018220204879452,0.0308273279885686,2.59731117517435e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.0313595124538217,0.0041149863081939,0.0232941392897617,0.0394248856178818,2.68875533666181e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,42119,-0.0269208424842124,0.00353409077060388,-0.033847660394596,-0.0199940245738288,2.75845023004516e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,0.0232307195801324,0.00305928819756785,0.0172345147128994,0.0292269244473653,3.35696789726755e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,0.0232982333697818,0.00307058316124966,0.0172798903737325,0.0293165763658312,3.47162928510563e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,39979,0.0247749921559108,0.0032724339959103,0.0183610215239266,0.031188962787895,3.99548678847982e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0235353880868521,0.00311452151407201,0.017430925919271,0.0296398502544333,4.45970688481922e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0431283283573145,0.005713196616479,0.0319304629890157,0.0543261937256133,4.66987612006158e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0197412431332353,0.0026151433621836,0.0146155621433554,0.0248669241231151,4.67407885534509e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,41880,0.0294316751077373,0.00391059854305903,0.0217669019633416,0.037096448252133,5.56280225792722e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0577931459806351,0.00767898409113657,0.0427423371620074,0.0728439547992628,5.63283527954212e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,0.0199130109542947,0.00264876109226033,0.0147214392134644,0.0251045826951249,5.92208973026711e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,42103,-0.0504962998481153,0.00672218506426589,-0.0636717825740764,-0.0373208171221541,6.19377520651355e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,42231,0.0301771632912499,0.00402253295117301,0.0222929987069508,0.038061327875549,6.6721101343704e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,0.0273400331822069,0.00364844939719492,0.0201890723637049,0.034490994000709,7.12258805742559e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.038290308080032,0.00511091038640444,-0.0483076924373847,-0.0282729237226793,7.21022137380203e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,42119,0.0450869363247842,0.0060289105285818,0.0332702716887639,0.0569036009608046,7.98301351225363e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0190059069076002,0.00254312872604082,0.0140213746045602,0.0239904392106403,8.28967512602596e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,42020,0.0561798440385997,0.00753121381092489,0.0414186649691869,0.0709410231080125,9.21129446231576e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,39958,0.0530250972583989,0.00711488487760353,0.039079922898296,0.0669702716185018,9.80905224165321e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,0.070298760840673,0.00943640049324422,0.0518034158739143,0.0887941058074317,1.00329150870663e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.0363067224988832,0.00488532640024412,0.0267314827544047,0.0458819622433617,1.13716365687386e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,42296,0.0274462966272941,0.00370383625091891,0.0201867775754931,0.0347058156790952,1.33454646834745e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,0.0211835610611987,0.00286154094573725,0.0155749408075537,0.0267921813148437,1.42692551479584e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,42185,0.0334887070773977,0.00452980488751562,0.024610289497867,0.0423671246569283,1.51980513218164e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0359191441653472,0.00486670265158107,0.0263804069682483,0.0454578813624461,1.66819029531326e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.054513171925267,0.0073895464172051,0.040029660947545,0.068996682902989,1.71149089382407e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,0.0270257239010651,0.00366752190838539,0.0198373809606297,0.0342140668415005,1.81923169122579e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0229746783529537,0.0031231313499021,0.0168533409071456,0.0290960157987618,1.9990701218596e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0369279133838094,0.00502162234546749,0.0270855335866931,0.0467702931809257,2.06326006717303e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,0.0292140277818835,0.00397385085324156,0.02142528010953,0.0370027754542369,2.07097211858261e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,0.0748015531142805,0.0101993766435855,0.0548107748928529,0.0947923313357082,2.36203238881096e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,-0.0659130643528524,0.00899027211738586,-0.0835339977029287,-0.0482921310027762,2.40555456519711e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FN1,Fibronectin,39979,0.0214859667732493,0.00293084400572789,0.0157415125220227,0.027230421024476,2.43960249422278e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,-0.0788381422270576,0.0107705927821421,-0.0999485040800562,-0.057727780374059,2.62853255642993e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,0.022775549377253,0.00311441217093667,0.0166713015222172,0.0288797972322889,2.76051345733983e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,42016,0.0270616233032234,0.00370420823986091,0.019801375153096,0.0343218714533508,2.91519861068738e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.0269513709139132,0.00370900218391512,0.0196817266334395,0.0342210151943868,3.89212730062598e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.0221293343554856,0.00304746549341194,0.0161563019883982,0.028102366722573,4.03285920904957e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,0.0220932388778141,0.00304532354906013,0.0161244047216562,0.0280620730339719,4.23922743418535e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.0236878082739936,0.0032689914179269,0.0172805850948569,0.0300950314531303,4.56428210557015e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,0.0209395911364675,0.00289505505528432,0.0152652832281102,0.0266138990448248,4.98160054041922e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,39859,0.0238175460084591,0.00329379111521252,0.0173617154226425,0.0302733765942756,5.10371912910741e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,-0.0500291275884275,0.00695727180759503,-0.0636653803313137,-0.0363928748455412,6.77473973670179e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,39709,0.0398730891672325,0.00554378420407587,0.0290072721272438,0.0507389062072212,6.77593691221747e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.0430514054640269,0.00599279141078392,0.0313055342988905,0.0547972766291634,7.1374464298713e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,39990,0.020035504205859,0.00278949109921651,0.0145681016513947,0.0255029067603234,7.27184399975794e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,42016,0.020116904413717,0.00280284174695037,0.0146233345896943,0.0256104742377398,7.48252152227781e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,39733,0.0297203313534428,0.00414563121323052,0.021594894175511,0.0378457685313746,8.02904276846434e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,39966,0.0200034497594063,0.00279173061982723,0.014531657744545,0.0254752417742677,8.24487023896073e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNLY,Granulysin,42137,0.0414770512362185,0.00579419121324365,0.0301204364582609,0.0528336660141761,8.58394061861649e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.025546392110566,0.0035712794864681,0.0185466843170885,0.0325460999040434,8.90357291155483e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.0294136576013481,0.00411615437582078,0.0213459950247394,0.0374813201779568,9.3927687982246e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.0302806445854278,0.0042375229611046,0.0219750995816628,0.0385861895891928,9.41052475328755e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.0327980644056016,0.00459291014166619,0.0237959605279359,0.0418001682832673,9.73394722542111e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOST,Sclerostin,42129,0.0297222058761994,0.00416280560743941,0.0215631068856182,0.0378813048667806,9.81320932613293e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.0328296966084183,0.00460478531752887,0.0238043173860617,0.0418550758307748,1.05908224766858e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,0.0299499088756474,0.00420628194693261,0.0217055962596595,0.0381942214916353,1.13304312255367e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDK,Midkine,42129,0.0391470059321573,0.00550029156662351,0.0283664344615752,0.0499275774027393,1.15639943340887e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,39886,0.0218480509671805,0.00307348791479978,0.0158240146541729,0.0278720872801881,1.24344239170718e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,41961,0.0364161425136438,0.00513464337375927,0.0263522415010757,0.046480043526212,1.3859339756324e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,0.072529742668135,0.0102268121871118,0.0524851907813958,0.0925742945548742,1.38636239861489e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,42249,0.0173017222687073,0.00244354800894815,0.0125123681711689,0.0220910763662457,1.50578791741622e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.0262973530800719,0.0037152250956173,0.019015511892662,0.0335791942674818,1.53194330910784e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,42185,0.0314639050547729,0.00445910800001375,0.022724053374746,0.0402037567347999,1.79540573359276e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,39966,0.0363498665906703,0.00515196934643253,0.0262520066716625,0.046447726509678,1.8194316655866e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.0262217409915764,0.0037176052566035,0.0189352346886335,0.0335082472945192,1.83011468631386e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0238670364028701,0.00338625053818874,0.0172299853480202,0.0305040874577201,1.89991257190768e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,39736,0.0234708839868689,0.00333884038867386,0.0169267568250682,0.0300150111486697,2.1916283411712e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,0.0138521028281668,0.00197438724798788,0.00998230382211061,0.0177219018342231,2.41444641080703e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,39929,0.0228179936860097,0.00325501531721857,0.0164381636642613,0.0291978237077581,2.51677772182987e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,39934,0.0367637538281788,0.00526714223371896,0.0264401550500897,0.047087352606268,3.12039203243019e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,0.0322002079781604,0.00461485069067224,0.0231551006244429,0.041245315331878,3.14588340000452e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,0.0231906334034305,0.00333032386030096,0.0166631986372406,0.0297180681696203,3.47287522985771e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,0.0202050463608047,0.0029079009151416,0.0145055605671272,0.0259045321544823,3.86327281423048e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,0.0294270303065825,0.00423838795454156,0.021119789915681,0.037734270697484,4.0141792413222e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0546786654121663,0.00789497922470919,0.0392045061317362,0.0701528246925963,4.57015089237563e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,42080,-0.0308570393544512,0.00447502474660967,-0.0396280878578061,-0.0220859908510962,5.61096959680291e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWC2,Brorin,41973,0.0302450222780456,0.00439038560599843,0.0216398664902886,0.0388501780658025,5.87315288354808e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,39358,0.0179496800212319,0.00261289765896616,0.0128284006096582,0.0230709594328056,6.79173526808096e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,0.0533996821774554,0.00777565776063257,0.0381593929666155,0.0686399713882952,6.81803475139442e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,42166,0.0240703270864349,0.00350889022028119,0.0171929022546837,0.030947751918186,7.19397143252149e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,42184,0.021103991321669,0.00307695511652427,0.0150731592932814,0.0271348233500566,7.24827689877707e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,42145,0.0180118272488708,0.00263067570705225,0.0128557028630484,0.0231679516346932,7.8749377688662e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,0.0710829481571794,0.0103836257744383,0.0507310416392803,0.0914348546750784,8.00472309862753e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,41994,0.0201271501098111,0.00294115897230783,0.0143624785240877,0.0258918216955345,8.07707177065569e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,42205,-0.0488686665462508,0.00714744173331608,-0.0628776523435503,-0.0348596807489513,8.41855042264045e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,42145,-0.0500995693667531,0.00733429974373768,-0.064474796864479,-0.0357243418690273,8.80102153422037e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,42070,0.0204101289909008,0.00299024058991376,0.0145492574346699,0.0262710005471318,9.13175545360992e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,39979,0.0221619452728855,0.00325207429060133,0.0157878796633069,0.0285360108824641,9.92242213132089e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,39979,-0.0252167454526563,0.00370074670446201,-0.0324702089934018,-0.0179632819119107,9.97404896038585e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0251686542952221,0.00369683896632042,0.0179228499212341,0.0324144586692102,1.03045362666858e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.026198653632003,0.00384946361828063,0.018653704940173,0.0337436023238331,1.05655601024173e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0878447414178843,0.0129187377109127,0.0625240155044955,0.113165467331273,1.10038071219218e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,42123,0.0199577127356468,0.00293730623935148,0.0142005925065179,0.0257148329647757,1.13188127676498e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,0.0212135560760345,0.00312491898515846,0.0150887148651239,0.0273383972869451,1.18018187995909e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0187044091367416,0.00276290467625738,0.0132891159712772,0.0241197023022061,1.34300211236899e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,39925,0.0349359950556145,0.00516622100917841,0.0248102018776248,0.0450617882336042,1.42414176819633e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGMN,Legumain,42185,0.0262749074423178,0.00389474130139386,0.0186412144915858,0.0339086003930498,1.57855259280228e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,42119,0.0359519476207067,0.00533705003834476,0.025491329545551,0.0464125656958625,1.69047514193126e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0463391773151158,0.00688173212013678,0.0328509823596477,0.0598273722705839,1.73601633634342e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0144695882090209,0.00215206271608093,0.0102515452855023,0.0186876311325396,1.84437179045015e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0194083422471308,0.00290035815832066,0.0137236402568223,0.0250930442374393,2.29240798655065e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,0.0561157234100471,0.00838980179513762,0.0396717118915773,0.0725597349285168,2.34147087402386e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRN,Progranulin,42077,0.0180077892850572,0.00269866191477114,0.0127184119321057,0.0232971666380086,2.60670902182329e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,42137,0.027196405177504,0.00407765808631185,0.0192041953283328,0.0351886150266752,2.66434657758737e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,41900,0.0335428708273813,0.00503332841934701,0.0236775471254612,0.0434081945293015,2.76683790837938e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,0.0910051865291489,0.0136985536274905,0.0641560214192676,0.11785435163903,3.1816787103574e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,-0.0279296917226355,0.00420662219328091,-0.0361746712214661,-0.0196847122238049,3.29181521295741e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.0305448752932782,0.00461542987649163,0.0214986327353546,0.0395911178512018,3.77735663448038e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,-0.0388468331699345,0.00587010008310368,-0.0503522293328177,-0.0273414370070513,3.78690929659559e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0227381009719002,0.00343553896608463,0.0160044445983743,0.0294717573454261,3.79690155768157e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,39713,0.0205989341295821,0.00311932612431142,0.0144850549259317,0.0267128133332325,4.19459360865874e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0662889121526015,0.010043100293295,-0.0859733887274596,-0.0466044355777434,4.25212113248034e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0304913400133404,0.00462007932577423,0.0214359845348229,0.0395466954918578,4.27464489791019e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGN,Mimecan,42137,0.0306473385156575,0.00464576931306798,0.0215416306620443,0.0397530463692708,4.3565960781401e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,-0.0364886451241517,0.00553271886859069,-0.0473327741065894,-0.0256445161417139,4.43919713840027e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.0288704836050879,0.00437935108633625,0.0202869554758689,0.037454011734307,4.48573355650083e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,41959,0.0306644465436406,0.00465581467242482,0.0215390497856879,0.0397898433015932,4.67897538528339e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,0.053369414135167,0.00812385180364466,0.0374466646000235,0.0692921636703106,5.23864367092114e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0231197360446661,0.00352009538159979,0.0162203490967305,0.0300191229926017,5.28925473258717e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,42262,0.0197936361375477,0.00301940590579725,0.0138756005621851,0.0257116717129103,5.74571657314516e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,39657,0.0672434551292055,0.0102623835016701,0.0471291834659321,0.0873577267924789,5.9128075914044e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,42070,0.0526731193470792,0.00806883037746262,0.0368582118072524,0.0684880268869059,6.90532235195922e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.031852819122393,0.00488241845751693,0.0222832789456598,0.0414223592991261,7.09122602507783e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,0.0430310429915064,0.00659647665747518,0.0301019487428551,0.0559601372401578,7.16895587036999e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,41654,0.0220332241920558,0.00337949070965906,0.015409422401124,0.0286570259829875,7.30464258195006e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAX,Protein max,41839,0.0743991545380743,0.0114232569132972,0.0520095709880117,0.0967887380881369,7.63487859672927e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0275901145421361,0.00423817104469902,0.0192832992945261,0.0358969297897462,7.84506994333263e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,39736,0.0214240049181548,0.00329328339681719,0.0149691694603931,0.0278788403759165,8.08290125638735e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,39911,0.0452108206423201,0.00695722540154166,0.0315746588552985,0.0588469824293418,8.45909824093482e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFI,Complement factor I,39979,0.0135716753793933,0.00208955159997984,0.00947615424343284,0.0176671965153538,8.64837698416002e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,41992,0.0224568261891058,0.00346908009090996,0.0156574292109222,0.0292562231672893,9.91458350947175e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0395228981183601,0.00612894109458324,0.027510173572977,0.0515356226637433,1.1763328744586e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,42310,0.0167714539441508,0.00260598600519247,0.0116637213739736,0.0218791865143281,1.26957354340001e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,0.0185154855520968,0.0028802531732779,0.0128701893324721,0.0241607817717215,1.3408718485367e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,42296,0.0293900949787258,0.00457909223878635,0.0204150741907045,0.038365115766747,1.42320712490457e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,39930,0.0453402027972871,0.00706813798384097,0.0314866523489588,0.0591937532456154,1.46691962712332e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,39970,0.0245135491544157,0.00382325138723069,0.0170199764354435,0.0320071218733878,1.49605444591028e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,0.0422713623208723,0.00659610878469066,0.0293429891028786,0.055199735538866,1.52741347583552e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0424254761447454,0.00662449412740132,0.0294414676550388,0.055409484634452,1.56989665449091e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,39954,0.0244625654615958,0.0038238283764481,0.0169678618437575,0.031957269079434,1.64258738908894e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,42119,0.0453725439199356,0.00711037695943225,0.0314362050794484,0.0593088827604228,1.81467504429509e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,39736,0.0748148128743356,0.0117278914067047,0.0518281457171944,0.0978014800314767,1.8504972100743e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,0.0241244458929307,0.00378277561142556,0.0167102056945366,0.0315386860913248,1.86021940975355e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.036404917408733,0.005720263817456,0.0251932003265193,0.0476166344909468,2.0277500120765e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,42119,0.0405216482380924,0.00637081036029988,0.0280348599319046,0.0530084365442801,2.07548774123718e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,42107,0.0195379563715741,0.00307519597829962,0.0135105722541069,0.0255653404890414,2.17360250448866e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,0.022488734031164,0.0035419113659059,0.0155465877539885,0.0294308803083396,2.23362280843099e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.0202182003761897,0.00318738930968003,0.0139709173292169,0.0264654834231626,2.32260309444074e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,42189,0.0244995727863443,0.00386714124602558,0.0169199759441342,0.0320791696285545,2.44317506402563e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,0.0213387706013033,0.00336904172864279,0.0147354488131635,0.0279420923894432,2.46744328043796e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,42107,0.0621390158298884,0.00981775811898191,0.0428962099166838,0.0813818217430929,2.54144997083349e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0357677494741381,0.00565352654973717,0.0246868374366532,0.046848661511623,2.60003999000346e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,0.0215166892822562,0.00340596958287032,0.0148409888998303,0.028192389664682,2.74414659580107e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.0841620369680715,0.013332915261438,0.058029523055653,0.11029455088049,2.83672554853555e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,39930,-0.051690887795881,0.00818918154532811,-0.0677416836247241,-0.0356400919670379,2.85569504284477e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALB2,Calretinin,41839,0.0199607360396834,0.00316671511088144,0.0137539744223558,0.0261674976570111,3.00629948813156e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.0713867425730578,0.0113309859705387,0.049178010070802,0.0935954750753136,3.066484081972e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.0838680040084653,0.0133269401303464,0.0577472013529863,0.109988806663944,3.20747442557923e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.0148913830299299,0.00236712384733712,0.0102518202891491,0.0195309457707106,3.27190886145032e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_E,,42119,0.0198033436357653,0.00315075725396653,0.0136278594179909,0.0259788278535397,3.37346307325423e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.0646887801430136,0.0103007898850147,0.0444992319683848,0.0848783283176425,3.48947156458499e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,0.0199213201742149,0.00317872296763784,0.0136910231576447,0.026151617190785,3.81569338828167e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,0.0204370937637396,0.00326426113144211,0.014039141946113,0.0268350455813661,3.94568159723668e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.0358701875711479,0.00574300534217806,0.0246138971004789,0.0471264780418169,4.34243582386977e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,42070,0.0201679836024238,0.00323119339592774,0.0138348445464054,0.0265011226584422,4.459567187663e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,42310,0.0131937913766725,0.00211448156625105,0.00904940750682049,0.0173381752465246,4.51224605050671e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,42138,0.0274232299388426,0.00439590467756473,0.0188072567708157,0.0360392031068695,4.5534952773349e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C5,Complement C5,39979,0.0100770081689396,0.00161689865693352,0.00690788680134985,0.0132461295365293,4.75872275512893e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.0263224854844099,0.00422566896609851,0.0180401743108569,0.034604796657963,4.82807108280904e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,39959,0.0150618972405609,0.00241919496254209,0.0103202751139784,0.0198035193671434,4.95393263893507e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,0.0231940844772413,0.0037295531894574,0.0158841602259048,0.0305040087285779,5.15045210456693e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,0.0666050489532829,0.0107118558045979,0.045609811576271,0.0876002863302948,5.21604350051349e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,41900,0.033293318969676,0.00535742931055203,0.022792757520994,0.043793880418358,5.30521510886763e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0368283626886692,0.00593499292681354,0.0251957765521147,0.0484609488252237,5.61683862737226e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,42296,0.0281527477414982,0.0045415710166806,0.0192512685488042,0.0370542269341922,5.84902997814194e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.0647074114197698,0.0104384301502979,0.0442480883251859,0.0851667345143537,5.88670552559287e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.0157977638330177,0.00256571284656029,0.0107689666537596,0.0208265610122759,7.61050566339155e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,42137,0.0804685374567769,0.0130902474593169,0.0548116524365159,0.106125422477038,8.10711983786254e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,0.0234960898754103,0.00382272309282911,0.0160035526134653,0.0309886271373554,8.14555317055151e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.0158546361522933,0.00258433898800368,0.010789331735806,0.0209199405687805,8.76289165331387e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0218359125845713,0.00356153799076006,0.0148552981226815,0.028816527046461,9.02447717778287e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,39657,0.0288064455437616,0.00470638092417305,0.0195819389323824,0.0380309521551408,9.63102769339798e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,0.0556029137949111,0.0091129723040491,0.0377414880789749,0.0734643395108473,1.07949358301558e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,0.0310125309201355,0.00508756599758134,0.0210409015648761,0.0409841602753949,1.11951522200161e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",39979,0.0109053443521953,0.00179314038480799,0.00739078919797168,0.014419899506419,1.22731070843813e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,42249,0.0183245304655372,0.00301417144085498,0.0124167544414615,0.024232306489613,1.23804148156366e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0584532571721878,0.00961382082224284,0.0396101683605918,0.0772963459837838,1.2402305651494e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,41825,0.0367461863832534,0.00605770891011398,0.02487307691943,0.0486192958470768,1.34696275646068e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,42262,0.0721430423995783,0.0119113451850288,0.0487968058369218,0.0954892789622348,1.42618713669644e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0130873512468703,0.00216261948332364,0.00884861705955594,0.0173260854341846,1.47933137096306e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,0.0281005573283224,0.00464429430539881,0.0189977404897408,0.0372033741669041,1.48163149591244e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.0179665900947487,0.00297158856076512,0.0121422765156491,0.0237909036738483,1.52263383170865e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,42261,0.0224922836259674,0.00372087213862372,0.0151993742342649,0.0297851930176699,1.53400769541873e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,0.0160105826101902,0.00265016634854968,0.0108162565670328,0.0212049086533476,1.56791081441164e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,39930,0.0752883405271954,0.0124614005469123,0.0508639954552472,0.0997126855991435,1.57265715043132e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,0.0169524650365221,0.00281059660675573,0.0114436956872808,0.0224612343857633,1.67510723672766e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.056331400828776,0.00935050667067945,0.0380044077542443,0.0746583939033077,1.74138814257754e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,42070,0.0275379984009388,0.00457456812380685,0.0185718448782774,0.0365041519236003,1.79168058514756e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,42232,0.0270692873330114,0.00450801735155088,0.0182335733239717,0.0359050013420511,1.96560574514831e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0533546376062747,0.00888657927820292,0.035936942220997,0.0707723329915524,1.97500736757359e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,0.0474450095608218,0.00790590352538252,0.031949438651072,0.0629405804705715,2.00793461709321e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,0.0158937673377058,0.00264812956216481,0.0107034333958628,0.0210841012795489,2.0111422699152e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,0.0356455301418149,0.00594503674242866,0.0239932581266548,0.0472978021569751,2.08799613961096e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,39645,0.0179447063024194,0.00299313180928263,0.0120781679562255,0.0238112446486134,2.09467438594887e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0335366038525918,0.00560082358775543,0.0225589896205912,0.0445142180845925,2.18074347459607e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,39850,0.0635395486333435,0.0106159014343228,0.0427323818220709,0.0843467154446161,2.22551069880998e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0316886606124696,0.00530620772545676,0.0212884934705744,0.0420888277543649,2.4023519571568e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,0.0205745920458552,0.00344595997023362,0.0138205105041973,0.0273286735875131,2.42163559681713e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,39958,0.0634563398563117,0.0106397153009827,0.0426024978663855,0.0843101818462378,2.5330744774305e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,42181,0.0344688657006391,0.00578406614997107,0.0231320960466958,0.0458056353545824,2.59627772641007e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,39657,0.0268496634648852,0.00450504516388755,0.0180197749436656,0.0356795519861048,2.60076435759789e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,39958,-0.055198558104514,0.00926582802120976,-0.0733595810260851,-0.0370375351829429,2.64171477891242e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0202416472111607,0.00340000341666844,0.0135776405144906,0.0269056539078309,2.6912317563624e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,39486,0.053160452578351,0.00895167072132509,0.0356151779645539,0.0707057271921482,2.9623840121469e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,0.0323328350401197,0.00544595135868905,0.0216587703770891,0.0430068997031502,2.97480371563524e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLPS,Colipase,42115,0.0469794496360729,0.00792591454017564,0.0314446571373286,0.0625142421348171,3.15417755635998e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0274858301303785,0.0046388033513147,0.0183937755618017,0.0365778846989553,3.19453465342787e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.0174830488252187,0.00295288560540135,0.011695393038632,0.0232707046118053,3.28308113190639e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,0.0804460781318038,0.0136084114294575,0.0537735917300671,0.107118564533541,3.48956069243364e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.0124145558849662,0.00210047381352066,0.00829762721046574,0.0165314845594667,3.496142644908e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,42249,0.0363803583316497,0.00615542620530263,0.0243157229692566,0.0484449936940429,3.4965107985898e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RETN,Resistin,42105,0.0272365396866736,0.0046099174197049,0.018201101544052,0.0362719778292952,3.5408896071377e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0226378856628272,0.00383175632463019,-0.0301481280591024,-0.0151276432665521,3.54687425326408e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,42070,0.0356844151459723,0.00604466180212519,0.0238368780138069,0.0475319522781377,3.64523663089951e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,42296,0.0305673727429199,0.0052034376914761,0.0203686348676267,0.0407661106182131,4.34077160468136e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,0.0556477983791383,0.00947799136149842,0.0370709353106014,0.0742246614476752,4.44918802627014e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,42070,0.0469717917979654,0.00802292592354623,0.0312468569878148,0.062696726608116,4.89014676719309e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.0139654080117782,0.002388504971351,0.00928393826793024,0.0186468777556262,5.12299299037427e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.0342293769234318,0.00586418060479499,0.0227355829380337,0.04572317090883,5.45975490515186e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,0.0275372047281859,0.00472439157660294,0.0182773972380441,0.0367970122183277,5.71284437816542e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0190112449901249,0.00326545470540432,0.0126109537675324,0.0254115362127173,5.94825946512039e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,0.0375070679175039,0.00645463075818744,0.0248559916314565,0.0501581442035512,6.35317456520716e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.0325196451096383,0.00559835017386786,0.0215468787688573,0.0434924114504193,6.43278690529206e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.0178260072156759,0.0030689635772593,0.0118108386042477,0.0238411758271042,6.44596132259598e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,41913,-0.027627988559119,0.00477000501989701,-0.0369771983981171,-0.0182787787201209,7.11139783385856e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0184477844614705,0.00318562842567448,0.0122039527471485,0.0246916161757925,7.15661138952836e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0358782745032688,0.00619770805854228,0.0237307667085259,0.0480257822980116,7.24086692990768e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,42230,0.016963787533975,0.00293202418430978,0.0112170201327278,0.0227105549352222,7.38010629972032e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,39937,0.0201162810455019,0.00347846435708535,0.0132984909056146,0.0269340711853892,7.52769579096906e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,0.0530973247718941,0.00919474836941376,0.0350756179678431,0.071119031575945,7.87907813784213e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0211344126228679,0.0036600321027372,0.013960749701503,0.0283080755442328,7.89273172960846e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,0.0317937934730086,0.00551212466736927,0.0209900291249648,0.0425975578210523,8.19801366605694e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,39959,0.00898368427269635,0.0015574990156247,0.00593098620207194,0.0120363823433208,8.23015754258746e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,42310,0.00985648921251477,0.00171552843547987,0.00649405347897423,0.0132189249460553,9.36228008617496e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,41900,0.0522369045180107,0.00909636001162403,0.0344080388952276,0.0700657701407938,9.52634255498622e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.0502557169166611,0.00875213464177793,0.0331015330187764,0.0674099008145459,9.54940011555461e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.032699842248214,0.00569925789717078,0.0215292967697593,0.0438703877266687,9.81058695849221e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,42296,-0.0179569192611768,0.00313030107696379,-0.0240923093720259,-0.0118215291503278,9.87061788863056e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,42085,0.0479005720827047,0.00836595083038361,0.0315033084551528,0.0642978357102566,1.05229915142637e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,41997,0.0492936146827051,0.00861067778802084,0.0324166862181842,0.0661705431472259,1.0583362941654e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,39575,0.0360161608302891,0.00630446724157032,0.0236594050368113,0.0483729166237669,1.14023133794916e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0191689478073704,0.00335780938493793,0.012587641412892,0.0257502542018487,1.16188113624256e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,42181,0.0262074802673993,0.0045943958557769,0.0172024643900766,0.0352124961447221,1.19309030529189e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,42116,0.0248087343937695,0.00435167516156606,0.0162794510771,0.033338017710439,1.21624153761679e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,41843,0.0329689208348788,0.00578351495386024,0.0216332315253127,0.0443046101444449,1.22006098361747e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0341452930160444,0.00599287635624662,0.022399255357801,0.0458913306742878,1.2400240716001e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,0.0469282112906549,0.00827401280519808,0.0307111461924667,0.0631452763888431,1.4428193883116e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,0.0290711679691709,0.00512604565055343,0.0190241184940862,0.0391182174442556,1.44653266299326e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,0.0140031117900876,0.00247254528709407,0.00915692302738319,0.0188493005527919,1.51974008580614e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,39929,0.0549042110512592,0.00969704514661697,0.03589800256389,0.0739104195386285,1.53300114059312e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,0.07306486083955,0.0129065822451884,0.0477679596389808,0.0983617620401193,1.5416685949805e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,42070,0.0467075924106375,0.00827010577246075,0.0304981850966144,0.0629169997246606,1.65836881464668e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0380908296297598,0.00675226927972865,0.0248563818414916,0.0513252774180279,1.73035994080405e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,0.0217146157117151,0.003850803450516,0.0141670409487038,0.0292621904747265,1.74434881819537e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,0.0562329133705508,0.00998907196439838,0.0366543323203299,0.0758114944207716,1.84448733749898e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.0657218716991962,0.0116815316226441,0.0428260697188137,0.0886176736795787,1.8887048221752e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,0.0161267295791291,0.00287322258488024,0.0104952133127639,0.0217582458454944,2.0304297790694e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,42224,0.0368431071257359,0.00656645996856822,0.0239728455873422,0.0497133686641296,2.05315070732873e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,0.0291024552539386,0.00518789024374221,0.0189341903762039,0.0392707201316733,2.0663407341352e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,42070,0.0400530095347116,0.00714936603664477,0.0260402521028878,0.0540657669665353,2.15650210551059e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0159637902229539,0.00285241224365078,0.0103730622253983,0.0215545182205094,2.22810704459484e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,42145,0.0177396949304631,0.00317931849926419,0.0115082306719053,0.0239711591890209,2.45531398776368e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,0.0139810912217893,0.00250605168554705,0.0090692299181171,0.0188929525254616,2.46587401262984e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,0.0503983125564581,0.00905619763402566,0.0326481651937678,0.0681484599191483,2.68117868450097e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,39736,0.0272812809746381,0.00490527586553627,0.017666940278187,0.0368956216710892,2.73447948035427e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,41900,0.0232811228116264,0.00419534023180616,0.0150582559572864,0.0315039896659665,2.9233086082816e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0138629870562073,0.00249812025152045,0.00896667136322724,0.0187593027491874,2.93128691546578e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,39736,0.0350280429488043,0.00631294054334028,0.0226546794838574,0.0474014064137512,2.94532687654833e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.041886728133041,0.00756109511164114,0.0270669817142243,0.0567064745518576,3.09642002754722e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,42224,0.0413877651657768,0.00747318111404206,0.0267403301822544,0.0560352001492992,3.11303595617245e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0202837764570053,0.00366471415663841,0.013100936709994,0.0274666162040166,3.17230348397895e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.0417251585156213,0.00754215429418319,0.0269425360990223,0.0565077809322204,3.23148414176691e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GH1,Somatotropin,42129,0.105689964469848,0.0191082162139002,0.0682378606906033,0.143142068249092,3.24083979898184e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,42096,0.0260564136737798,0.00471257690245997,0.0168197629449582,0.0352930644026013,3.27814692653568e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,0.029481183881479,0.00533776401834517,0.0190191664055224,0.0399432013574355,3.40343620534015e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,39979,0.0111675680329538,0.00202413871105102,0.00720025615929376,0.0151348799066137,3.51987941545112e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,0.0409046392110298,0.00742061152517671,0.0263602406216834,0.0554490378003761,3.62064532983266e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,42119,0.0466261635232291,0.00846527139011752,0.0300342315985988,0.0632180954478595,3.69699169356655e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,42137,0.0145271770981645,0.00263839291767592,0.00935592697951967,0.0196984272168093,3.73616132696897e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,0.0135486623479069,0.00246117467254459,0.00872475998971953,0.0183725647060943,3.75892864005929e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,0.0462303543731438,0.00840675396347319,0.0297531166047364,0.0627075921415512,3.89808285607444e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,42119,0.0529757327381458,0.00964421350348464,0.0340730742713159,0.0718783912049756,4.02288262947687e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,0.0339205516119038,0.00617732186499778,0.0218130007565082,0.0460281024672995,4.064814268181e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0359437348045957,0.00655344859944021,0.0230989755496929,0.0487884940594985,4.23340378944067e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0240455041842421,0.0043849337484336,0.0154510340373123,0.032639974331172,4.24164902421895e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,0.043020251249461,0.00785241695020061,0.0276295140270678,0.0584109884718542,4.36500137777185e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0223011215928026,0.00407145624134297,0.0143210673597704,0.0302811758258349,4.40761732980953e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0191393357901971,0.00349927513282971,0.0122807565298509,0.0259979150505433,4.61092096760115e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,42070,0.0325974157559017,0.00596513294825373,0.0209057551773244,0.044289076334479,4.72042436166048e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,0.0346639776487639,0.00635563750914164,0.0222069281308463,0.0471210271666815,5.00990030154669e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.0284259817795612,0.00522996272615604,0.0181752548362953,0.038676708722827,5.56746380605431e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0566297492096068,0.0104399937552169,0.0361673614493817,0.0770921369698319,5.91894069263353e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,39929,0.016735737188128,0.00308815457265608,0.010682954225722,0.0227885201505339,6.10473658657674e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0252084912547887,0.00465178941375513,0.0160909840038287,0.0343259985057488,6.11292917847682e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,39736,0.0213525659067196,0.00394267736939656,0.0136249182627023,0.0290802135507369,6.23002087482634e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,42166,0.0332247935246915,0.00615055065447652,0.0211697142419175,0.0452798728074655,6.70429722252104e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,0.0195643245853808,0.0036247544592522,0.0124598058452465,0.0266688433255151,6.87553786708591e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,0.0264629925367474,0.0049044721273896,0.0168502271670637,0.036075757906431,6.93976281212445e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.0196716310886787,0.00364731714862082,-0.0268203726999756,-0.0125228894773819,7.02773847066358e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,0.0164235217727389,0.00305705114038039,0.0104317015375933,0.0224153420078845,7.90163544634838e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,39966,0.029655520314248,0.0055205069268363,0.0188353267376489,0.0404757138908472,7.94556124048391e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,0.0294084269242617,0.00548351444976828,0.0186607386027159,0.0401561152458075,8.31568002173019e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,41992,0.0290074652745103,0.0054153241657729,0.0183934299095954,0.0396215006394252,8.6227914061627e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,0.0168178641496993,0.0031435260069893,0.0106565531760003,0.0229791751233983,8.93744100802228e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0216321669631921,0.00404469387839257,0.0137045669615427,0.0295597669648415,9.02609262527737e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0261943694152935,0.00489884057498137,0.01659264188833,0.035796096942257,9.08719969853858e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.0160000264582418,0.00299266327699833,0.010134406435325,0.0218656464811585,9.11639239935346e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,0.0240713339355845,0.00451021830903974,0.0152313060498666,0.0329113618213024,9.59735781653279e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,39875,0.0419056635600358,0.00785294817972275,0.0265138851277792,0.0572974419922924,9.67023405075579e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,41967,0.0603582570298433,0.0113172495013335,0.0381764480072297,0.0825400660524569,9.80162519119595e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.0109982653512732,0.0020656133394392,0.00694966320597236,0.015046867496574,1.02863123805314e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,0.0207940645853163,0.0039096254321589,0.0131311987382849,0.0284569304323478,1.06185573256448e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0349315999677296,0.00656927856506939,0.0220558139801936,0.0478073859552657,1.06931745897155e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.0243615593150827,0.00458350188154566,0.0153778956272532,0.0333452230029122,1.08317991863024e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0175216919327426,0.00329649077966559,0.011060570004598,0.0239828138608871,1.08530196246743e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,42181,0.0192166450108088,0.00361702752821029,0.0121272710555166,0.0263060189661009,1.09641564054388e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0146465914773892,0.00275672545393347,0.00924340958767963,0.0200497733670988,1.09909988163133e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.0334938940855908,0.00630834107900128,0.0211295455707483,0.0458582426004333,1.1170305535251e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.0507515471253756,0.00956325730267575,0.0320075628121311,0.06949553143862,1.1359040367425e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,42239,0.0345198513968752,0.00651188780122737,0.0217565513064696,0.0472831514872809,1.16932700384258e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,42070,0.0469813638267192,0.00886913210838986,0.0295978648942751,0.0643648627591633,1.19457938059765e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,41839,0.0272219960740342,0.00514583933005353,0.0171361509871293,0.0373078411609391,1.24198680264867e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,39929,0.0530623535929367,0.0100381461366679,0.0333875871650676,0.0727371200208058,1.27294190805333e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0219403579164901,0.00415272242835536,0.0138010219569135,0.0300796938760666,1.28797232337002e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0152589994593353,0.00288818140047792,0.00959816391439859,0.020919835004272,1.29256257093724e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,0.0407916005705148,0.00772479360628413,0.0256510051021979,0.0559321960388317,1.31142128571427e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0301649226390237,0.00571487034336215,0.0189637767660339,0.0413660685120135,1.32396604435904e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0278125082824478,0.00527594383208867,0.017471658371554,0.0381533581933416,1.3774770061654e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,42137,0.0286750802299301,0.00544059814821687,0.018011507859425,0.0393386526004351,1.38085884603444e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,42249,0.0199705850968834,0.00378930037279754,0.0125435563662002,0.0273976138275665,1.38307868231905e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,42016,0.0206877647381391,0.0039259107452241,0.0129929796774998,0.0283825497987783,1.38880072816638e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0268094442000187,0.00508863608741288,0.0168357174686895,0.036783170931348,1.39699630805703e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,42144,0.0135523984092737,0.00257274061260429,0.00850982680856927,0.0185949700099781,1.40267872893256e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPL,Periplakin,39657,0.0183134625988143,0.00347722005553983,0.0114981112899562,0.0251288139076723,1.41508657604207e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,41984,0.0198889835429932,0.00377751073436711,0.0124850625036337,0.0272929045823528,1.4227863558551e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,42145,0.0432136194158121,0.00820763036625864,0.0271266638979452,0.0593005749336791,1.42290446357261e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,42027,0.0262111489847899,0.00497872784366927,0.0164528424111981,0.0359694555583817,1.4263945163407e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,0.0524932970334623,0.00997280173844774,0.0329466056261048,0.0720399884408199,1.43420897115263e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.0178241964127052,0.00338985818282661,0.0111800743743651,0.0244683184510454,1.47810088341943e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,0.0162375124183593,0.0030917889236769,0.0101776061279526,0.0222974187087661,1.52904530216694e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0212458588295822,0.00405245204735491,0.0133030528167665,0.0291886648423978,1.60650138456196e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,0.0143933504598289,0.0027543901432987,0.00899474577896348,0.0197919551406944,1.76663672725526e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,39958,0.0300188841809126,0.00574524466042172,0.018758204646486,0.0412795637153392,1.77243902894669e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.0103938230362093,0.00199319587922422,0.00648715911292988,0.0143004869594888,1.87400074456968e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,42088,0.0405702316043357,0.00778868232832212,0.0253044142408243,0.055836048967847,1.92791994508977e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,42217,0.0563073229674932,0.0108289374187406,0.0350826056267617,0.0775320403082247,2.0249193271987e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0245618846172195,0.00472391769582204,0.0153030059334083,0.0338207633010307,2.0281463924179e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,0.0270679593581557,0.00520861214325523,0.0168590795573754,0.0372768391589359,2.05733090195425e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,0.0291590798892118,0.0056116036170244,0.018160336799844,0.0401578229785797,2.06412519958666e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.0179810246658556,0.00347327568412845,0.0111734043249639,0.0247886450067474,2.28725944305016e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0272369736883597,0.00527045031843316,0.0169068910642307,0.0375670563124887,2.40920410919954e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,42070,0.0172728691505843,0.00334609247495905,0.0107145278996646,0.0238312104015041,2.47669039139485e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.0497562281503839,0.00964774647492856,0.0308466450595239,0.0686658112412439,2.54768581435636e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,0.0482069120180205,0.00934934480366601,0.0298821962028351,0.0665316278332059,2.56394554748858e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,0.0309648779206861,0.00600569628294957,0.019193713206105,0.0427360426352673,2.56784697655918e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.020090632463159,0.00390004005050184,0.0124465539641754,0.0277347109621426,2.63021154970099e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,42119,0.0306232946358581,0.00594608082303027,0.0189689762227188,0.0422776130489974,2.63916435742963e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,0.0232671663332571,0.00451850659534431,0.0144108934063823,0.0321234392601319,2.65325391593051e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,41839,0.0340306887231135,0.00660923526987561,0.0210765875941573,0.0469847898520697,2.65691463954977e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.0399789482848962,0.0077795455513413,0.0247310390042673,0.0552268575655251,2.80909978594654e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.0191461919776641,0.00372755589909414,0.0118401824154396,0.0264522015398886,2.84018357429992e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLC,Galectin-10,42119,0.0370783090695041,0.0072269361801622,0.0229135141563862,0.051243103982622,2.92865408364452e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,0.01889100173662,0.00368818479702006,0.0116621595344607,0.0261198439387793,3.07216004404096e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,42185,0.0210363873237639,0.00410830212885092,0.0129841151512161,0.0290886594963118,3.08963697220648e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0202789829406069,0.0039628470397537,0.0125118027426896,0.0280461631385242,3.15145303713243e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPTC,Opticin,42070,0.0249040822243893,0.00487702934026325,0.0153451047174733,0.0344630597313053,3.32828581567123e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.030818399359,0.00603638028317819,0.0189870940039708,0.0426497047140293,3.35436990991498e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,41843,0.0207538559797352,0.00406685396262223,0.0127828222129956,0.0287248897464748,3.38632605692232e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0361637321478576,0.00709429346184109,0.0222589169626491,0.0500685473330662,3.4860853805234e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,39930,0.043166766443891,0.00847721779099198,0.0265514195735467,0.0597821133142353,3.59825332443916e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.051872173346704,0.0101907325015489,0.0318983376436683,0.0718460090497398,3.62657230315643e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.0466919173450068,0.00917735772095025,0.0287042962119443,0.0646795384780693,3.68331678261784e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0230107013245091,0.00452671845974393,0.014138333143411,0.0318830695056072,3.75956629987108e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,41839,0.0248729293438117,0.00489353430376707,0.0152816021084282,0.0344642565791951,3.7695443539443e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,0.017885786241284,0.00351937681333427,0.0109878076871489,0.0247837647954192,3.78335128754892e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,39948,0.0241383976131379,0.00476134929340548,0.0148061529980631,0.0334706422282126,4.04821833640305e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,42299,0.0242361034221838,0.00478883581780611,0.0148499852192838,0.0336222216250837,4.22558834025997e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,0.0358679748883731,0.00708927611922704,0.0219729936946881,0.0497629560820581,4.25930045910969e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,0.0271152560775028,0.00536477689535749,0.0166002933626021,0.0376302187924035,4.37582004363569e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0176698783778632,0.00349760323503958,0.0108145760371856,0.0245251807185407,4.42839667599126e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,42163,-0.0460898071830641,0.00913165319450991,-0.0639878474443035,-0.0281917669218247,4.54002757242563e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.0650844384497027,0.0129223475338143,0.0397566372834266,0.0904122396159788,4.80002153493533e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,42144,0.0179914176512002,0.00357501511281415,0.0109843880300845,0.0249984472723159,4.90224065726251e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.0490497024149666,0.00974823683773649,0.0299431582130031,0.0681562466169301,4.93738513837725e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,39822,0.0170539454216951,0.00338995566001807,0.0104096323280597,0.0236982585153305,4.96182199542124e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,39876,0.0256317375235637,0.00509712230463688,0.0156413778064754,0.035622097240652,5.01492259514595e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,42134,0.0211042767091579,0.00420274275656422,0.012866900906292,0.0293416525120238,5.19089325194365e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POSTN,Periostin,39966,0.0204547179473708,0.0040752443826765,0.0124672389573249,0.0284421969374167,5.26559549104091e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,0.00892999913388139,0.00177992522695218,0.00544134568905512,0.0124186525787077,5.32593142679805e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,41913,0.015626176690401,0.00313052206466245,0.00949035344366259,0.0217619999371394,6.06520139755097e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,42119,0.0236544684127484,0.00474867556293947,0.0143470643093871,0.0329618725161098,6.39461644955304e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,0.0326952236981675,0.00656691591154139,0.0198240685115464,0.0455663788847886,6.47814284983389e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0122427896764703,0.00246000133234041,0.00742118706508308,0.0170643922878575,6.545717190922e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.0203646870957631,0.00409382774244018,0.0123407847205804,0.0283885894709459,6.62237697633174e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.0466307543704185,0.00937575203093781,0.0282542803897804,0.0650072283510566,6.67191737634449e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0183038302567288,0.00368213242028682,0.0110868507129666,0.025520809800491,6.74300324501992e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0375075431775038,0.00754631252867899,0.022716770621293,0.0522983157337146,6.76552419534977e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRELP,Prolargin,42123,0.0124944218798536,0.00251389642957938,0.00756718487787805,0.0174216588818292,6.77228401818801e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.0304773759660876,0.00615072176338981,0.0184219613098436,0.0425327906223316,7.31810949105249e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,0.0600086878043517,0.0121126104862898,0.0362679712512237,0.0837494043574797,7.34956524913568e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,0.0304046021832746,0.00614121562998472,0.0183678195485046,0.0424413848180447,7.49339962089152e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,42123,-0.023789467812727,0.00480564507313498,-0.0332085321560716,-0.0143704034693824,7.49855559633689e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,42286,0.0161022312302302,0.00325290956444439,0.0097265284839192,0.0224779339765412,7.50580451642918e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,0.019772315669959,0.00399686597993037,0.0119384583492955,0.0276061729906226,7.63088239788346e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.0142861517569974,0.00288878650111104,0.00862413021481981,0.0199481732991751,7.6910654840149e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0335515434673942,0.0067857016768118,0.0202515681808431,0.0468515187539453,7.74511552296078e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.0148609454866701,0.00300598991604565,0.00896920525122058,0.0207526857221195,7.75333501552111e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0285902279306518,0.00578400658577596,0.0172535750225309,0.0399268808387727,7.80384540497234e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.0523963580656909,0.0106119818909846,0.0315968735593612,0.0731958425720207,8.02672474501741e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.0776453489676481,0.0157375322171324,0.0467997858220685,0.108490912113228,8.18041580341705e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.0144075368104694,0.00292230502949069,0.00867981895266766,0.0201352546682711,8.31171935034744e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,42216,0.0310500878057168,0.0062983690911585,0.0187052843870461,0.0433948912243874,8.32571567030121e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,0.0209951876403362,0.00426276009880399,0.0126401778466804,0.029350197433992,8.5251404127741e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,42119,0.0252955112819152,0.00513936265569084,0.0152223604767611,0.0353686620870692,8.67114066000507e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,0.025516795742963,0.00518694176220683,0.0153503898890376,0.0356832015968884,8.80548672497893e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0147618797466627,0.00300660505424093,0.00886893384035052,0.020654825652975,9.22124069044822e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.031514671146782,0.00641906574775396,0.0189333022811842,0.0440960400123798,9.25846996922585e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.0423766577434471,0.00863419746069903,-0.0592996847664172,-0.025453630720477,9.30858270978245e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,39575,0.0369372582579474,0.00753122006750243,0.0221760669256426,0.0516984495902522,9.49838396797196e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,39934,-0.0273592063883959,0.00558251498089938,-0.0383009357509587,-0.0164174770258331,9.67317493986997e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,0.0333273198187417,0.0068018538083527,0.0199956863543704,0.046658953283113,9.70594627532555e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,41913,0.0319047351410782,0.00651478832513649,0.0191357500238107,0.0446737202583457,9.83139808916743e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,0.022354576785204,0.00456595117434224,0.0134053124834932,0.0313038410869148,9.89562876198675e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTG,Protogenin,42262,-0.0129256111654203,0.00264180366754172,-0.0181035463538021,-0.00774767597703857,1.00584567681273e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,42016,0.0223475015294907,0.00456874716960213,0.0133927570770706,0.0313022459819109,1.01290178819554e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,39919,0.0210251555037166,0.00430227748547239,0.0125926916321907,0.0294576193752425,1.03796980914833e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,42145,0.0357112630005603,0.00731119043420369,0.021381329749521,0.0500411962515995,1.04894217648403e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.0444242324669567,0.00909449432594723,0.0265990235881002,0.0622494413458133,1.04981418901889e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.0471284477364423,0.00967008572817409,0.0281750797092211,0.0660818157636635,1.11049567620333e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,0.0357292991736125,0.00734296621844742,0.0213370853854555,0.0501215129617694,1.15538664950234e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,42081,0.0220600293540418,0.00453429559237108,0.0131728099929944,0.0309472487150891,1.15662758408426e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0339958893771564,0.00699287229839592,0.0202898596723004,0.0477019190820124,1.17825895738502e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.0524581405671492,0.0107920778997172,0.0313056678837036,0.0736106132505948,1.1847972268731e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,0.0248358110735054,0.00511954893615926,0.0148014951586333,0.0348701269883775,1.24364963866095e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0269985918674746,0.00556900183872559,0.0160833482635725,0.0379138354713768,1.26120087158084e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,0.0143330053065608,0.0029571482265996,0.00853699478242554,0.020129015830696,1.26779970038249e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,42015,0.0306295042964102,0.00632713878166976,0.0182283122843375,0.0430306963084829,1.30645097906634e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,42087,0.0344374814056143,0.00711519241895654,0.0204917042644595,0.0483832585467691,1.31281729120706e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0223475611813878,0.00462429298300795,0.0132839469346922,0.0314111754280834,1.3652990930671e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,42158,0.0160564715659053,0.00332322086588249,0.00954295866877559,0.022569984463035,1.3692278308395e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,0.0616735227821023,0.0127704447372309,0.0366434510971298,0.0867035944670749,1.38446789057848e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,39649,0.0224902669386042,0.00465906578832323,0.0133584979934907,0.0316220358837178,1.40316944783438e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,0.0248199578027059,0.00515603023105546,0.0147141385498372,0.0349257770555747,1.49734519135626e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0373613967591034,0.00776292910832414,0.0221460557067881,0.0525767378114187,1.50476104792557e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,42119,-0.0376945384103915,0.00783428404720877,-0.0530497351429207,-0.0223393416778624,1.51431022953906e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,0.0126725282624037,0.00263458811060215,0.00750873556562346,0.0178363209591839,1.52489415192519e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,42181,0.0317113690053292,0.00659533196397845,0.0187845183559314,0.044638219654727,1.53963864144363e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPSE,Heparanase,39866,0.0493778874457529,0.0102915477177518,0.0292064539189593,0.0695493209725464,1.62389200625382e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.0361026828576698,0.00753879211691051,0.0213266503085252,0.0508787154068144,1.69452722651648e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.0394844457230813,0.00825639344254001,0.0233019145757029,0.0556669768704597,1.75137421212337e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0100879551382099,0.00210993356241479,0.00595248535587693,0.0142234249205429,1.76092257700797e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0290737545965743,0.00609979153385648,0.0171181631902156,0.041029346002933,1.89543103310344e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.0368351355042823,0.00773204612412308,0.0216803251010011,0.0519899459075636,1.91796855627114e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,39959,-0.0197877065970156,0.00415352778343179,-0.0279286210525419,-0.0116467921414893,1.92073313172621e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,39979,0.0170118937226484,0.00357366533730158,0.0100075096615373,0.0240162777837595,1.95639760304165e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0401293755031982,0.00843610114339675,0.0235946172621406,0.0566641337442558,1.98699071488844e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,42137,0.0118862876579664,0.00250105784714474,0.00698421427756269,0.0167883610383701,2.02978737355913e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,0.0585489721659568,0.0123205726633982,0.0344006497456963,0.0826972945862173,2.03757501655466e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,42070,0.0300676340921116,0.00633926502402592,0.0176426746450208,0.0424925935392024,2.12653028134321e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,0.0473377305777699,0.009987425850762,0.0277623759102764,0.0669130852452635,2.16181285671657e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,0.0278823667374864,0.00588866108362909,0.0163405910135734,0.0394241424613995,2.21332010730668e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,42145,-0.0319629802209228,0.00676011268350727,-0.045212801080597,-0.0187131593612486,2.28832088504646e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MME,Neprilysin,42070,-0.0395253995896031,0.00836542273773758,-0.0559216281555688,-0.0231291710236375,2.32607829709961e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.0460139886544763,0.00974117339197605,0.0269212888062033,0.0651066885027494,2.34488911962807e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,39636,0.0227612734394374,0.00482150036964966,0.013311132714924,0.0322114141639507,2.37824910788445e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,42166,0.0155788618163401,0.00330077101103865,0.00910935063470433,0.0220483729979758,2.38476940843999e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELE,E-selectin,42310,-0.0255299019415272,0.00542542200902945,-0.036163729079225,-0.0148960748038295,2.55585526646951e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,0.014097172544908,0.00300088728789452,0.00821543346063473,0.0199789116291813,2.6577290807035e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0251183345398773,0.00534976092206057,0.0146328031326386,0.035603865947116,2.69588491282289e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0168987418807224,0.00360506781722113,0.00983280895896896,0.0239646748024758,2.79239888625027e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,41913,0.0242553574700561,0.00517623496362514,0.0141099369413508,0.0344007779987614,2.81482534784151e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,0.0461295823825793,0.0098437194934831,0.0268358921753525,0.0654232725898062,2.81565689840077e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,0.0391125508545504,0.00834971813921817,0.0227471033016828,0.0554779984074181,2.84277467671331e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.0366960947732536,0.007838562433248,0.0213325124040875,0.0520596771424196,2.87553192863607e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,0.0405688584846939,0.00866597946779676,0.0235835387278122,0.0575541782415755,2.87694542466319e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,42070,0.0447642704032919,0.00956560472395615,0.0260156851443379,0.063512855662246,2.90076225425106e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,42070,0.027981162295323,0.00598203059138681,0.0162563823362048,0.0397059422544411,2.93165007700012e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.038770737252386,0.00829677537292046,0.0225090575214619,0.0550324169833101,3.00268397125552e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,0.0299886696579607,0.00641881978095719,0.0174077828872846,0.0425695564286368,3.01726257700465e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.0246095160656927,0.00526920543072874,0.0142818734214644,0.034937158709921,3.03479984204784e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0284874050433879,0.00610344337223407,0.0165246560338092,0.0404501540529667,3.07927967446116e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,41843,0.0272359049954136,0.00583561173188508,0.0157981060009189,0.0386737039899084,3.08341282812323e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,42272,0.0143227180364172,0.00307021652148999,0.00830509365429679,0.0203403424185375,3.1146408587357e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,0.00409045282703975,0.000880574793272086,0.00236452623222647,0.00581637942185304,3.43605854396699e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,0.0334260526931441,0.00720155778257142,0.0193109994393041,0.0475411059469841,3.49138668910294e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0258975186923606,0.00558013601172211,0.0149604521093852,0.0368345852753359,3.49913137498406e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,0.0318252280772417,0.00687301916649264,0.0183541105109161,0.0452963456435672,3.68259418551643e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0324210348091438,0.00700521572427882,0.0186908119895573,0.0461512576287303,3.72488033470362e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.0108137562243265,0.00233770859435904,0.00623184737938279,0.0153956650692702,3.76650050257124e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.0564392482914036,0.0122090768718097,0.0325094576226565,0.0803690389601507,3.82208737874516e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASPN,Asporin,39958,0.0138554120959488,0.00299731125070654,0.007980682044564,0.0197301421473336,3.83111626507862e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0435872937990893,0.00942912336608061,0.0251062120015713,0.0620683755966073,3.83175925490383e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0170524900610194,0.0036922055357485,0.00981576721095237,0.0242892129110865,3.90749960432389e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.0416958331312758,0.00903531454070216,0.0239866166314996,0.059405049631052,3.97868877075064e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.0484252017410982,0.010503100142169,0.0278391254624469,0.0690112780197496,4.05211838093158e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,0.0475793650804365,0.0103286098062726,0.0273352898601423,0.0678234403007308,4.13925517353982e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,0.0224833761163627,0.00488352131786707,0.0129116743333433,0.0320550778993822,4.19108222392528e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,0.0531184951672199,0.0115408854748176,0.0304983596365774,0.0757386306978624,4.21710668855321e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,39990,0.026483099572059,0.00575945240951966,0.0151945728494005,0.0377716262947176,4.30751340552896e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,0.0106682902128569,0.00232225811568863,0.00611666430610717,0.0152199161196066,4.3888706965744e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,0.0136766557889,0.00298006002642876,0.00783573813709967,0.0195175734407004,4.48522097152934e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0425849795137311,0.00928378328723877,0.0243887642707431,0.0607811947567191,4.5364738359965e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.0462258442177536,0.0100780521920009,0.026472861921432,0.0659788265140753,4.54184217737738e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,0.030175237930145,0.00659028435431452,0.0172582805956886,0.0430921952646015,4.72886541746844e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,0.0366851689133343,0.00801622368846862,0.0209733704839358,0.0523969673427327,4.77374432042738e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,39736,-0.0261621710143842,0.00572068630372563,-0.0373747161696864,-0.0149496258590819,4.8537978612676e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.0536335481493224,0.0117298844193192,0.0306429746874569,0.076624121611188,4.86461530804769e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0289194054180745,0.00632514700075338,0.0165221172965979,0.0413166935395512,4.87070090091586e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,41843,0.0369146662814536,0.00807544539104905,0.0210867933149975,0.0527425392479098,4.89272719984833e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD248,Endosialin,39966,0.0199244412591883,0.00436089320226622,0.0113770905827465,0.0284717919356301,4.95476878073264e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,39757,0.0634491914809926,0.0138966112947447,0.036211833343293,0.0906865496186922,5.02909634790268e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,0.0429221953138203,0.00940369607301486,0.0244909510107111,0.0613534396169294,5.05340318006762e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0183591100157856,0.00402415426844099,0.0104717676496413,0.02624645238193,5.11545451208942e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,42196,0.0145243255697032,0.00318445359559349,0.00828279652233996,0.0207658546170664,5.13529519533129e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,0.0212729604830844,0.00466835080642853,0.0121229929024845,0.0304229280636843,5.23914866699874e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLG,Plasminogen,39742,0.0107023149295169,0.00235271521615499,0.00609099310585311,0.0153136367531807,5.44913156954285e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0147950938208326,0.00325964681476065,0.00840618606390175,0.0211840015777635,5.71549901699884e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,42171,0.0190124358063872,0.00419271707145865,0.0107947103463282,0.0272301612664461,5.81976026945889e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,41900,0.0297217629513698,0.00655668601261098,0.0168706583666523,0.0425728675360874,5.86462575278678e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,42145,0.0171759298653906,0.00379534917379395,0.00973704548475441,0.0246148142460267,6.07599206528052e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,-0.0256390013867866,0.00567189652279653,-0.0367559185714678,-0.0145220842021054,6.22634655713142e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,39736,0.0361445551859589,0.00799543310059267,0.0204735063087973,0.0518156040631205,6.22861319789792e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0105490557557143,0.00233821557664605,0.00596615322548804,0.0151319582859406,6.49893885208868e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,0.0206186024957524,0.00457580105211287,0.0116500324336112,0.0295871725578937,6.66050938650823e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,0.0172616825316824,0.00383143559510659,0.00975206876527353,0.0247712962980914,6.6947906373097e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.054272970895045,0.0120509197252212,0.0306531682336114,0.0778927735564786,6.73686353932109e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,41714,0.0127651343178499,0.00283605492697106,0.00720646666098657,0.0183238019747131,6.82111524853826e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.0418548316754163,0.00933081675842849,-0.0601432325219362,-0.0235664308288965,7.34067438298258e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0126607375124513,0.00282742971977374,-0.0182024997632079,-0.00711897526169479,7.61572373161693e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,39929,0.0193127935174815,0.0043146867389217,0.0108560075091949,0.027769579525768,7.67756761921313e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0233124243002479,0.00521498729796992,0.0130910491962269,0.033533799404269,7.88788460937954e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,39903,0.035132344647563,0.00786383012568347,0.0197192376012234,0.0505454516939026,7.98753348805873e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,42016,0.0160339586093126,0.00359038546753644,0.00899680309294118,0.023071114125684,8.04199984858079e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,0.0363515390014225,0.00814356862722358,0.0203901444920643,0.0523129335107807,8.1148843326997e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0131230762030022,0.0029398689698633,0.0073609330220701,0.0188852193839342,8.11585137584139e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,41913,0.0230161151922818,0.00515737491531832,0.0129076603582579,0.0331245700263057,8.15756792775549e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,39930,0.017633908456065,0.00395109086832485,0.00988977035414831,0.0253780465579817,8.15819215467045e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,0.0189278310513864,0.00426004812503161,0.0105781367263244,0.0272775253764484,8.93753618619149e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,39958,0.0344613335991207,0.00775797813271875,0.0192556964589919,0.0496669707392494,8.99481241029362e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0134906821586558,0.00304115452621871,0.00753001928726712,0.0194513450300444,9.23460198125465e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.0346754426848903,0.00781814225171661,0.0193518838715257,0.0499990014982549,9.26899774698966e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,0.0264120682914862,0.0059601927133038,0.0147300905734108,0.0380940460095617,9.43513066647081e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,0.0264256122981218,0.00597241681151791,0.0147196753475467,0.0381315492486969,9.75199797378287e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,39736,0.022064095405787,0.00499043789850644,0.0122828371247143,0.0318453536868596,9.90500558249425e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,0.0243280824903766,0.00551093366328418,0.0135266525103396,0.0351295124704136,1.02029114446074e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,39966,0.0404929705942017,0.0091765216671933,0.0225069881265028,0.0584789530619006,1.03043741475606e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,0.0296028712979872,0.00672001459296167,0.0164316426957823,0.042774099900192,1.06667697806811e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.0187732465205159,0.00426862997331533,0.0104067317728179,0.0271397612682139,1.1009948364195e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.0193532891497235,0.004401026062881,0.0107272780664767,0.0279793002329703,1.10524104762933e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OCLN,Occludin,39934,0.0209710629143891,0.00477205535697512,0.0116178344147179,0.0303242914140603,1.12008993424945e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,42165,0.0252781368609493,0.00575491682863945,0.013998499876816,0.0365577738450827,1.12934289296159e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.012502831781383,0.0028464507630821,0.00692378828574213,0.0180818752770239,1.13103896395361e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,0.0128381515320666,0.00292692503150819,0.00710137847031055,0.0185749245938226,1.16201050558618e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,0.0182895741489238,0.00417134681431572,0.010113734392865,0.0264654139049826,1.17289441105479e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,42145,0.0125638894532583,0.00286800320468962,0.00694260317206667,0.01818517573445,1.1918224231214e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.0514002115935647,0.0117368895549981,0.0283959080657683,0.074404515121361,1.20090122283e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.0445604463759322,0.0102085972287518,0.0245515958075787,0.0645692969442856,1.28255429912347e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,41831,0.01859732872656,0.00426404521759982,0.0102398001000643,0.0269548573530556,1.30193359083728e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,0.029140645511403,0.00669826725571303,0.0160120416902055,0.0422692493326006,1.368292482842e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,42070,0.0149976598553651,0.00344990668100169,0.00823584276060182,0.0217594769501284,1.38856843238059e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,0.0115732227806666,0.00266242114002883,0.00635487734621005,0.0167915682151231,1.39092868717451e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.0202481137383732,0.00466202870262686,-0.0293856899955218,-0.0111105374812245,1.41444441932135e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,42230,-0.0322886590509476,0.00743848744108018,-0.0468680944354648,-0.0177092236664304,1.43017053689845e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0345969371055085,0.00797238569966208,0.0189710611341708,0.0502228130768462,1.43802791913757e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,0.0129119078644382,0.00299104429826067,0.00704946103984731,0.0187743546890291,1.59388510340821e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,0.0387880470696161,0.00898611260221174,0.0211752663692811,0.0564008277699511,1.59910135148164e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,42286,0.0203859445553704,0.00473100394510081,0.0111131768229728,0.029658712287768,1.65131610888391e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,42249,0.0301779764679569,0.00700366544182026,0.0164507922019891,0.0439051607339246,1.65229469796696e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,39736,0.0250710252422079,0.00581835144202225,0.0136670564158443,0.0364749940685715,1.65434489161938e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,0.0113838301868833,0.00264401009253455,0.00620157040551561,0.016566089968251,1.67768521667629e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,42199,0.0148682303114519,0.00345605692323672,0.00809435874190793,0.0216421018809959,1.70384420844071e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,42070,0.0248455726151228,0.00578033828394843,0.0135161095785838,0.0361750356516617,1.7332993786931e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,0.0257646696863129,0.00601694182663588,0.0139714637061066,0.0375578756665192,1.86491484251086e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELP,P-selectin,42217,0.0255523727436255,0.00599181301734837,0.0138084192296227,0.0372963262576283,2.01658415642567e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.0167779459137448,0.00393482159790846,0.00906569558184422,0.0244901962456454,2.02191676155051e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,0.0139690123659446,0.00328259707049367,0.00753512210777702,0.0204029026241122,2.09997135557362e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.01343988597029,0.00316184532311044,0.0072426691369935,0.0196371028035864,2.14584236900253e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAST,Gastrin,39929,-0.0599203182176768,0.0140999927119937,-0.0875563039331844,-0.0322843325021692,2.15798808990645e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,42147,0.0212256756041517,0.00500390695676519,0.0114180179688919,0.0310333332394115,2.23186566847396e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0324568478086452,0.00765272243813496,0.0174575118299007,0.0474561837873897,2.24073308777015e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,42185,0.0216052417056791,0.00509503871068427,0.011618965832738,0.0315915175786203,2.2455082414109e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,41881,0.0236646994315708,0.0055862069490498,0.0127157338114332,0.0346136650517085,2.28792280104808e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,0.0416786063915935,0.00984438239825009,0.0223836168910233,0.0609735958921637,2.31692417787209e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,42185,0.0186538376877247,0.00440655957167946,0.010016980927233,0.0272906944482165,2.31906060287497e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,39826,0.0502317821803506,0.0118749687136715,0.0269568435015544,0.0735067208591468,2.35487062591164e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,0.0262966234845917,0.00621676185829649,0.0141117702423306,0.0384814767268528,2.35578529801906e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,39930,0.0154154149888555,0.00364944426606574,0.00826250422736666,0.0225683257503444,2.41832945892384e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.0551765599522303,0.0130654456043102,0.0295682865677823,0.0807848333366783,2.42552017914217e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0213690048996353,0.00506085001766633,0.0114497388650093,0.0312882709342613,2.43316130185369e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.01486290321632,0.00352432794363519,0.00795522044679504,0.021770585985845,2.4893002346315e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLU,Clusterin,39979,0.0136706478284506,0.00324179526985431,0.00731672909953621,0.0200245665573651,2.49490210413492e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.0149128438505891,0.00353786586635145,0.00797862675254028,0.021847060948638,2.51165619085533e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,0.0305587153427139,0.00725032966356969,0.0163480692021173,0.0447693614833105,2.51625503705105e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,42137,0.0122396541830294,0.00290407253745885,0.00654767200961009,0.0179316363564488,2.51786590394511e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0406399612213646,0.00964865116223547,0.021728604943383,0.0595513174993461,2.54772261968116e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,0.0130937924607978,0.00310924514656292,0.00699967197353453,0.0191879129480612,2.55603732905953e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,39701,0.0295572688606917,0.00702124142613572,0.0157956356654657,0.0433189020559177,2.57732831810925e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,0.0347468972870426,0.00825992777917896,0.0185574388398519,0.0509363557342334,2.61140368046123e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COCH,Cochlin,39958,0.0207258249430321,0.00494741608091219,0.0110288894244442,0.03042276046162,2.82027744551397e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0171098353405001,0.00408509772170939,0.00910304380594971,0.0251166268750505,2.82766906589559e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,0.0219075863146426,0.00523464716456938,0.0116476778720867,0.0321674947571986,2.86827339528249e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,39934,0.031248114600495,0.00746775789125199,0.0166113091336411,0.0458849200673489,2.8807139441423e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,0.050136623009791,0.0119924761792232,0.0266313696985136,0.0736418763210684,2.92515979571812e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0252237207353403,0.00603679244997623,0.0133916075333869,0.0370558339372937,2.95483003365174e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,0.0282507066093199,0.00676186973492965,0.0149974419288578,0.041503971289782,2.95987483926286e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0215169453324998,0.00515142109295435,0.0114201599903093,0.0316137306746903,2.97729152482223e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORT1,Sortilin,42129,0.0171148504443672,0.00410302594813385,0.00907291958602481,0.0251567813027095,3.04789565189836e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,0.0130394080313501,0.00313338950221563,0.00689796460700746,0.0191808514556927,3.18203292170832e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,0.0345657703835985,0.00830958100196963,0.018278991619738,0.050852549147459,3.20947340846375e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,0.0185581303002957,0.00446389533518638,0.0098088954433304,0.027307365157261,3.23875322918045e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,42051,0.0308615076376561,0.00742425387566743,0.016309970041348,0.0454130452339643,3.2466436720917e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,42247,0.023025639752534,0.0055408817728732,0.0121655114777025,0.0338857680273655,3.26425542489216e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.0237383581605658,0.00571644387139729,0.0125341281726271,0.0349425881485045,3.31050747580665e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.0648854613769666,0.0156345615608714,0.0342417207176586,0.0955292020362746,3.3470292123915e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,39736,-0.015297976351952,0.00369299841179276,-0.0225362532390658,-0.00805969946483821,3.46187786938235e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F2,Prothrombin,39979,0.00663310370913122,0.00160169334005442,0.00349378476262456,0.00977242265563788,3.47825781281829e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,39736,0.0175636731581986,0.00424259977002105,0.00924817760895738,0.0258791687074399,3.50112834913466e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,42199,0.0114141267824533,0.00275783622159316,0.00600876778813069,0.0168194857767759,3.51233754382066e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0153163872515136,0.003709795278568,0.00804518850552035,0.0225875859975069,3.67139609949151e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0202875683332362,0.00491622297401684,0.0106517713041632,0.0299233653623092,3.70713258461657e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,42119,0.0286106774393612,0.00693926898545539,0.0150097102278686,0.0422116446508537,3.76186607268364e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.020428221299232,0.00495621415340132,0.0107140415585654,0.0301424010398986,3.78699987120225e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0322373630639587,0.00782611621261316,0.0168981752872369,0.0475765508406805,3.82879269401662e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0131788711716521,0.00320113147046174,0.00690465348954714,0.0194530888537572,3.86648788881556e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,-0.0123011988447584,0.00299005850031314,-0.0181617135053722,-0.00644068418414469,3.9110925413769e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,0.024654397429561,0.00599389400698231,0.0129063651758756,0.0364024296832463,3.92411445955968e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,41839,0.030157210414092,0.00733181311804738,0.0157868567027192,0.0445275641254649,3.92571466972106e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,41832,0.0480526451666714,0.0117026574848357,0.0251154364963934,0.0709898538369493,4.04758685804024e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,39934,0.0340526530614232,0.00829301554721291,0.0177983425888859,0.0503069635339605,4.05070716030286e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0230101269147379,0.00560459518690235,-0.0339951334810665,-0.0120251203484093,4.05664852846861e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.029601806195817,0.00721610147360727,0.0154582473075467,0.0437453650840872,4.1170915881467e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.00681098219506575,0.00166029507849843,0.00355680384120882,0.0100651605489227,4.11961891201014e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.00950358155612263,0.00231773355996712,0.00496082377858706,0.0140463393336582,4.15357471445458e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0216423752530955,0.00527863937855793,0.011296242071122,0.031988508435069,4.16126000332263e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEP,Leptin,42145,0.0306662410247957,0.00748430054255867,0.0159970119613807,0.0453354700882106,4.20232573220224e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNC,Tenascin,42217,0.0212581890964611,0.00518844637618635,0.0110888341991358,0.0314275439937863,4.20568531188306e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0178622586648105,0.00436187598995353,0.00931298172450159,0.0264115356051194,4.24441717245259e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.0564048922053114,0.0137833977439994,0.0293894326270725,0.0834203517835503,4.30196262294859e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,39713,0.0457616529823779,0.01119457870517,0.0238202787202447,0.0677030272445111,4.38470896474675e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0374217949470779,0.00916332553114029,0.0194616769060429,0.0553819129881128,4.4553089474075e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0248426566275955,0.00608649529381729,0.0129131258517136,0.0367721874034774,4.49886312745518e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,41839,0.0316813643046954,0.00777952208804361,0.0164335010121299,0.0469292275972608,4.6800982779257e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.0418936948747718,0.0102910063817244,0.0217233223665921,0.0620640673829516,4.70976432527725e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,42296,0.0255711058359013,0.00628188934356615,0.0132586027225116,0.0378836089492909,4.71540231311107e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0446507440864122,0.0109741781767512,0.0231413548599799,0.0661601333128445,4.75449971875159e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,42249,0.0200410283058365,0.00492804149212241,0.0103820669812766,0.0296999896303964,4.79445349991694e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,39930,0.0259938515636439,0.00639861225258264,0.013452571548582,0.0385351315787059,4.88938705208542e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,0.0159008711608725,0.00391738551788164,0.00822279554582445,0.0235789467759205,4.9603269756531e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,0.0237745778834817,0.00585777363119205,0.0122933415663453,0.0352558142006182,4.96905995542866e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.0342463592288043,0.00843819304425069,0.0177075008620729,0.0507852175955356,4.97216439261414e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,41839,-0.0230245311431698,0.00567451768026767,-0.0341465857964944,-0.0119024764898451,4.98788853591247e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0235383185461376,0.00581179574859538,0.0121471988788906,0.0349294382133845,5.1538496804301e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,39908,0.0266362208156361,0.00658413433005804,0.0137313175287224,0.0395411241025499,5.25549977631574e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.0155806448514035,0.00385311959025463,0.00802853045450438,0.0231327592483025,5.29165981262872e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,42200,0.0162844734829471,0.00402776023035075,0.00839006343145967,0.0241788835344346,5.30490417484118e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.0371312878602494,0.00918863906374275,0.0191215552953136,0.0551410204251851,5.35752656091538e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0230660754904092,0.00571075315712202,0.0118729993024501,0.0342591516783684,5.40196444794056e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,0.024764318012616,0.00613307745244011,0.0127434862058334,0.0367851498193986,5.43034759081423e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,42070,-0.0579034669727921,0.0143769676614518,-0.0860823235892375,-0.0297246103563466,5.66783621340165e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEXN,Nexilin,39990,0.0302834533020703,0.00752506119478168,0.0155343333602982,0.0450325732438424,5.75033164585217e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0101535319383946,0.00252616113850092,0.00520225610693283,0.0151048077698564,5.86746477738251e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,0.0428617977000585,0.0106644313576704,0.0219595122390244,0.0637640831610926,5.87899704138024e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.0328527675264531,0.00817664363659313,0.0168265459987305,0.0488789890541756,5.90488573344257e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,39657,0.00740958765684388,0.00184637361107193,0.0037906953791429,0.0110284799345449,6.0334651738655e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0173530135920627,0.00433095129953638,0.00886434904497143,0.025841678139154,6.1967967841637e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.00833614096888049,0.00208086042648112,0.00425765453297749,0.0124146274047835,6.20601589886213e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,42070,-0.0151412186863071,0.00378176010752024,-0.0225534684970468,-0.00772896887556747,6.26807922457277e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,0.0340953250910732,0.008525120417133,0.0173860890734926,0.0508045611086539,6.38450631903567e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,39958,0.0289866578896465,0.00724784557467795,0.0147808805632777,0.0431924352160153,6.39195602624048e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0133050523860201,0.00332776482911299,0.00678263332095868,0.0198274714510816,6.42323215423947e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSPN,Claspin,41820,0.0153010026010075,0.00382904144504391,0.00779608136872145,0.0228059238332936,6.47602270886035e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.0270664116278203,0.00677500951952574,-0.0403454302860907,-0.0137873929695498,6.51041899452735e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,39929,0.0201533851626559,0.00504801993018834,0.0102592660994867,0.030047504225825,6.58387119859294e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.0425753823080378,0.0106652414043611,0.0216715091554901,0.0634792554605855,6.59384058219246e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,39736,-0.0417452145516592,0.0104588961207645,-0.0622446509483577,-0.0212457781549608,6.61168859964275e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,39726,0.00902402058109488,0.0022618743639856,0.00459074682768309,0.0134572943345067,6.66031280991617e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.0331118663454165,0.00830714476492003,0.0168298626061732,0.0493938700846598,6.75710122166642e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,41883,0.0380143578688142,0.0095391823194839,0.0193175605226258,0.0567111552150027,6.78191662019511e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,0.045710730448413,0.01147092662866,0.0232277142562393,0.0681937466405867,6.78552559370407e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,0.0148808464970114,0.00373882954356789,0.00755274059161829,0.0222089524024044,6.9321041810736e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.0179941569043157,0.0045213854179424,0.0091322414851486,0.0268560723234828,6.94064787912311e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,39934,0.0236425783450735,0.0059452847151163,0.0119898203034456,0.0352953363867015,7.03141461669434e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.0357471399578341,0.00899586960377687,0.0181152355344315,0.0533790443812368,7.11250563503615e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,0.0227241634902787,0.00572789349470651,0.0114974922406539,0.0339508347399034,7.31621753396583e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0188729331675353,0.00475996647947046,0.00954339886777321,0.0282024674672974,7.37969313914877e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0198351040931052,0.00500348791677712,0.010028267776222,0.0296419404099884,7.40121428194043e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,39518,0.0188040817482646,0.0047492116123087,0.00949562698813951,0.0281125365083896,7.56114728802235e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.0422206504274909,0.0106698133428368,0.0213078162755309,0.063133484579451,7.63684274175424e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,0.0424868663035393,0.0107472775425587,0.0214222023201243,0.0635515302869542,7.74866176691646e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0196692090935661,0.00497626301884011,0.00991573357663952,0.0294226846104928,7.76973752012427e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,0.00995041974285056,0.00251755576490099,0.00501601044364462,0.0148848290420565,7.77621560573299e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,42296,0.0143917123528078,0.00364605628724829,0.00724544202980111,0.0215379826758144,7.94656835459941e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,42296,0.0336100726820076,0.00851652985393637,0.0169176741682923,0.0503024711957229,7.97139937335184e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0285084970792344,0.00722668286404766,0.014344198665701,0.0426727954927679,8.02377955041111e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.00844846199421953,0.00214226149347365,0.00424962946701118,0.0126472945214279,8.06363159976733e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.0144819302475237,0.00367465502037815,0.00727960640758255,0.0216842540874649,8.1539551730812e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,0.0180511899123139,0.00458268931775345,0.00906911884951719,0.0270332609751107,8.23263226122276e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0245234537719107,0.00623010173365191,0.0123124543739529,0.0367344531698684,8.31705422120437e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.0401792805320939,0.0102492824778089,0.0200906868755885,0.0602678741885993,8.89175418053607e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,42145,0.0283624549743116,0.00723825224743613,0.0141754805693368,0.0425494293792864,8.9572270188176e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,39657,0.0150208988858556,0.00383696058153414,0.00750045614604868,0.0225413416256625,9.10255632334289e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,41839,-0.0152672862369178,0.00390072154333983,-0.0229127004618639,-0.00762187201197177,9.12474944498649e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,0.0266568922066947,0.0068188716679477,0.0132919037375172,0.0400218806758722,9.31099261169825e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,-0.00990848900061064,0.00254044549253081,-0.014887762165971,-0.00492921583525026,9.66282755448609e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,0.0104160450163232,0.00267075557226494,0.00518136409468394,0.0156507259379625,9.66410196387065e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.0361289327820046,0.00929631077001773,0.0179081636727699,0.0543497018912394,0.00010233332887066
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,42119,0.0283008048221254,0.00728996751685235,0.0140124684890948,0.042589141155156,0.000104025788709914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,41839,0.019010752761728,0.00489976508596167,0.00940721319324313,0.0286142923302129,0.000104992016944096
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,39736,0.0227223849921508,0.00586311002027797,0.011230689352406,0.0342140806318956,0.000107023613821686
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,42016,0.0278027882802267,0.00717795246379822,0.0137340014511821,0.0418715751092712,0.000107855250389403
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.0395680675481177,0.0102162701343701,0.0195441780847523,0.0595919570114832,0.000107988362123575
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,0.0283459681377011,0.00732025116763958,0.0139982758491275,0.0426936604262746,0.000108330488650244
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,0.0401704683122633,0.0103745700211613,0.0198363110707872,0.0605046255537394,0.000108562755875914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,42208,0.0464601673069951,0.0120209130772915,0.0228991776755037,0.0700211569384864,0.000111630260958259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,39958,0.0135096360110192,0.00349688016028221,0.00665575089686604,0.0203635211251723,0.000112468813959967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0267224118598914,0.00692033264305314,0.0131585598795073,0.0402862638402756,0.000113349962346521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,39649,0.0548243392622315,0.0142020788805537,0.0269882646563461,0.0826604138681168,0.000113891143568335
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,-0.00995551515996183,0.00258032808437324,-0.0150129582053334,-0.00489807211459028,0.000114738636201594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0347364325233965,0.00900431944898401,0.0170879664033878,0.0523848986434051,0.000114963357522438
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,0.0269116529134225,0.00697713800404389,0.0132364624254965,0.0405868434013485,0.000115260855902173
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.0583053472597223,0.0151242753182954,0.0286617676358633,0.0879489268835813,0.000116329319234353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,0.0354484990906791,0.00919934454118475,0.017417783789957,0.0534792143914012,0.000117037891339011
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0326830411128969,0.00848423267260586,0.0160539450745894,0.0493121371512044,0.000117601399268189
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0240293679993116,0.00623829375206394,0.0118023122452662,0.0362564237533569,0.000117752790961841
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,0.0102703912793939,0.00266626552195345,0.00504451085636514,0.0154962717024227,0.000117810493710982
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,0.0152973995513351,0.00397662225441925,0.00750321993267338,0.0230915791699968,0.0001202158639605
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,0.046819248321069,0.0121793938104048,0.0229476364526755,0.0706908601894625,0.000121650715250615
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,42296,0.0262230218922236,0.00682346054236911,0.0128490392291801,0.039597004555267,0.000122054591646512
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,0.0143116658130157,0.00372797372147564,0.00700483731892344,0.0216184943071079,0.000124102657291312
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,0.0168974744659279,0.00440719019113404,0.00825938169130521,0.0255355672405506,0.000126613091510609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,0.0194263771797962,0.00507026753576487,0.00948865280969701,0.0293641015498953,0.000127969221481951
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,0.0330617701116124,0.00863941601389834,0.0161285147243717,0.0499950254988532,0.000130381209529221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0104937434127394,0.00274308485220617,0.00511729710241531,0.0158701897230635,0.000131191653027963
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,41814,0.0378118208562451,0.00988547310159553,0.0184362935771179,0.0571873481353724,0.000131379581968843
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0207354799615728,0.0054268356889965,0.0100988820111397,0.0313720779120059,0.00013355202137824
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0166505489871537,0.00436680647356069,0.0080916082989748,0.0252094896753327,0.000138046691905844
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0204731207010315,0.00538136780570096,0.00992563980185765,0.0310206016002054,0.000142761181565133
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0310787130293458,0.00817050853502426,0.0150645163006983,0.0470929097579934,0.000143260704031085
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,39806,0.0110344080132302,0.0029056700572737,0.0053392947009737,0.0167295213254866,0.000146908628694993
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0197875536153245,0.00521114942004646,0.00957370075203341,0.0300014064786155,0.000147126925754711
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.0249886944794054,0.00660356924052622,0.012045698767974,0.0379316901908368,0.000154933643932935
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,0.0253408086000963,0.00669741820570627,0.0122138689169121,0.0384677482832806,0.000155214588198857
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,0.0509061332053557,0.0134582942159112,0.0245278765421698,0.0772843898685416,0.000155920592002351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0163764021361256,0.00433017118745724,0.00788926660870943,0.0248635376635418,0.000156415381380378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,0.0251481948296316,0.00665127220553078,0.0121117013067912,0.0381846883524719,0.000156896880801046
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,0.0206096905791154,0.00545577593435739,0.00991636974777489,0.0313030114104559,0.000159183097859174
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,0.0202987764373987,0.00538008959091151,0.00975380083921216,0.0308437520355853,0.00016201559509095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,42224,0.029060189396852,0.00770518943501365,0.0139580181042253,0.0441623606894788,0.000162949723249549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0121257262097748,0.00321681249230575,0.00582077372485549,0.018430678694694,0.000164277015029045
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,0.0127699385957603,0.00338812421652026,0.00612921513138062,0.01941066206014,0.000164737478203943
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0159465825688207,0.00423296762006616,0.00764996603349108,0.0242431991041504,0.000165900439161198
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,0.0362374970159637,0.00963443835063178,0.0173539978487254,0.055120996183202,0.000169783366161077
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.0174126084488573,0.00463981398861315,0.00831857303117552,0.0265066438665391,0.000175717545820605
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.048341330422283,0.012902519369191,0.0230523924586686,0.0736302683858974,0.000179951002175256
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0203756241800026,0.00543963067987324,0.00971394804745104,0.0310373003125541,0.000180730385317851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,0.00932314993014356,0.0024923397943125,0.00443816393329106,0.0142081359269961,0.000184413346376213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,42119,0.0249463228620511,0.00666996466995145,0.0118731921089463,0.038019453615156,0.000184708085319477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,0.0189021124850012,0.00505587720768104,0.0089925931579464,0.0288116318120561,0.000185787001088607
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.0209108359568778,0.00560407129158839,-0.031894815688391,-0.00992685622536451,0.000191240915787351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,-0.0115275195403463,0.00308943855045851,-0.017582819099245,-0.00547221998144764,0.000191310855166341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,42249,0.0236558731936238,0.00634059292111052,0.0112283110682472,0.0360834353190004,0.00019159957965247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0185266151592585,0.00496902692897544,0.00878732237846661,0.0282659079400503,0.000193487598714417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.019431372424575,0.00521173376269164,0.00921637424969942,0.0296463705994506,0.000193511884588985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,0.0192360271108946,0.0051600557925639,0.00912231775746932,0.0293497364643198,0.000194038701555568
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0226595452982827,0.00608276470841177,0.0107373264697957,0.0345817641267698,0.000195953465374006
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0124258248786256,0.00333562673323146,0.00588799648149193,0.0189636532757593,0.00019611780551029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,0.0352754948191837,0.00947124953901297,0.0167118457227183,0.0538391439156492,0.000196508785485487
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,39930,0.0250462734973352,0.00673168740440473,0.0118521661847019,0.0382403808099685,0.000199668702860002
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.0318510052686215,0.00856114424511122,0.0150711625482035,0.0486308479890395,0.000199718535352905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.0374067010846691,0.0100562262747654,0.0176964975861289,0.0571169045832094,0.000200228941151676
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,39930,0.0414053045182935,0.011141810728516,0.0195673554904021,0.063243253546185,0.000203206908104646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,42016,0.0156951058589247,0.00423033353189236,0.00740365213641568,0.0239865595814337,0.000207985672153176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0171409510742481,0.00462208889216639,0.00808165684560194,0.0262002453028942,0.000209342804624329
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.0133483424643288,0.00360445458809153,0.00628361147166945,0.0204130734569882,0.000213658908904095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,0.0129022778586926,0.00348556085993964,0.00607057857321087,0.0197339771441743,0.000215097740104754
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,0.0141077467770218,0.00381137215027923,0.00663745736247448,0.0215780361915691,0.000215370980160221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,42143,0.0143574076825261,0.00387924305885802,0.00675409128716434,0.0219607240778878,0.000215530498247867
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0109197508339982,0.00295068054523801,0.0051364169653317,0.0167030847026647,0.000215806746816934
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,0.0435101791784718,0.011787109561042,0.0204074444388295,0.0666129139181142,0.000223957140060394
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.0161259293047087,0.00436942725309238,0.00756185188864761,0.0246900067207697,0.000224586852445232
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,42137,0.0178376802318189,0.00483723816584533,0.00835669342676203,0.0273186670368757,0.000227286482359803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,39929,0.0154062603853279,0.00417811816220217,0.00721714878741168,0.0235953719832442,0.000227644206691902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,42112,0.0261835010988194,0.0071113627532174,0.0122452301025133,0.0401217720951255,0.00023238167240865
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,0.0281571544541853,0.00764852320234263,0.0131660489775938,0.0431482599307769,0.000232869475559038
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,42070,0.0260452807736631,0.00707647526295657,0.0121753892582683,0.039915172289058,0.000233644803109172
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,39736,0.026379396180939,0.00716694726938986,0.0123321795329348,0.0404266128289431,0.000233691175419322
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,42129,0.0122472503855088,0.00332957705328295,0.00572127936107424,0.0187732214099434,0.000235685226566369
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.0326102788835841,0.0088772832011632,0.0152108038093042,0.0500097539578639,0.000240217007458229
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,0.0394598129072565,0.0107437474530234,0.0184020678993307,0.0605175579151823,0.000240996292689208
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,0.0190358674299685,0.00518393076824893,0.00887536312420055,0.0291963717357364,0.000241520310740409
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,42103,0.0275694687099468,0.00751044136884808,0.0128490036270046,0.042289933792889,0.000242706631936653
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,0.0235420968349095,0.00642606463683828,0.0109470101467065,0.0361371835231125,0.000249714585123695
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.0227611126176662,0.00621372637124216,0.0105822089300316,0.0349400163053009,0.000250192091223842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,42262,-0.0249708562975191,0.00682789843313771,-0.038353537226469,-0.0115881753685692,0.00025596281992846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0258596064198193,0.00707329832822329,0.0119959416965017,0.0397232711431369,0.000257430943622082
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.034933259209805,0.00955550641255068,0.0162044666412057,0.0536620517784043,0.000257513201325027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PI3,Elafin,41966,0.0221148330511447,0.00605049917273357,0.0102558546725869,0.0339738114297025,0.000258124312328202
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,42249,0.0239267575712609,0.00654693995189751,0.0110947552655418,0.03675875987698,0.000258501410124867
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,42262,0.0246067538781477,0.00673357992949835,0.011408937216331,0.0378045705399645,0.000258815620754929
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0102021364149966,0.00279448165834814,0.00472495236463429,0.015679320465359,0.000262400350345342
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,39966,0.0160047930125454,0.00438376537071141,0.00741261288595105,0.0245969731391398,0.00026247138953735
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,-0.00784686172551542,0.00214988049576621,-0.0120606274972172,-0.00363309595381365,0.000263326145917637
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,0.0121810710442174,0.00333787095479453,0.00563884397282013,0.0187232981156147,0.000263889246909179
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,41843,0.0287509211119451,0.00788124438829996,0.0133036821108772,0.044198160113013,0.000265285723727279
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,42296,0.0178168916473944,0.00488420856412085,0.00824384286171755,0.0273899404330713,0.000265418734313409
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0180949873268861,0.0049611954116312,0.00837104432008896,0.0278189303336832,0.000266215384578042
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,42181,0.00868627825484888,0.00238302582594951,0.00401554763598784,0.0133570088737099,0.000268324425543677
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,0.0151234642117431,0.00415303830930662,0.00698350912550208,0.023263419297984,0.00027221915213741
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,42016,0.0163743079361244,0.00450014242482096,0.00755402878347537,0.0251945870887735,0.000275131682511498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,42115,0.0344121942060119,0.00947390523537532,0.0158433399446762,0.0529810484673475,0.000281931208867827
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,39757,0.0650206667549016,0.0179033163043717,0.029930166798333,0.10011116671147,0.000282749304854981
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,0.0137443775760868,0.00378514669388394,0.00632549005607428,0.0211632650960993,0.000283233504831969
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0200314561438847,0.00551789406456241,0.0092163837773424,0.0308465285104271,0.000284407789193429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.0301540489644895,0.00830657171987917,0.0138731683935264,0.0464349295354527,0.00028450853286791
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,42185,-0.0258437366264104,0.00715092703859392,-0.0398595536220545,-0.0118279196307663,0.000302551733399997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,0.022824616022348,0.00631939532707669,0.0104386011812777,0.0352106308634183,0.000305138887265483
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,42249,0.0116924172719276,0.00323747465714443,0.00534696694392453,0.0180378675999307,0.000305422117439982
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,42122,0.0253574136604098,0.00702282863480697,0.0115926695361881,0.0391221577846314,0.000306461901294836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,42166,0.0319262517144398,0.0088446634791343,0.0145907112953365,0.049261792133543,0.000307699766629278
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,42249,0.0105977050659861,0.0029398035698164,0.00483569006914597,0.0163597200628263,0.000313382614309871
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,41913,0.0186769951163341,0.00518828978876038,0.00850794713036376,0.0288460431023045,0.000319574144209339
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,42249,0.00875954004644666,0.00243545949297119,0.00398603944022313,0.0135330406526702,0.0003234574276804
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.0111209079104864,0.00309757795051396,-0.0171921606934938,-0.00504965512747903,0.00033182441113895
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.0219384207132775,0.00611600403809771,0.009951052798606,0.033925788627949,0.00033588487858397
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,0.0303501116616124,0.00847582282643083,0.0137374989218079,0.0469627244014168,0.000344030896421626
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,42148,0.0239072913607181,0.0066818954666141,0.0108107762461545,0.0370038064752818,0.000347547116573465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.0194592243127675,0.00544582885859853,0.00878539974991434,0.0301330488756206,0.000354110273425179
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,39966,0.0166216989249636,0.00465744871773582,0.0074930994382014,0.0257502984117258,0.000360039998858695
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,0.0190555479548328,0.00534418337709338,0.00858094853572981,0.0295301473739358,0.000364192753266605
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,0.0273131241029154,0.00766427178456811,0.0122911514051619,0.0423350968006689,0.000367174948406559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,39966,0.0107599650335717,0.00302833413847982,0.00482443012215127,0.0166954999449922,0.000382267099846048
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,42016,0.0215063187436304,0.00605330962237118,0.00964183188378293,0.033370805603478,0.0003824333747618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,-0.0142317145888953,0.00400663522679537,-0.0220847196334143,-0.00637870954437639,0.000383815853265829
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,0.0106528096263323,0.00300118276586308,0.00477049140524061,0.0165351278474239,0.000387246203219683
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,0.0493026188355356,0.0138925396942496,0.0220732410348064,0.0765319966362648,0.000388218775630223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,0.0228312844456828,0.00643582488966487,0.0102170676619397,0.0354455012294259,0.00039017733590911
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,0.00796129459763097,0.0022445686489036,0.00356194004577991,0.012360649149482,0.000391094144616046
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.0141002053930404,0.00397786139541697,0.00630359705802312,0.0218968137280576,0.000394684305833461
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,42070,0.0133325991912847,0.00376168282498133,0.00595970085432128,0.0207054975282481,0.000394964076325438
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,0.0319338389825245,0.00901542647096527,0.0142636030994326,0.0496040748656164,0.000398528473985381
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0206229364396186,0.00582566719026585,0.00920462874669749,0.0320412441325396,0.000401752997995358
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,0.028693640288584,0.00811255750149532,0.0127930275856531,0.0445942529915148,0.000406127724021852
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,0.00967038401684112,0.00273588813011551,0.00430804328181472,0.0150327247518675,0.000409949768908065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,42153,0.0192855408994795,0.00546034489494654,0.00858326490538427,0.0299878168935747,0.000413913807099545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.017848774622977,0.00505603282236829,0.00793895029113512,0.0277585989548188,0.000416903186631809
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0219716415848661,0.0062322801846158,0.00975637242301909,0.034186910746713,0.000424179315093023
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,0.0187235041627272,0.00531117023638484,0.00831361049941292,0.0291333978260415,0.000424392094670657
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.026602680569005,0.00755402188875857,0.0117967976670382,0.0414085634709718,0.00043057337012415
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREH,Trehalase,39966,-0.0285429277600574,0.00811297274761817,-0.044444354345389,-0.0126415011747258,0.000436208857080881
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.0144547457708954,0.00411080771588263,-0.0225119288940254,-0.00639756264776547,0.000439130436304985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,42217,0.017619703534109,0.00501354598667209,0.00779315340023171,0.0274462536679863,0.000442147188627096
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,41843,0.0247545773385279,0.0070477413303899,0.0109410043309637,0.0385681503460921,0.000445536912420686
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0202815487380002,0.00577490868723556,0.00896272771101848,0.0316003697649819,0.000446459320773679
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,42146,0.0212889972245245,0.00606559248742984,0.00940043594916204,0.033177558499887,0.000449905674011694
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.00970468271115394,0.00276930577846185,0.00427684338536871,0.0151325220369392,0.000459449037069756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,39657,0.0185342744851728,0.00528913758422033,0.00816756482010099,0.0289009841502447,0.000459767464397616
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.0216991477846268,0.00619924909595162,0.00954861955656163,0.033849676012692,0.000466244910122491
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0174398160507024,0.00498395799924412,0.00767125837218394,0.0272083737292209,0.0004681611726091
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,0.0226370308445052,0.00647166114979057,0.0099525749909157,0.0353214866980947,0.000470787068528527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0180617603809677,0.00516693285698751,0.00793457198127215,0.0281889487806632,0.000474726872618846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,0.0223237083099413,0.00639496598489676,0.00978957497954365,0.0348578416403389,0.000483046978062644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,0.0142656466557289,0.00409792442738884,0.00623371477804676,0.022297578533411,0.000501074107601893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,42145,-0.0142923618152221,0.0041083131425223,-0.0223446555745658,-0.0062400680558784,0.000505080972150889
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,39958,-0.0338972130096692,0.00976586422247782,-0.0530383068857257,-0.0147561191336127,0.000520471354231474
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,41800,0.017974498877515,0.00517891231386481,0.00782383074233996,0.02812516701269,0.000520744989080702
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,42145,0.0232980156732802,0.00672044682046895,0.0101259399051611,0.0364700914413994,0.000528452875509124
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.011643613900784,0.00335945992967348,-0.0182281553629441,-0.00505907243862402,0.000530285076703706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,42310,0.0109472431387583,0.00317030441811242,0.00473344647925798,0.0171610397982587,0.000555944687701912
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,39979,0.00840253312857161,0.00243608572064721,0.00362780511610308,0.0131772611410401,0.00056429928361821
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,41900,0.0292291162032251,0.00847640659213465,0.0126153592826412,0.045842873123809,0.000565892978865327
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.00978168934819352,0.00284501593977036,0.00420545810624361,0.0153579205901434,0.000587723759584866
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',39575,0.0159430374549701,0.00463913427093513,0.00685033428393721,0.0250357406260029,0.000591159478864696
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,39919,0.0196316400631892,0.00571376148156276,0.00843266755932621,0.0308306125670522,0.000592814056328981
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.0241864995471802,0.00706592152368478,-0.0380357057336024,-0.010337293360758,0.000621219165620912
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,39586,0.039112856659243,0.0114264437494908,0.0167170269102411,0.0615086864082449,0.00062157240145698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.0120313510003314,0.00351678366871125,0.00513845500965735,0.0189242469910055,0.00062546168422478
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,0.011465800375156,0.00336426280078328,0.00487184528562081,0.0180597554646913,0.00065639592031432
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,42310,0.0111277541327276,0.00326669532510877,0.00472503129551439,0.0175304769699408,0.000660084530852711
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,42310,0.0271220670404161,0.0079626664173366,0.0115152408624364,0.0427288932183958,0.000660740996154519
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,39958,-0.010242562944268,0.00300748879069519,-0.0161372409740306,-0.00434788491450542,0.000662265335928278
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBIN,Erbin,42070,0.0374900882044688,0.0110137627111533,0.0159031132906084,0.0590770631183292,0.00066617071416956
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,0.00783905265201132,0.00230470025568117,0.00332184015087622,0.0123562651531464,0.000672529612194371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.0310662593811511,0.009149975419983,0.0131323075579844,0.0490002112043177,0.000687684746474255
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,41843,0.0162129934947934,0.004778791567151,0.0068465620231775,0.0255794249664094,0.000694106631656872
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,42144,0.0108036865121546,0.00318471656599338,0.00456164204280753,0.0170457309815016,0.00069493080517598
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0210583175000023,0.00620832235195419,0.00889000569017208,0.0332266293098325,0.000696386052223106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,42123,-0.0205448694845331,0.00606019182805368,-0.0324228454675183,-0.00866689350154788,0.000700578766590224
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,39960,-0.0136625240225463,0.00403359520198629,-0.0215683706184394,-0.00575667742665312,0.000708539078459124
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,42145,0.0156146062798934,0.00461121347005426,0.00657662787858704,0.0246525846811998,0.000710626423198414
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0206870075379112,0.00611320907319361,0.00870511775445168,0.0326688973213707,0.000716490725964202
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.0410964973186187,0.01214832319053,0.0172857838651799,0.0649072107720574,0.000719296310745219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,39929,0.0276955842277173,0.00818870352787208,0.011645725313088,0.0437454431423466,0.0007215903699118
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0120329797132929,0.00356361583498483,0.00504829267672261,0.0190176667498631,0.00073587467380384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,42170,0.0134251399356364,0.00398179107090568,0.00562082943666123,0.0212294504346115,0.000749324211746267
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0205939747552577,0.00611268254321771,0.00861311697055095,0.0325748325399644,0.000756858862872298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,0.0304189970457259,0.00904249404431375,0.012695708718871,0.0481422853725809,0.000770335436854604
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,41949,0.0253555516626133,0.00754772233884705,0.010562015878473,0.0401490874467535,0.000783406168256984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,42249,0.0408162904888888,0.0121503516714267,0.0170016012128924,0.0646309797648852,0.000783631207927438
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,0.0134527363337241,0.00400818113530007,0.00559670130853597,0.0213087713589122,0.000792510057116106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,42016,0.0348171517186313,0.0103829793548721,0.0144665121830819,0.0551677912541807,0.000800776440850991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.0282479583670418,0.00844332884420648,0.0116990338323971,0.0447968829016865,0.000823729139153327
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,0.00809590207703026,0.00242094911806938,0.00335084180561427,0.0128409623484462,0.000827725678665828
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,0.0206543081108644,0.00617789893721554,0.00854562619392189,0.0327629900278068,0.000830764048234157
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,-0.00890873031326262,0.00266482451652635,-0.0141317863656543,-0.00368567426087096,0.000831285803856108
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,42185,0.0332696327951697,0.00995259914361499,0.0137625384736844,0.0527767271166551,0.000831591198458537
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,-0.0157335975841087,0.00470764849839828,-0.0249605886409694,-0.0065066065272481,0.000834056697071626
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0160505014173647,0.00480699601203559,0.00662878923377496,0.0254722136009545,0.000843162217649731
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,0.0207033361913658,0.00622169755475482,0.00850880898404634,0.0328978633986852,0.000878294922102236
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,42249,0.0131801244817985,0.00396375713382991,0.00541116049949184,0.0209490884641051,0.00088600918086335
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0209975710622587,0.00631485564822706,0.00862045399173371,0.0333746881327838,0.000886722224329637
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,42099,0.0171932954051385,0.0051762142303487,0.0070479155136551,0.027338675296622,0.000897416129116256
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,41976,0.0232494270452087,0.00700313621904095,0.00952328005588848,0.036975574034529,0.000903036443288228
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,39736,0.0167639349073157,0.00505861581850843,0.00684904790303913,0.0266788219115922,0.000922857415573993
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBN1,Drebrin,39657,0.0182246323932816,0.00550084356645866,0.00744297900302266,0.0290062857835406,0.000925770211396731
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.0150559513903478,0.00454562212411644,0.00614653202707961,0.023965370753616,0.000928596364276241
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSN,Gelsolin,39943,0.00676924757144639,0.00204415884969619,0.00276269622604185,0.0107757989168509,0.000930846415473455
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,0.0237544352452459,0.0071794354824221,0.0096827416996986,0.0378261287907932,0.000939795575597274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.031092093708381,0.00939712203912566,0.0126737345116947,0.0495104529050673,0.000940328648305415
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,0.0110269471261098,0.00333646105513707,0.00448748345804111,0.0175664107941784,0.000952843783035708
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,0.0302748108462822,0.00916223552643684,0.012316829214466,0.0482327924780984,0.000954653423800239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,0.0325485165853533,0.00985060953448896,0.013241321897755,0.0518557112729517,0.000954897595697238
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,-0.0163886810219077,0.00496119302288222,-0.0261126193467568,-0.00666474269705854,0.000957748744599588
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0125002220003476,0.00378622427311865,0.00507922242503502,0.0199212215756601,0.000964178783424207
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,41913,0.0165277326083014,0.00501418421664277,0.00669993154368154,0.0263555336729212,0.000982601207539467
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPART,Spartin,39736,0.0276419344488461,0.00839132312672379,0.0111949411204675,0.0440889277772247,0.000990422892399913
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.01076031761862,0.0032741506757408,-0.0171776529430719,-0.004342982294168,0.00101768974131813
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,41839,0.0252382061880545,0.00768151697768392,0.0101824329117941,0.040293979464315,0.00102038743903558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,41997,0.0222295670010882,0.00676769385824699,0.00896488703892413,0.0354942469632523,0.00102367886026443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0247125490468222,0.00753099881258254,0.00995179137416043,0.039473306719484,0.00103545988653015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,42296,0.0334226363646825,0.0101857044119245,0.0134586557173105,0.0533866170120545,0.00103577936616497
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.0300299079289795,0.00915452745137427,0.012087034124286,0.0479727817336731,0.00103952129957408
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.0185474569343549,0.00565451763787177,0.00746460236412628,0.0296303115045836,0.001040285823339
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.0276497968558948,0.00843716644159132,-0.0441866430814138,-0.0111129506303759,0.00105126946437483
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.0122755823561051,0.00375128586505802,0.00492306206059138,0.0196281026516188,0.00106975390633279
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,0.0316418333438803,0.00968246198297723,0.0126642078572449,0.0506194588305156,0.0010859958409983
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.0225314202329478,0.00690030339061428,0.00900682558734379,0.0360560148785518,0.00109680789147385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,42081,0.0382769916027209,0.0117303936094516,0.0152854201281958,0.0612685630772459,0.00110490051378072
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,41843,0.0280003550572556,0.00858111306325732,0.0111813734532712,0.0448193366612399,0.00110510492705445
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,0.0203925154904714,0.0062522594461326,0.00813808697605147,0.0326469440048913,0.00111103782963619
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,-0.0205180959120074,0.00629535672869864,-0.0328569951002567,-0.00817919672375805,0.00112039348048938
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.036139948970221,0.0110888828393323,0.0144057386051298,0.0578741593353122,0.00112098452309963
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,39575,0.0150433089806765,0.0046173867450483,0.00599323096038184,0.0240933870009712,0.00112553276060498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0213231832894507,0.00654856607160377,0.00848799378910736,0.0341583727897941,0.00113206649213106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.031478518009181,0.00966813364477982,0.0125289760654126,0.0504280599529495,0.00113312742281912
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,39906,0.0114244327591962,0.00351228606855615,0.00454035206482619,0.0183085134535663,0.00114647166119703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00990350811023883,0.00304883179769991,0.00392779778674701,0.0158792184337306,0.00116381235968876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,39759,0.00858160046671163,0.0026440955443543,0.0033991731997772,0.0137640277336461,0.00117560788290447
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,0.00936968737272775,0.00289782563083383,0.00368994913629343,0.0150494256091621,0.00122640310252358
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,0.0839518478354125,0.0259998056229276,0.0329922288144744,0.134911466856351,0.00124603377418383
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,0.0141275818659845,0.00437726487082045,0.00554814271917641,0.0227070210127926,0.00125236300051807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NADK,NAD kinase,42145,0.0189866329977997,0.00588403370858049,0.00745392692898195,0.0305193390666175,0.00125478014536686
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BGN,Biglycan,41820,-0.0408408996000157,0.0126811977910081,-0.0656960472703916,-0.0159857519296399,0.00128237742291457
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,42137,-0.0133748795994492,0.00415462328123642,-0.0215179412306726,-0.0052318179682258,0.0012881768567832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,0.0185230618899778,0.00575521015752929,0.00724284998122043,0.0298032737987352,0.00129178070288613
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0258169669119595,0.00802147314408375,0.0100948795495553,0.0415390542743636,0.00129233705081111
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,42143,0.0363625419696624,0.011322354320573,0.0141707275013394,0.0585543564379855,0.00132319851940228
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,42148,0.0325665996025738,0.0101411674926461,0.0126899113169873,0.0524432878881602,0.00132432193997386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.027789383779617,0.00866066369227217,-0.0447642846164704,-0.0108144829427635,0.00133652351716212
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,42137,0.0251469233240808,0.00784095695405795,0.0097786476941272,0.0405151989540343,0.00134380808659782
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,39919,0.0126626283567559,0.00394935755270888,0.00492188755344651,0.0204033691600653,0.00134850651097708
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,42119,0.0292953595827982,0.00914934408265046,0.0113626451808032,0.0472280739847931,0.00136836470767559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,42296,0.0122154786634946,0.00381689559939981,0.00473436328867093,0.0196965940383182,0.00137564196245674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0198502394432925,0.00620622760118952,0.00768603334496107,0.032014445541624,0.00138492110896431
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.016991296950429,0.00531422919924558,0.00657540771990766,0.0274071861809504,0.00139091388463001
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,0.0117201859576706,0.00367096009180945,0.00452510417772406,0.0189152677376171,0.00141289143398661
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,0.0118520618719699,0.00371575657913571,0.00456917897686389,0.0191349447670759,0.00142828166137148
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,41910,0.0250891661428512,0.00788891531008277,0.00962689213508893,0.0405514401506134,0.00147456832964904
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,42145,0.0284303153431452,0.00894165206326453,0.0109046772991468,0.0459559533871437,0.00147842480834577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,0.0174891116136689,0.00550238240240094,0.00670444210496302,0.0282737811223747,0.00148388558371003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,0.00998161261881328,0.00314073105637391,0.00382577974832041,0.0161374454893061,0.001486327797789
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,0.022441583727988,0.00706798763095709,0.00858832797131211,0.0362948394846639,0.00150119767900542
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.00949662063083058,0.00299452795134297,0.00362734584619837,0.0153658954154628,0.00152091558250869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,0.0274796342935813,0.00867451431250263,0.0104775862410761,0.0444816823460864,0.00153984037607475
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.012067089573015,0.00381563318965838,0.00458844852128462,0.0195457306247455,0.00156812777480869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,39919,0.00904546850966495,0.00286217670669201,0.00343560216454861,0.0146553348547813,0.00157997087374914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,39638,-0.0267593352368622,0.00847118513878449,-0.0433628581088798,-0.0101558123648446,0.00158811693261661
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,0.0192034864222637,0.0060846733790679,0.00727752659929067,0.0311294462452368,0.0016027319864019
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,41864,0.0168926912765888,0.00535298364857524,0.00640084332538133,0.0273845392277963,0.00160442616408114
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,0.00922032816876441,0.00292299940434316,0.00349124933625182,0.014949407001277,0.0016117719869794
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,39979,0.00877184185735485,0.00278253815254858,0.00331806707835964,0.0142256166363501,0.00162321085899686
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,42274,0.0182250952279036,0.00578853638057917,0.00687956392196838,0.0295706265338387,0.00164474506083968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,39492,0.023907533517452,0.00759694449051281,0.00901752231604685,0.0387975447188571,0.00165403401900935
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,0.0243083528482829,0.00772549637228119,0.00916637995861179,0.039450325737954,0.00165585117547896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.0378011676834767,0.0120169868489239,0.0142478734595859,0.0613544619073674,0.00166088250218898
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,42187,0.00922102919348052,0.00293160935823924,0.00347507485133162,0.0149669835356294,0.00166228210001894
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,42137,0.00914770298332884,0.00290902809586862,0.00344600791542635,0.0148493980512313,0.0016667895917672
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,39575,0.0203152918157985,0.00647061703553903,0.007632882426142,0.032997701205455,0.00169614610155484
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,42145,0.0238411013152823,0.00759702438500862,0.00895093352066543,0.0387312691098992,0.00170344367538759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0167227258498854,0.00533831554530236,0.00625962738109279,0.027185824318678,0.00173643191276421
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.0286421491029329,0.00914849524936649,0.0107110984141745,0.0465731997916912,0.00174783224269108
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0127625678897266,0.00408614007811233,0.0047537333366264,0.0207714024428267,0.00179172305742067
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,0.0206773286554259,0.00662120396702227,0.00769976888006229,0.0336548884307896,0.00179458577452934
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,41797,0.0159359174326659,0.00510344119737797,0.00593317268580506,0.0259386621795267,0.00179659239700155
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0130942381607817,0.00419370828707453,0.00487456991811563,0.0213139064034478,0.00179788256393061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,0.013473831267137,0.00431635987184522,0.00501376591832041,0.0219338966159537,0.00180348150397215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.0286424216637429,0.0091771685244246,0.0106551713558707,0.0466296719716152,0.00180587080436361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.024317152114991,0.00779364568396999,0.00904160657440978,0.0395926976555721,0.00181227952912303
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.0391725179028567,0.0125606505332311,0.0145536428577237,0.0637913929479897,0.00182052592966636
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.0207414097519419,0.00666775006091094,0.00767261963255646,0.0338101998713273,0.00187118682686778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,42119,0.0199457549850968,0.00641595628300479,0.00737048067040746,0.0325210292997862,0.00188255700188565
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,0.0105578306223328,0.00340107365277226,0.00389172626289919,0.0172239349817664,0.00191235062612902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0221986030554058,0.00716185166150525,0.00816137379885546,0.036235832311956,0.00194297360541177
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,42016,0.0201664055882532,0.00651694783372121,0.00739318783415966,0.0329396233423468,0.00197580030741058
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,39925,0.0103771244380709,0.00335428932612094,0.00380271735887385,0.0169515315172679,0.00198166612221708
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,0.0277256342294435,0.00896730099985412,0.0101497242697295,0.0453015441891576,0.00199398456086797
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,41839,-0.0248695585188874,0.00805336564300108,-0.0406541551791696,-0.00908496185860532,0.00201860774150556
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.00811150291189968,0.00262809096689006,0.00296044461679516,0.0132625612070042,0.00202961518127287
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,-0.034018373842173,0.0110430755146865,-0.0556628018509586,-0.0123739458333874,0.00207137149143039
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.018534165703769,0.00603520297984579,0.00670516786327128,0.0303631635442668,0.00213763106837099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.0300673743678999,0.00979307169634994,0.010872953843054,0.0492617948927458,0.0021438489908412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,0.0114326040898436,0.00372613424346565,0.00412938097265096,0.0187358272070363,0.00215770218897519
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00876886246380616,0.00286109742770052,0.00316111150551314,0.0143766134220992,0.00218302380121419
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0193933775037991,0.00632861657108426,0.00698928902447395,0.0317974659831243,0.00218540590636148
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.0219401434456356,0.00716099152559796,0.00790460005546361,0.0359756868358076,0.00218953778674983
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MB,Myoglobin,42310,0.0184650006093737,0.00603300918495423,0.00664030260686342,0.030289698611884,0.0022127539652353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.0110805808339829,0.00362059587535762,0.00398421291828199,0.0181769487496839,0.0022144799109748
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,42119,0.0104791892457112,0.00342511812282285,0.00376595772497836,0.0171924207664439,0.00222132152815823
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,39930,-0.0367649980035251,0.0120246979411722,-0.0603334059682227,-0.0131965900388276,0.00223743883756733
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,41839,0.0227022929508857,0.00742741837866587,0.00814455292870057,0.0372600329730708,0.00224344479603302
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,0.0119473596376793,0.00391119626466715,0.00428141495893173,0.0196133043164269,0.00225764108200656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,42048,0.0190723440677995,0.00624924052853069,0.00682383263187933,0.0313208555037196,0.00227806556112481
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.015693017099611,0.00515181111645645,0.00559546731135637,0.0257905668878657,0.00232351019329778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0129045397896265,0.00424011366635043,0.00459391700357964,0.0212151625756733,0.00234335587612911
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,0.0191558268578071,0.00630307045135322,0.00680180877315482,0.0315098449424594,0.00237715238441634
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,0.0159548586250194,0.00525343124415689,0.00565813338647194,0.026251583863567,0.00239474294719343
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.0224076197204699,0.00738892867066508,0.00792531952596635,0.0368899199149734,0.00243027918367277
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,42169,0.00890560567900316,0.00293802978466946,0.00314706730105103,0.0146641440569553,0.0024408442187272
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,41797,0.0229354394378168,0.00758021038850355,0.00807822707634982,0.0377926517992837,0.00248536352971493
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,39657,0.00966843124151851,0.00319579523585643,0.00340467257923992,0.0159321899037971,0.00248907949282247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,-0.0144104922930659,0.00476510283296877,-0.0237500938456847,-0.00507089074044713,0.00249782050444816
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.0163915881478209,0.00542011953469011,0.00576815385982831,0.0270150224358135,0.00249840284398276
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0159829841041673,0.00528606858323778,0.00562228968102125,0.0263436785273133,0.00250341165385584
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,0.0139306024853375,0.00461387620885844,0.00488740511597494,0.0229737998547,0.00253845566464781
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,39657,0.0273198481566457,0.00904831953752092,0.00958514186310466,0.0450545544501867,0.00253913661807825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.01993221678889,0.00660888128881307,0.00697880946281634,0.0328856241149636,0.00256737268467745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,-0.0215231427104303,0.00713682332411315,-0.0355113164256921,-0.00753496899516855,0.00256895415144452
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,0.00888172181037213,0.00294572558864488,0.00310809965662816,0.0146553439641161,0.00257443508828777
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,39908,0.0278021483260764,0.00924000917397747,0.00969173034508053,0.0459125663070722,0.00262783661091955
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,41839,0.0204743677580548,0.00681049338239667,0.00712580072855729,0.0338229347875522,0.00264946193402722
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,0.0091577738310464,0.00304778273135183,0.00318411967759681,0.015131427984496,0.00266308661299146
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BSG,Basigin,42284,0.00674188205280919,0.00224549563056718,0.00234071061689752,0.0111430534887209,0.00268341251245507
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0128081800944522,0.00426639222022204,0.00444605134281701,0.0211703088460874,0.00268708590164478
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.0202360920166637,0.00674719671456855,0.00701158645610933,0.0334605975772181,0.00271289389171797
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0169486851541782,0.00565280218196687,0.00586919287752311,0.0280281774308332,0.00272107314497726
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0215241851768383,0.00718581566609887,0.00743998647128453,0.0356083838823921,0.00274703556311606
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0217116138605041,0.00725165519213606,0.00749836968391742,0.0359248580370908,0.00275930977301728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,0.0179156799398556,0.00598632545712232,0.00618248204389589,0.0296488778358154,0.00277071382992209
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSPN,Persephin,42119,0.0277992464849475,0.00929187754760737,0.00958716649163709,0.046011326478258,0.00277857116183817
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.0175860305101173,0.00587880495700423,0.00606357279438902,0.0291084882258456,0.00278183145974235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0119803551478063,0.00400948325951874,0.0041217679591496,0.0198389423364631,0.00281307129967701
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0172349140842455,0.00576849703630591,0.00592865989308595,0.0285411682754051,0.00281531816644826
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.0346808162848584,0.01160751841208,0.0119300801971816,0.0574315523725352,0.0028160397984863
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,0.040520075384737,0.0135643538097257,0.0139339419176746,0.0671062088517994,0.00282009067778373
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0211915503588965,0.00709893685383276,0.00727763412538427,0.0351054665924087,0.002840235818214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.00841501273153307,0.00282079863804256,0.00288624740096965,0.0139437780620965,0.00285857167141571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,0.0147026607862216,0.00493394939551354,0.00503211997101503,0.0243732016014281,0.00288956961145502
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,0.0097110222713691,0.00326078039582552,0.00331989269555107,0.0161021518471871,0.00290533096518587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,0.0242921612465431,0.00815664639319637,0.00830513431587821,0.040279188177208,0.00290575596895826
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.016554640543191,0.0055625365016574,0.00565206899994246,0.0274572120864395,0.00292569954000064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0207416560271868,0.00696978189213879,0.00708088351859475,0.0344024285357788,0.00292603480947012
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.010998404617068,0.00370120571507002,0.00374404141553073,0.0182527678186052,0.00296915638959026
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0172847475107389,0.00581806105133374,0.0058813478501248,0.0286881471713531,0.00297483150167654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,42145,0.0119730453092107,0.00403316804963808,0.00406803593192006,0.0198780546865013,0.00299639225302288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.0262992910775818,0.00886150404646373,0.00893074314651284,0.0436678390086507,0.00300462689245755
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.0265487221728155,0.00894791386420081,0.00901081099898192,0.0440866333466491,0.00301331320491314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.0316654936082383,0.0106760700679818,0.0107403962749939,0.0525905909414826,0.00302203057975644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,42210,0.0134827810582672,0.00454668912548877,0.00457127037230916,0.0223942917442251,0.00302807794233153
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0122243974844896,0.00412803510907152,0.00413344867070938,0.0203153462982698,0.00306968698662387
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.00883962610855678,0.00298580376286139,0.00298745073334847,0.0146918014837651,0.00307741809972344
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,42310,0.00849436881402364,0.0028722899040554,0.00286468060207506,0.0141240570259722,0.00310824073242691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.00884133621777746,0.00299034380361297,0.00298026236269604,0.0147024100728589,0.00311558846908215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,-0.0290255394790674,0.00982250629838144,-0.048277651823895,-0.00977342713423978,0.00313204812006585
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,0.0161460569486383,0.00546735349995455,0.00543004408872735,0.0268620698085492,0.00315189321102966
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,41913,-0.00868034697815144,0.00294038278703854,-0.014443497240747,-0.0029171967155559,0.00316156501340029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0239788831177205,0.00814430132191384,0.00801605252676935,0.0399417137086716,0.00324392731312503
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,41992,-0.0163984983837145,0.00557222919257059,-0.0273200676011528,-0.00547692916627612,0.0032571390467393
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.0154698134501773,0.00526568395658689,0.00514907289526699,0.0257905540050876,0.00331179467531183
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,42145,0.0388422425081793,0.0132225600506993,0.0129260248088087,0.0647584602075499,0.00331348944005371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARTN,Artemin,41913,0.0142478891961191,0.00485858376885763,0.00472506500915814,0.02377071338308,0.00336797013797745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,0.0114350584885522,0.00389927837667929,0.00379247287026081,0.0190776441068436,0.00336800488556879
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.0228784983865001,0.00781246700483922,0.00756606305701519,0.0381909337159849,0.00341213957856425
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,0.0241380927507662,0.00824272036361175,0.00798236083808716,0.0402938246634452,0.00341374912912233
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,0.0198807997407849,0.00679152033011724,0.00656941989375514,0.0331921795878147,0.00342623686541323
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0110604741215115,0.00379136896601261,0.00362939094812678,0.0184915572948962,0.00353795973411934
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,0.0125810402611296,0.00431535457208019,0.00412294529985241,0.0210391352224068,0.00355811756238824
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,0.00639983021565267,0.00219925865578457,0.0020892832503149,0.0107103771809904,0.00362156088529802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,0.0110275812580032,0.00379238782075114,0.00359450112933098,0.0184606613866754,0.00364545126546597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,41697,-0.0125421424622114,0.0043223080823836,-0.0210138663036833,-0.00407041862073957,0.00371734400305751
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0201364640333716,0.00694552814601685,0.00652322886717862,0.0337496991995647,0.00374836404715465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0170294717939303,0.00588925157812712,0.00548653870080117,0.0285724048870595,0.00383882704068628
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,0.00887056056218146,0.00307056121879882,0.00285226057333577,0.0148888605510271,0.00387193762327887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,39966,0.0178606126811299,0.00618950029489028,0.00572919210314494,0.0299920332591149,0.00391365123344924
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0228500767018374,0.0079315931420737,0.00730415414337292,0.0383959992603018,0.00397186101784654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,42119,0.0210833833231336,0.00734494335988311,0.00668729433776267,0.0354794723085045,0.00410508090874698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,0.015293222942642,0.0053294419585437,0.00484751670389638,0.0257389291813877,0.00411786704823106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,-0.0140643833786493,0.00490504308460826,-0.0236782678244815,-0.00445049893281711,0.00414715396206012
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.0245793794658418,0.00857290511739409,0.00777648543574938,0.0413822734959342,0.00415016233896805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0125492006303639,0.00438589477936149,0.00395284686281538,0.0211455543979124,0.00422728560669563
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0139944795150013,0.00489864635771824,0.00439313265387356,0.0235958263761291,0.00428709575517124
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00701364937678052,0.00245750149560049,0.00219694644540356,0.0118303523081575,0.00432405491099801
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,0.0137185108338071,0.00480833815849146,0.00429416804316384,0.0231428536244504,0.00433780079914634
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,0.0126944391952961,0.00445694288041687,0.00395883114967902,0.0214300472409132,0.00440429816390106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,39638,-0.0192849896467046,0.00678451532738616,-0.0325826396883815,-0.00598733960502777,0.00448432520940195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,39919,0.0261764932924734,0.0092106306498957,0.00812365721867781,0.044229329366269,0.00449134666584886
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,39929,0.0258705351843425,0.00911454980565659,0.00800601756525564,0.0437350528034295,0.00454241148506897
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0208731876608794,0.00735767835988969,0.00645213807549561,0.0352942372462632,0.00456193713800807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,41900,-0.0428420732472323,0.0151088418406426,-0.0724554032548917,-0.0132287432395728,0.00458140222518466
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,39854,0.0131603130009482,0.00464185571358456,0.00406227580232251,0.022258350199574,0.00458871936230531
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.0100750969662836,0.00355501919789826,0.00310725933840301,0.0170429345941642,0.00460433625926253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.00945327795609353,0.00334334020874752,0.00290033114694838,0.0160062247652387,0.00469817133247181
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.0220997145831309,0.00782531808876178,0.00676209112915778,0.037437338037104,0.00474917380555743
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0211338324619569,0.00748461751140384,0.00646398213960538,0.0358036827843084,0.0047567864003553
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGRN,Neugrin,39929,0.0068192215469616,0.00241708226659218,0.00208174030444093,0.0115567027894823,0.00479183840534754
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0145615831907813,0.00516366958948138,0.00444079079539778,0.0246823755861648,0.00481087370406554
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.0101293800384538,0.00359471571890589,0.00308373722939824,0.0171750228475093,0.00484153908642862
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,41913,-0.0250430644140112,0.00888895405812825,-0.0424654143679426,-0.00762071446007987,0.00484969576101131
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,39586,0.0165260556490051,0.00587825212076691,0.00500468149230192,0.0280474298057082,0.00494154284592074
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.0317671581012171,0.011302928268383,0.00961341869518636,0.0539208975072479,0.0049547144775261
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,0.00826619193397993,0.00294379090844085,0.00249636175343586,0.014036022114524,0.00499343631561805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,0.0236128078491605,0.00841805598523258,0.00711341811810465,0.0401121975802164,0.00503869258159544
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0207532370858989,0.00740216290938234,0.00624499778350948,0.0352614763882882,0.00505965394741515
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,0.0265765330981836,0.00948093032564795,0.00799390965991358,0.0451591565364535,0.00506910839286396
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,42119,-0.0101849406388196,0.00363985618919175,-0.0173190587696354,-0.00305082250800378,0.00514655966389699
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,39930,0.0210382932937995,0.00752572145602427,0.0062878792399919,0.0357887073476071,0.00519037415985175
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,0.0197003112234729,0.00705303318500308,0.00587636618086685,0.0335242562660789,0.0052268992424548
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,0.0195240948537847,0.00699406612977797,0.00581572523941988,0.0332324644681495,0.00525480330213409
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,0.00892239249132434,0.00320017492847348,0.00265004963151633,0.0151947353511324,0.00530926518982434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,39934,0.0320675921048447,0.0115165478134464,0.00949515839048986,0.0546400258191996,0.00537026126720217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,0.0141560137147064,0.0050854923494311,0.0041884487098214,0.0241235787195913,0.00538330017543717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0155377883851336,0.00558449128020274,0.00459218547593618,0.0264833912943309,0.00540656917464755
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,42144,0.00971996985111321,0.00350585719570556,0.00284848974753031,0.0165914499546961,0.00557044626674187
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,42119,0.01512730154617,0.00547405241476167,0.00439815881323717,0.0258564442791029,0.00572702215913549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.0230353573031631,0.00833770736560452,0.00669345086657826,0.039377263739748,0.00573868910368436
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,0.00745826718984057,0.00270016407842865,0.00216594559612043,0.0127505887835607,0.00574987017120264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,0.0181608306569597,0.00658228038498648,0.00525956110238617,0.0310621002115332,0.00580654426271406
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,41900,0.00964705301446163,0.00350039260765207,0.00278628350346357,0.0165078225254597,0.00585941643912301
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,42119,0.0118595372985983,0.00430371747455127,0.00342425104847783,0.0202948235487188,0.0058654152960747
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,0.00947971102612699,0.00344117748606057,0.00273500315344828,0.0162244188988057,0.00588083479547944
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,39657,0.0089030022517002,0.00323412211911126,0.00256412289824213,0.0152418816051583,0.00591781804315534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,0.0101446619148646,0.00368868850329241,0.00291483244841146,0.0173744913813177,0.00596362111452111
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,42119,0.0165174142445382,0.0060079600601059,0.00474181252673059,0.0282930159623457,0.00598102188033867
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,0.0181105943146611,0.0065876876591723,0.00519872650268341,0.0310224621266388,0.00598291381689744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,0.036570204420042,0.0133075018833884,0.0104875007286008,0.0626529081114832,0.00600409259103742
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,42296,0.00271750302680846,0.000988971812456982,0.000779118274392772,0.00465588777922414,0.00600739257289869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,0.012982440301698,0.00473112934341584,0.00370942678860296,0.0222554538147931,0.0060782493004276
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0497818409539953,0.0181490223310216,0.014209757185193,0.0853539247227977,0.00609714555374693
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,-0.013078043136484,0.00477071341955104,-0.022428641438804,-0.00372744483416398,0.00612736519879922
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,-0.0293972894141647,0.0107523594388197,-0.0504719139142513,-0.0083226649140782,0.00626454999393709
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0119984779663628,0.00439726960951132,0.00337982953172065,0.020617126401005,0.00636840004240103
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.0142046541813039,0.00520666932884434,0.00399958229676896,0.0244097260658388,0.00637891814402098
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,39990,0.0272005392889245,0.00997164003498899,0.00765612482034609,0.0467449537575029,0.00638579099178813
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,0.0118656287093967,0.00435184929666101,0.00333600408794113,0.0203952533308523,0.00640785575788158
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,42310,0.0256868086123878,0.00946634979704339,0.00713276301018281,0.0442408542145929,0.00666625370800368
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,39736,0.018848059334736,0.0069550571454185,0.00521614732971569,0.0324799713397562,0.00673904710995447
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,0.00988727081264685,0.00364926018715747,0.0027347208458182,0.0170398207794755,0.00675108130807997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,0.0165663241759331,0.00611792703739747,0.00457518718263406,0.0285574611692321,0.00678092716689724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,0.0150001449361281,0.00554135478038609,0.0041390895665714,0.0258612003056849,0.00679921153571901
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,39929,-0.0200957586744028,0.00742545046033851,-0.0346496415766663,-0.00554187577213931,0.00681322067609566
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0191940052879133,0.00709470695675445,0.00528837965267461,0.0330996309231521,0.00683246206867793
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0216651597054574,0.00801139126303626,0.00596283282990632,0.0373674865810085,0.00685534507049077
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.0264783401820533,0.00979337485764286,0.00728332546107333,0.0456733549030333,0.00686771833470978
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.0212431344344378,0.00785749279346791,0.00584244855924067,0.0366438203096349,0.00686893062236025
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,0.0129837167642976,0.00480877649215087,0.00355851483968186,0.0224089186889133,0.00694441112568538
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,42299,0.00986061574627881,0.00365343649268366,0.00269988022061883,0.0170213512719388,0.00696340123820836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,-0.0138479470598517,0.00513206374553782,-0.0239067920011058,-0.00378910211859752,0.00697934777187658
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,0.0111907126740715,0.00414790192028113,0.00306082491032048,0.0193206004378225,0.00698595525703159
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,0.0101294763301439,0.0037600310793097,0.00275981541469687,0.0174991372455909,0.00707102115147995
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.0346038708627623,0.012850110449679,0.00941765438139143,0.0597900873441332,0.00709237009442869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.014004960467434,0.00521136574731214,0.00379068360270216,0.0242192373321658,0.0072118564993351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,0.0140711797126771,0.00524207864972078,0.00379670555922438,0.0243456538661298,0.00727773738260717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,0.021121490687247,0.00787910286951464,0.00567844906299831,0.0365645323114957,0.00735752100283537
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0182857177093545,0.00682726086177604,0.00490428642027344,0.0316671489984355,0.00740796858627574
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,39638,-0.015407734340168,0.005762874330787,-0.0267029680285105,-0.00411250065182548,0.00751479181004016
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,41913,0.0097938862944337,0.00366411112165074,0.00261222849599824,0.0169755440928692,0.00752852002101463
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,42262,0.00636310927860903,0.00238137509762043,0.00169561408727298,0.0110306044699451,0.00754830149743698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0161706119686391,0.00605783614221368,0.00429725312990032,0.0280439708073779,0.00760857453562267
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0183790729449106,0.00688713092597725,0.00488029632999516,0.031877849559826,0.00762769566785637
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,42249,-0.00923445509233873,0.0034618082221604,-0.0160195992077731,-0.00244931097690435,0.00765027181883953
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,39919,0.0300845754962201,0.0112930812063196,0.00795013633183366,0.0522190146606065,0.00773308780668271
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCT,Secretin,39649,-0.013844336125872,0.00519882482631495,-0.0240340327854493,-0.00365463946629469,0.00775656178506942
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,42110,0.00844891745615965,0.00317445598463049,0.00222698372628388,0.0146708511860354,0.00778778703639421
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,42018,0.0136918472820785,0.00515548185737568,0.00358710284162215,0.0237965917225348,0.00792177447702539
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,0.013530893125473,0.00509800110030499,0.00353881096887519,0.0235229752820708,0.00796019271398785
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0253494817028701,0.00955528647575054,0.00662112021039905,0.0440778431953412,0.00799110378902717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0110651234010524,0.00417475275866079,0.00288260799407721,0.0192476388080275,0.00804685632921125
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.0205659153440962,0.0077657745065441,0.0053449973112698,0.0357868333769226,0.00809982148681578
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,39586,0.0118493435449942,0.00448466614199105,0.00305939790669178,0.0206392891832967,0.00824883933265527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.012079262630507,0.00457195871460836,0.00311822354987464,0.0210403017111394,0.00825264250758257
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,41843,0.0109746411947419,0.00415433630077919,0.00283214204521473,0.0191171403442691,0.00825803284021843
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,42262,0.00957582970351751,0.00362695997696752,0.00246698814866118,0.0166846712583738,0.00829560145860525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,42310,0.0129792810787639,0.00492274013945181,0.00333071040543839,0.0226278517520895,0.00838366825758392
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0120851253521828,0.00459371704828507,0.00308143993754408,0.0210888107668216,0.00852824994128529
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,0.0159287451386137,0.00605954571048042,0.00405203554607212,0.0278054547311553,0.00858081469501714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0125369494165803,0.00478565632131277,0.00315706302680724,0.0219168358063533,0.00881292227758597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,0.0146058703383314,0.00558397308584637,0.00366128309007257,0.0255504575865903,0.00891513036102369
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,39966,0.0140244956364592,0.00536203079765347,0.00351491527305844,0.02453407599986,0.00892095708750249
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,39919,0.00992971172466487,0.00379721571219546,0.00248716892876177,0.017372254520568,0.00893462613667691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,39575,0.0110531956695767,0.00423007595926795,0.00276224678941151,0.0193441445497419,0.00898732457668934
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,0.0120154082009942,0.00460446275976445,0.00299066119185585,0.0210401552101325,0.00907709365557464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,39575,0.00875702433298868,0.00335769127214534,0.00217594943958381,0.0153380992263936,0.00911831798473255
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,0.013719443476256,0.00526872693759334,0.00339273867857304,0.0240461482739389,0.00922799109265945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,42115,0.02590821559976,0.00995129838590665,0.00640367076338299,0.0454127604361371,0.00923778527987306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,39900,0.0147359218700969,0.00567024751759069,0.00362223673561915,0.0258496070045746,0.00936678061742119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0187067768643275,0.00720168601657265,0.00459147227184511,0.0328220814568099,0.00940133449391169
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,0.0102465149207715,0.00394501504220168,0.00251428543805621,0.0179787444034868,0.00940763913116704
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0072425823988981,0.00279135180959705,0.00177153285208787,0.0127136319457083,0.00947895926988943
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,41900,0.0145387799298853,0.0056035737372883,0.00355577540480019,0.0255217844549703,0.00948173929757847
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,41913,0.0222656236264211,0.00859431143359469,0.00542077321657555,0.0391104740362667,0.00958743332302998
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0123616286779499,0.00477880445934657,0.00299517193763058,0.0217280854182691,0.00970060179147247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0141283780560438,0.00546720979767667,0.00341264685259757,0.0248441092594901,0.00977073039374907
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,42262,-0.00461733884991403,0.00178833026593486,-0.00812246617114636,-0.0011122115286817,0.00983533976743064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_DRA,,42060,0.0100723271144651,0.00390869442996647,0.00241128603173086,0.0177333681971994,0.00997953547602843
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.00897121177251181,0.00349045545692656,0.00212991907693576,0.0158125044680879,0.0101762470779402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,0.00701056942225281,0.00272809429451533,0.00166350460500277,0.0123576342395029,0.0101871324919825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,41839,0.015269537647695,0.00594917198082265,0.00360916056528261,0.0269299147301074,0.0102790368462805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,41751,-0.0299630269316174,0.0116804705899158,-0.0528567492878524,-0.00706930457538251,0.0103219008852549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.0287298183757124,0.0112092232190619,0.0067597408663511,0.0506998958850737,0.0103863840733095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,39925,0.00706250741754579,0.00276203268830373,0.00164892334847048,0.0124760914866211,0.0105709512950985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,0.00784440872696923,0.00307538594501673,0.00181665227473644,0.013872165179202,0.0107634644691546
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,0.0374762365123478,0.0147374784458584,0.00859077875846528,0.0663616942662303,0.011004111386503
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,0.010593418741995,0.00416734934651053,0.00242541402283437,0.0187614234611556,0.0110331848127351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0106334661266136,0.0041850127769863,0.00243084108372041,0.0188360911695067,0.0110698298145145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPARC,SPARC,42181,0.0190936131713182,0.0075253311447006,0.00434396412770504,0.0338432622149314,0.011183944401221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0180373935044413,0.00712448668548438,0.0040733996008919,0.0320013874079907,0.0113632395452164
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0130108407301944,0.00514323125283868,0.00293010747463058,0.0230915739857582,0.0114293899029441
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,42035,0.0184633865538613,0.00730103638237565,0.004153355244405,0.0327734178633175,0.0114543223494426
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,39736,0.013861259477821,0.00548721284718623,0.00310632229733597,0.024616196658306,0.0115473440084794
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,0.0117766049801265,0.00466203505807806,0.0026390162662935,0.0209141936939595,0.0115483150848146
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,0.00985214520303971,0.00390186257651697,0.00220449455306645,0.017499795853013,0.011581756348401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,42079,0.00779869559993243,0.00308865723176139,0.00174492742568011,0.0138524637741848,0.0115829511438716
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0188052837120147,0.00745653463603587,0.00419047582538443,0.033420091598645,0.011683431328774
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.020565669172345,0.00816326008858703,0.00456567939871446,0.0365656589459756,0.0117729775122593
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,41839,0.019893232717687,0.0079083276939298,0.00439291043758459,0.0353935549977894,0.0118988137161406
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,42249,-0.0101191940293032,0.00402431613539441,-0.0180068536546762,-0.00223153440393013,0.011931103878997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0117471028893001,0.00467262799890807,0.00258875201144024,0.0209054537671599,0.0119499058076431
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,0.0104407116966864,0.00415387995020065,0.0022991069942931,0.0185823163990797,0.0119682363150612
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,0.0128299778186412,0.00510570549505348,0.00282279504833635,0.022837160588946,0.0119894551597322
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,0.00770992682255296,0.00306834800448582,0.00169596473376074,0.0137238889113452,0.0119916542995398
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.00701211885841497,0.0027910644413887,0.00154163255329312,0.0124826051635368,0.0120047428710204
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.0209173517138532,0.00834324484817867,-0.0372701116162834,-0.00456459181142303,0.012184194563386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.0109694032201677,0.00437723156593683,-0.0195487770894039,-0.00239002935093154,0.0122239810898102
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,39929,0.0177433726856307,0.00709136265960107,0.00384430187281258,0.0316424434984488,0.0123595228606301
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.00809786827492648,0.00323978568079063,0.00174788834057685,0.0144478482092761,0.0124506433435775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.00725896059059582,0.0029082129581677,0.00155886319258712,0.0129590579886045,0.0125713124687092
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,39934,-0.012587186608584,0.00505554102548702,-0.0224960470185385,-0.00267832619862943,0.012796427905466
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0100199887084959,0.00402445194597571,0.00213206289438353,0.0179079145226083,0.0127965404727471
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0109508652903211,0.00440147655177971,0.00232397124883288,0.0195777593318093,0.0128607171071691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0189107391419289,0.00760331115935987,0.00400824926958359,0.0338132290142743,0.0128908285232624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0215868548625668,0.00871456082230233,0.0045063156508542,0.0386673940742793,0.0132602451126472
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,39990,0.0195449613296276,0.00789844079574282,0.00406401736997172,0.0350259052892836,0.0133554602697027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.0167908501259902,0.00679072008709638,0.00348103875528125,0.0301006614966991,0.0134252421704283
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,42167,0.00558968678796904,0.00226770727086001,0.00114498053708341,0.0100343930388547,0.0137171885909261
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,0.0180249230019593,0.00731501872396696,0.00368748630298408,0.0323623597009346,0.0137508502617587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.0129546573483232,0.00526369864273838,-0.0232715066880904,-0.00263780800855598,0.013862340122221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,0.0205068652024984,0.00833403576130857,0.00417215511033362,0.0368415752946632,0.0138850568121129
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,39929,0.025985286450381,0.0105671116069851,0.00527374770069028,0.0466968252000717,0.0139445152432205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANG,Angiogenin,42152,0.00865041343621778,0.00352294351792378,0.00174544414108717,0.0155553827313484,0.0140832795986573
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,-0.0191737276986835,0.00782385526556321,-0.0345084840191873,-0.00383897137817957,0.0142743510135384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,-0.0186723409012736,0.00761967560999768,-0.0336069050968691,-0.00373777670567819,0.0142768766447132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0134328844491284,0.0054815859358643,0.00268897601483438,0.0241767928834224,0.0142794270360242
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.00902922259958579,0.00368893131717668,0.00179891721791949,0.0162595279812521,0.0143940407231224
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0276464659076459,0.0112994907474611,0.00549946404262217,0.0497934677726696,0.0144298138140798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,0.028675178756815,0.0117226921024063,0.00569870223609869,0.0516516552775314,0.0144551635718829
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,0.00756536631192359,0.00309298925451616,0.00150310737307192,0.0136276252507753,0.0144588393441062
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.00961601727394714,0.00393513852106707,0.00190314577265568,0.0173288887752386,0.0145531784176001
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LXN,Latexin,41960,0.0179508954557783,0.00736837188232153,0.00350888656642814,0.0323929043451285,0.0148550727510851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,0.011819102775844,0.00486229272485987,0.00228900903511866,0.0213491965165693,0.0150800667035134
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,42062,0.00843358954621158,0.00347056508581959,0.00163128197800519,0.015235897114418,0.015110408043161
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00479588755437662,0.00197757079024562,0.000919848805495198,0.00867192630325805,0.0153179096680222
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,39638,0.0077870700905593,0.00321266911256542,0.00149023862993108,0.0140839015511875,0.0153723557182274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.0206764206500422,0.00853352119919748,0.00395071909961511,0.0374021222004692,0.0154104192808207
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,0.025132551392989,0.0103904551784778,0.0047672592431725,0.0454978435428054,0.0155874550736044
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,42070,-0.0101829891077684,0.00421116717998689,-0.0184368767805427,-0.00192910143499411,0.0156153156751954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,39638,0.0307703270790101,0.012740091457758,0.00579974782180443,0.0557409063362158,0.0157411610197756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,42262,-0.0104382769083247,0.0043259339475566,-0.0189171074455356,-0.00195944637111373,0.0158369236781634
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,0.00819315386246013,0.00339749588926458,0.00153406191950155,0.0148522458054187,0.0158993840779591
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,0.0178318843818506,0.00740578697168007,0.00331654191735767,0.0323472268463435,0.0160608471563908
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.00822523612689815,0.00341794937627448,0.00152605534940016,0.0149244169043961,0.0161205724069397
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,39930,-0.0247511236949984,0.0102872813790081,-0.0449141951978544,-0.00458805219214249,0.0161445022550333
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,42262,-0.0120845490135646,0.00502405695917723,-0.021931700653552,-0.00223739737357726,0.0161707762716038
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EZR,Ezrin,42249,0.0062904527812266,0.00261546006612603,0.00116415105161957,0.0114167545108336,0.0161811006615331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.0223534033106495,0.00929546304831355,0.0041342957359549,0.040572510885344,0.0161991234046186
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,0.0113084830220411,0.00470603432286996,0.00208465574921596,0.0205323102948662,0.0162782732275545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.0176213705495204,0.00733776383130852,0.00323935344015571,0.0320033876588851,0.0163433411560813
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.014635543113998,0.00609831190833326,0.00268285177366484,0.0265882344543312,0.0164145123600734
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0134770099347835,0.00562149723415657,0.00245887535583657,0.0244951445137303,0.016527732307871
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,0.00727571633139996,0.00303566978173091,0.00132580355920738,0.0132256291035925,0.0165576436577689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,-0.021093344455389,0.00880163432110706,-0.0383445477247588,-0.00384214118601917,0.0165650458831999
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.0182593205405796,0.00762771310620643,0.003309002852415,0.0332096382287442,0.0166909063398549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.0072943414811049,0.00305034000047878,0.0013156750801665,0.0132730078820433,0.0168043736088843
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0163531893839069,0.00685164059543652,-0.0297824049509625,-0.00292397381685135,0.0170115025767035
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAYN,Layilin,41997,0.00917798054840168,0.00384615216162618,0.00163952231161437,0.016716438785189,0.0170337721139808
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0316628978796913,0.0133031067507306,0.00558880864825932,0.0577369871111232,0.0173213954516504
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,41839,0.0118951497135332,0.00500190251449047,0.00209142078513187,0.0216988786419345,0.0174150299733478
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,0.0202662682188013,0.00852265590867665,0.00356186263779503,0.0369706737998075,0.0174243014264684
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,0.00630752800747585,0.0026528890555422,0.00110786545861314,0.0115071905563386,0.0174418736727348
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0114598943408649,0.00482319689931767,-0.0209133602635276,-0.0020064284182023,0.0175184580613417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.0285052364913995,0.012009923720478,0.0049657859992627,0.0520446869835363,0.0176356752358613
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,0.021962511485787,0.00925962399472326,0.00381364845612941,0.0401113745154446,0.0177131170746364
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.0184791330530413,0.0078000446765067,0.0031910454870882,0.0337672206189944,0.0178480669817954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,39638,0.00750229639925731,0.00316835671696261,0.00129231723401059,0.013712275564504,0.0179073525419224
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,42296,-0.0101762591624148,0.00430477966418266,-0.0186136273042128,-0.00173889102061679,0.0180954094535602
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0133777341823584,0.00566090302451793,0.00228236425430326,0.0244731041104135,0.0181360895214521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,-0.0370530145616178,0.0156988068098535,-0.0678226759089307,-0.0062833532143049,0.0182772502214455
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,42247,0.00775946089901744,0.00329520066408492,0.001300867597411,0.0142180542006239,0.0185479346625953
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,42137,-0.0100420432929076,0.0042748255099927,-0.0184207012924933,-0.00166338529332196,0.018832546857194
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,41839,0.0126748957987964,0.00539789254877396,0.00209502640319943,0.0232547651943934,0.018883109058134
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0156588357449575,0.00666949106970923,0.0025866332483274,0.0287310382415876,0.0189002085714771
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,39934,0.00762853858762413,0.00325630231755139,0.0012461860452234,0.0140108911300248,0.0191619881184807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0194576587367317,0.00830751180936206,-0.0357403818830813,-0.00317493559038202,0.0191888263707511
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.0184232520390018,0.00786669934153669,0.00300452132958985,0.0338419827484137,0.019202041735018
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,0.0168362341399732,0.00719019017678843,0.0027434613934679,0.0309290068864785,0.0192183063480788
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.00872145948430558,0.00373757790836607,0.00139580678390808,0.0160471121847031,0.0196388026728409
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,0.01201012449773,0.00515229008542859,0.00191163593029,0.0221086130651701,0.0197668301365535
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,39914,0.0245044463706888,0.0105123379615338,0.00390026396608252,0.045108628775295,0.0197698991776616
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,39958,0.0188294534411569,0.00807806415686298,0.00299644769370548,0.0346624591886084,0.0197741251323703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,0.0057711100173399,0.0024771869230019,0.000915823648256166,0.0106263963864236,0.0198366301465422
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0104512154999655,0.00449386565394986,0.00164323881822379,0.0192591921817072,0.0200541167962305
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,0.013883235345622,0.00597220278891446,0.00217771787934965,0.0255887528118943,0.0201091096898218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.0131256638951652,0.00564871744923873,0.00205417769465725,0.0241971500956731,0.0201589200067214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.00993535930094169,0.0042768563768994,0.00155272080221888,0.0183179977996645,0.0201909210741247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,0.00791856466147023,0.0034096601756174,0.00123563071726014,0.0146014986056803,0.0202267097233314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.014007798029263,0.00603261658152958,0.00218386952946501,0.0258317265290609,0.0202500165612126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.025516323307564,0.0109913552844788,0.0039732669499856,0.0470593796651423,0.0202785169753324
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00977081914698918,0.00420981896549162,0.0015195739746256,0.0180220643193528,0.020307161367095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0156825617491895,0.0067690879045317,0.00241514945630734,0.0289499740420716,0.0205329552009722
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,39657,0.00768572502277748,0.00331876869826296,0.00118093837418209,0.0141905116713729,0.0205854094919021
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,-0.0254766083601775,0.0110094318892474,-0.0470550948631024,-0.00389812185725261,0.0206786358639123
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,0.00821349288070574,0.0035504772290511,0.00125455751176558,0.0151724282496459,0.0207181955699929
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,-0.0058401337849882,0.00252554135087905,-0.0107901948327111,-0.000890072737265263,0.0207688180059999
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.00704186132638865,0.00304664982614877,0.00107042766713706,0.0130132949856402,0.0208316159113811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,0.0207183361458659,0.00897593622291979,0.00312550114894312,0.0383111711427887,0.0210059988840914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.00595162865450195,0.00258209061834764,0.000890731042540584,0.0110125262664633,0.0211835833412496
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,0.0185689496468568,0.00806076335559819,0.00276985346988435,0.0343680458238293,0.0212624640168031
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.00662223380234772,0.0028773646733009,0.000982599042677948,0.0122618685620175,0.021378985055458
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MENT,Protein MENT,39736,-0.00589545996173388,0.00256487408309766,-0.0109226131646053,-0.000868306758862467,0.0215496336223613
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,0.0129915103301658,0.00565767048093376,0.00190247618753563,0.024080544472796,0.0216792182211964
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.0254141103317728,0.011072797889425,0.00371142646849977,0.0471167941950459,0.0217407585942597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,0.00946396270690072,0.00412645494046428,0.00137611102359074,0.0175518143902107,0.0218356884532866
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,39934,0.00858102018577374,0.00374268755942794,0.00124535256929498,0.0159166878022525,0.0218810429799169
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,39657,0.0157806120815782,0.00688399563698522,0.00228798063308721,0.0292732435300693,0.0219034398908618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.009400310497888,0.00410264975775964,0.00135911697267911,0.0174415040230969,0.0219660662603154
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,0.00753516252791283,0.00329015650450842,0.00108645577907632,0.0139838692767493,0.0220272030659089
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,0.00687309598499229,0.00300656355207056,0.000980231422934004,0.0127659605470506,0.0222713014441206
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALLD,Palladin,39657,0.00938752193127068,0.00410973325469165,0.00133244475207504,0.0174425991104663,0.0223776552926728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.00676580632918397,0.00296664384216708,0.000951184398536499,0.0125804282598314,0.0225859780341176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,0.0116692582918403,0.00512191747470163,0.0016303000414251,0.0217082165422555,0.0227279139701868
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTR,Transthyretin,39862,-0.00610699778446783,0.0026806458647119,-0.0113610636793032,-0.000852931889632514,0.0227344127552449
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,0.0218499213125477,0.00961571659177548,0.00300311679266775,0.0406967258324276,0.0230862623022117
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,0.0080706780251848,0.00356063754046568,0.00109182844587207,0.0150495276044975,0.0234314168020127
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,41839,0.0119840270595247,0.00528747120866183,0.00162058349054753,0.0223474706285019,0.0234371583890292
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,-0.0211348258711846,0.00932959453530247,-0.0394208311603775,-0.0028488205819918,0.0235067723589084
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,42217,0.00722142135949579,0.00318793238918641,0.000973073876690417,0.0134697688423012,0.0235138005990785
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,0.0134544361171062,0.00594347486434781,0.00180522538298448,0.0251036468512279,0.023606697331684
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,39560,-0.00975229575146375,0.00431003616750031,-0.0181999666397644,-0.00130462486316315,0.0236740058018898
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.00807270421490143,0.00357659862351082,0.00106257091282023,0.0150828375169826,0.024018180507029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.0165473292221556,0.00734560239457917,0.00214994852878046,0.0309447099155308,0.0242987068855905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0174251039238288,0.00775135844745885,0.00223244136680944,0.0326177664808481,0.0245919716607621
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00722894179130868,0.00321862873462301,0.00092042947144759,0.0135374541111698,0.0247228431283306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,39638,-0.00441750094468613,0.00196709705973279,-0.0082730111817624,-0.00056199070760986,0.0247432245553104
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0163338750712845,0.00727651570472001,0.00207190429003329,0.0305958458525357,0.0248008763610568
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,0.0134396555051645,0.00599035940087981,0.00169855107944007,0.0251807599308889,0.0248779990569034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,39929,-0.00647108522031108,0.00288428880045609,-0.012124291269205,-0.000817879171417134,0.0248797374113898
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,39934,0.00905445198305003,0.00403693500049352,0.00114205938208274,0.0169668445840173,0.0249223421000124
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,42113,0.00578410891993891,0.00258003152810598,0.000727247124851188,0.0108409707150266,0.0249855931248994
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0282738505701279,0.0126271512004085,0.00352463421732738,0.0530230669229285,0.025163756566314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,0.00792071799792352,0.00353739270235323,0.000987428301311195,0.0148540076945358,0.0251666391105879
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,41992,0.0111030021443603,0.00495878737371986,0.00138377889186934,0.0208222253968512,0.025168632683856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,39959,0.00703341298907034,0.00314418914147103,0.00087080227178713,0.0131960237063536,0.0253085346562444
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.0120256031079512,0.00538956262016294,0.0014620603724319,0.0225891458434706,0.0256826626256562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,0.0163212751385011,0.00732924567003865,0.00195595362522532,0.0306865966517768,0.0259761930093933
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,42081,0.024848271083562,0.0111735962395983,0.00294802245394942,0.0467485197131746,0.0261758306894375
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.0112972104149532,0.00508177023699843,0.00133694075043622,0.0212574800794701,0.0262296980372583
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.00964311413002801,0.00434227330919781,0.00113225844400031,0.0181539698160557,0.0263874650825145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0145497627257771,0.00655713845393783,0.00169777135605893,0.0274017540954952,0.02650873867823
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.020196653719854,0.00910772194867988,0.00234551870044139,0.0380477887392665,0.0266072259250627
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,42145,-0.0114731526243103,0.00517492856096502,-0.0216160126038017,-0.00133029264481886,0.0266351949881686
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,41843,0.00937152007508916,0.00422864919544159,0.00108336765202364,0.0176596724981547,0.0266949387613613
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.0137107323018604,0.00620618797506563,0.00154660387073176,0.025874860732989,0.0271773206951774
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.00718477119414998,0.00325617008867675,0.000802677820343557,0.0135668645679564,0.0273654287145374
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,0.0188602140091075,0.0085561852331553,0.00209009095212308,0.0356303370660919,0.0275214834188124
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0138604025051097,0.00629262354987873,0.00152686034734736,0.026193944662872,0.0276404868954979
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,39638,-0.0122184896175391,0.00555917964570506,-0.023114481723121,-0.00132249751195713,0.0279773254843187
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.00870604224282245,0.00396267547391177,0.000939198313955381,0.0164728861716895,0.0280368189681023
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,0.0155604924637082,0.00708716835696437,0.00166964248405805,0.0294513424433584,0.0281387342701746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,42070,0.0450186729936791,0.0205312928226516,0.00477733906128196,0.0852600069260763,0.0283470709731903
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,-0.0179774350026127,0.00822036234934129,-0.0340893452073217,-0.00186552479790381,0.0287640053005896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,0.0102659314234299,0.00469899664114464,0.00105589800678645,0.0194759648400734,0.0289277225673217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,0.00535349138917517,0.0024580715522691,0.000535671146727746,0.0101713116316226,0.0294323005498171
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,0.0110810250479701,0.00509116578069503,0.00110234011780788,0.0210597099781324,0.0295337146875034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.0242967453145614,0.0111674620288056,0.00240851973810242,0.0461849708910204,0.0295969012423561
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,39929,0.0169065413715283,0.00777864753854616,0.00166039219597779,0.0321526905470787,0.0297667232541832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,39919,0.0080587986218578,0.00370970388084013,0.000787779015411144,0.0153298182283045,0.0298494814739264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0103457337096152,0.004762600700473,0.00101103633668814,0.0196804310825423,0.0298552631917807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,41865,0.0174483457903247,0.00804021480379614,0.00168952477488428,0.0332071668057651,0.0300143609831881
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.0145024712910287,0.00668290520193162,0.00140397709524277,0.0276009654868147,0.0300217756824869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,39958,0.0213037204619236,0.00983114817308323,0.00203467004268049,0.0405727708811668,0.0302585012937663
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.0123577115588358,0.00570506273745738,0.00117578859341938,0.0235396345242523,0.0303250235183288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,39586,0.0150030041901981,0.00692952302510409,0.00142113906099406,0.0285848693194021,0.0304026581458074
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,0.0140691226923511,0.00650453215947522,0.00132023965977971,0.0268180057249226,0.0305605709059997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,0.0195605395785737,0.00905139710119803,0.00181980126022559,0.0373012778969219,0.0307121436927547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,0.00894661467593749,0.00414085524793885,0.000830538389977348,0.0170626909618976,0.0307461772089521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0118838798228362,0.00550802464755129,-0.0226796081320367,-0.00108815151363565,0.0309797395272244
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,0.016622471784042,0.00770492852480566,0.00152081187542286,0.0317241316926611,0.0309974102514361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.00554802298166932,0.0025739944196496,-0.0105930520441825,-0.000502993919156095,0.0311472012242227
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,39897,0.020397134409904,0.00947307289380179,0.0018299115380525,0.0389643572817555,0.0313264368844543
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,39919,-0.00905449098069091,0.00420635072034499,-0.0172989383925671,-0.000810043568814726,0.0313730614854748
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,41820,0.0110487690183584,0.00513400174461437,0.000986125598914259,0.0211114124378026,0.0314093093936761
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,0.00746085828477151,0.00347078140942723,0.000658126722294145,0.0142635898472489,0.0316030058355122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,0.0139185152545785,0.00647497848065087,0.00122755743250279,0.0266094730766542,0.03160920152865
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,0.0153949593807195,0.00716428720823502,0.00135295645257888,0.0294369623088602,0.0316676200057289
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,42296,0.00603286474898106,0.00281522183487925,0.00051502995261772,0.0115506995453444,0.0321351059891235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,-0.0172714411516222,0.00806222205004399,-0.0330733963697084,-0.00146948593353595,0.0321897228676024
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,41913,0.0262957591621683,0.0122757522617863,0.00223528472906716,0.0503562335952695,0.0322043738311388
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,41814,-0.0140314931644722,0.0065610477351459,-0.0268911467253582,-0.00117183960358624,0.0324859074807704
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESPL1,Separin,39560,0.0122701383760857,0.0057444237164414,0.00101106789186061,0.0235292088603109,0.0327008061599601
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,39966,0.0263328935120728,0.0123407852273191,0.00214495446652748,0.0505208325576182,0.0328796648400637
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,0.0130868022993052,0.00613417445518663,0.00106382036713938,0.025109784231471,0.0329081883214174
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,0.0198401174361517,0.00929958010341184,0.00161294043346452,0.0380672944388389,0.0329098812277677
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,39929,0.021830793358335,0.0102386454281636,0.00176304831913425,0.0418985383975357,0.0330122267673195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,0.00926386755784354,0.00434704096609079,0.000743667264305593,0.0177840678513815,0.0331007551768059
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,39649,0.0161076130568972,0.00758466566676836,0.00124166835003119,0.0309735577637632,0.0337167467094097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,39575,0.0149421904312719,0.00704511257529665,0.00113376978369046,0.0287506110788533,0.0339500553229578
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,0.00732302577658513,0.00345559178992761,0.000550065868327002,0.0140959856848432,0.034093296634922
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,42119,-0.00898963852852957,0.00424565554544647,-0.0173111233976047,-0.000668153659454489,0.0342463699398156
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,39575,-0.0127224693664279,0.00601080190860541,-0.0245036411072945,-0.000941297625561326,0.0343161690129919
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,0.0316140198572848,0.0149400661235962,0.00233149025503633,0.0608965494595333,0.0343617087708636
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.00820513090786971,0.00388227860381265,-0.0158143969713425,-0.000595864844396927,0.0345819300510168
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,0.00661566673581943,0.00313057934972241,0.000479731210363514,0.0127516022612753,0.0346020234450079
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MLN,Promotilin,42119,0.0202359414329255,0.00960328427255078,0.00141350425872593,0.039058378607125,0.0351195112379072
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,-0.0235475912325325,0.011207974729124,-0.0455152217016155,-0.00157996076344944,0.0356623490381406
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,0.0164421539699622,0.0078421678745708,0.00107150493580344,0.031812803004121,0.03604806945395
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,39919,0.010155261027885,0.00484639426837443,0.000656328261871118,0.0196541937938989,0.0361552918425046
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,39586,0.0105076878112126,0.00501633426072123,0.000675672660198965,0.0203397029622262,0.0362210040249715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,-0.00908313905539095,0.0043370282488061,-0.0175837144230509,-0.000582563687730997,0.0362539408746426
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,42195,-0.00765635093934696,0.00365663217028469,-0.0148233499931049,-0.000489351885588979,0.0362939719604619
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.00907193928816065,0.00433356503269614,0.000578151824076204,0.0175657267522451,0.0363345220348162
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,39979,-0.0157169029932664,0.00752454303407908,-0.0304650073400614,-0.000968798646471435,0.0367522357027757
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.0109907500015255,0.00526796696924366,0.00066553474180789,0.021315965261243,0.0369711886476474
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,0.0082973209182756,0.0039773485610049,0.000501717738706007,0.0160929240978452,0.0369846078365618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,39757,0.011977767133832,0.00574171427341109,0.000724007157946223,0.0232315271097177,0.0369925862420208
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,39575,0.0114543358765554,0.00549172042552846,0.000690563842519623,0.0222181079105912,0.037024644758624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.00463704351004255,0.00222504538219878,0.000275954560932932,0.00899813245915217,0.0371774466907405
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,0.0125662436819849,0.00603088848252789,0.000745702256230227,0.0243867851077396,0.0372151822913018
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0165216340225564,0.00793160413483877,0.000975689918272384,0.0320675781268404,0.0372730045150479
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0137201480024736,0.00659878730013225,0.00078652489421439,0.0266537711107328,0.0376184805994814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,39720,0.00816959135526524,0.00393671916558911,0.000453621790710582,0.0158855609198199,0.0379883092908404
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,0.00736806973479836,0.00355300933072452,0.000404171446578298,0.0143319680230184,0.0381253668925161
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,39736,0.00616329037246576,0.00297565033222462,0.000331015721305501,0.011995565023626,0.0383592129400831
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.00701584079917943,0.00338873541370637,0.000373919388314941,0.0136577622100439,0.0384429337088972
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.008346906104905,0.00403428580036863,0.000439705936182496,0.0162541062736275,0.0385694593147864
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.0245635838893993,0.0118803417265685,0.00127811410532504,0.0478490536734735,0.0387020190857429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,0.0102754591581021,0.00498031968862059,0.000514032568405773,0.0200368857477985,0.0391116126503987
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,0.0119153137720693,0.00577973427813582,0.000587034586923108,0.0232435929572155,0.0392720480303141
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,0.011109085334877,0.0053972900640563,0.000530396809326672,0.0216877738604274,0.0395877196836195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.0112952571090585,0.00549130190130433,0.000532305382502023,0.022058208835615,0.0397119210474316
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0164476683723284,0.00800906641019605,0.000749898208344139,0.0321454385363127,0.0400346596064966
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.0224470717170065,0.0109413088167916,0.00100210643609502,0.043892036997918,0.0402288194605437
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,0.01537195486416,0.00749385229772113,0.000684004360626591,0.0300599053676934,0.0402638198729685
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,0.0220594043277456,0.0107619347333587,0.000966012250362497,0.0431527964051287,0.0404113791953749
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0118907733323859,0.00580423398248144,0.000514474726722312,0.0232670719380495,0.040516803636213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,0.0163748301439008,0.00800851864300826,0.000678133603604584,0.032071526684197,0.0409101760632885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,0.0167334150554791,0.00818548891714083,0.000689856777883038,0.0327769733330751,0.0409498789099301
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0151278275703063,0.00740209291148295,0.000619725463799721,0.0296359296768129,0.0410006682514368
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.00952548493585663,0.00466117908629668,0.000389573926715134,0.0186613959449981,0.0410148556172435
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.018390251168335,0.00900796282458965,-0.0360458583045307,-0.000734644032139287,0.0412151395589128
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,41839,0.0145241061807355,0.00711868832000672,0.000571477073522302,0.0284767352879486,0.0413424035777317
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,41740,0.0183141628719485,0.00897695545112592,0.000719330187741691,0.0359089955561553,0.0413572569820514
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,0.00886690079759793,0.00434753423791489,0.000345733691284751,0.0173880679039111,0.0414216493049738
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,42145,0.0148596022618318,0.00733121617959676,0.000490418549822109,0.0292287859738414,0.0426927448113879
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,-0.00865973876931546,0.0042748477968829,-0.0170384404512059,-0.000281037087424963,0.0428108265172608
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,42152,0.00878875199974608,0.00434595856157835,0.000270673219052511,0.0173068307804397,0.043166874369804
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0114913956825566,0.00569199723334488,0.000335081105200641,0.0226477102599126,0.0435249874588563
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,0.0278749076513148,0.0138348927210677,0.000758517918022051,0.0549912973846076,0.0439424093275025
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,0.0207047545308806,0.0102763848609841,0.000563040203351683,0.0408464688584094,0.0439462592967326
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,42025,-0.0156555505422269,0.00777268064436064,-0.0308900046051737,-0.000421096479280021,0.0440109156929422
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,0.012816768079047,0.00636840046800724,0.000334703161752801,0.0252988329963412,0.0441854856985455
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.0127058110867839,0.00633507238277938,0.000289069216536347,0.0251225529570315,0.0449202174603244
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,42199,0.00611274103132669,0.00304944504079983,0.000135828751359026,0.0120896533112944,0.0450318080141411
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,41839,0.00731358509699852,0.0036562398227892,0.000147355044331696,0.0144798151496653,0.0454880130969552
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0107442902037978,0.00537842998709639,0.000202567429088916,0.0212860129785068,0.0457774523111747
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.0204571824920627,0.0102445365816389,0.000377890792050493,0.0405364741920748,0.0458577958548688
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,39919,0.00865557842139168,0.00434622681641193,0.000136973861224304,0.0171741829815591,0.0464482255035651
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.0136256320484284,0.00684911399513164,0.000201368617970347,0.0270498954788864,0.046677530013786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.00868666364619718,0.00437169761546528,-0.0172551909725091,-0.000118136319885239,0.0469446693533728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,42145,0.0108709484427379,0.00547258239774696,0.000144686943153824,0.0215972099423219,0.0470047719944054
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.0169081263484506,0.00852382378640765,0.000201431727091562,0.0336148209698095,0.0473213929559726
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0180953319154753,0.00912329807937368,0.000213667679902909,0.0359769961510477,0.047344635147494
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,42239,0.00429437340226781,0.00216763696030351,4.58049600729274e-05,0.00854294184446269,0.0475966037156646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.0173224258566929,0.00875011353331321,0.000172203331399012,0.0344726483819868,0.0477636360105024
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0133400593982089,0.00674008665708639,0.00012948955031959,0.0265506292460982,0.0478169426342713
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,-0.0169990133765235,0.00859962227591573,-0.0338542730373184,-0.000143753715728719,0.0480940721619562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,39806,0.00758790220521709,0.00384662526989492,4.85166762230387e-05,0.0151272877342111,0.048564238364401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0128811631869255,0.00653096858104606,8.04647680752706e-05,0.0256818616057758,0.0485938036901837
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERVV_1,,39575,0.00926867559748322,0.00469985946232566,5.6951051324923e-05,0.0184804001436415,0.0486212508496806
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.00770058880978026,0.00390901069650961,3.89278446214269e-05,0.0153622497749391,0.0488674369006323
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,0.0151255585942415,0.00768806044239164,5.69601271539107e-05,0.0301941570613291,0.0491569274932482
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.00622224491650788,0.00316378142519679,2.12333231221747e-05,0.0124232565098936,0.0492373497444884
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.00659736356269247,0.00335489389414254,2.1771530173101e-05,0.0131729555952118,0.0492670701467655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,0.0160512006753373,0.00816633525798252,4.51835696915377e-05,0.032057217780983,0.0493777421896977
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.00450438197694579,0.00229313603293988,9.83535238362979e-06,0.00899892860150794,0.0495214144344063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0100154747353463,0.00510547903755592,8.73582173667627e-06,0.0200222136489559,0.0498205825161777
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0142304416435876,0.00726985461185305,-1.84733956444232e-05,0.0284793566828195,0.0503180446308969
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,0.0139797652059069,0.00714374696592139,-2.19788472989937e-05,0.0279815092591129,0.0503767470264917
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,42119,-0.00934670226227722,0.0047787936904987,-0.0187131378956547,1.97333711002383e-05,0.0505009606768429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,42107,0.00845731966501564,0.00432637495876485,-2.23752541634679e-05,0.0169370145841947,0.0506239519304779
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0083001660220015,0.00424908795340289,-2.80463666681632e-05,0.0166283784106712,0.0507968623739065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.0176123366859676,0.00902936541789452,-8.52195331056613e-05,0.0353098929050408,0.0511302408956057
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,42016,0.00255319719901242,0.00130947131377831,-1.33665759930565e-05,0.0051197609740179,0.0512216722243101
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,42070,-0.0198887386098113,0.0102035176957956,-0.0398876332935706,0.000110156073948039,0.051291781718141
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00751058635837285,0.00385646530240826,-4.80856343473262e-05,0.015069258351093,0.0514965531478275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,0.0164327805979693,0.0084491401136592,-0.00012753402480279,0.0329930952207413,0.0518110305895249
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,0.00621244752290802,0.00319848764194482,-5.65882553038195e-05,0.0124814833011199,0.0521245958076847
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,39657,0.00946611448351133,0.00488269281816619,-0.000103963440094407,0.0190361924071171,0.0525623469182059
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,39638,0.0153428023984914,0.00792041183522779,-0.000181204798555089,0.0308668095955379,0.0527559395290234
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-0.00670083046604224,0.00346222600377772,-0.0134867934334466,8.51325013620872e-05,0.0529611359333602
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,42119,0.0143670123313398,0.00742848408544448,-0.000192816476131421,0.0289268411388109,0.0531286082600991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,42119,0.0109355381965139,0.00565703660171883,-0.000152253542854959,0.0220233299358828,0.0532464623416928
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.0123953410465301,0.00641520989500029,-0.0249691524407307,0.000178470347670431,0.0533621160295231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,42119,0.00801379696848203,0.00415953179729234,-0.000138885354210949,0.016166479291175,0.0540491461861169
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,0.011499067355016,0.00597102920096744,-0.000204149878880209,0.0232022845889121,0.0541537217370979
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,0.0111652454902348,0.00580230158667123,-0.000207265619640825,0.0225377566001104,0.0543411057498861
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,41913,0.0195018835340749,0.0101465356882906,-0.000385326414974622,0.0393890934831244,0.0546240757480156
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.00920669752977087,0.00480319641184952,-0.000207567437454188,0.0186209624969959,0.0552909260004213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,39919,0.00994294068635789,0.00518818528541054,-0.000225902473046774,0.0201117838457626,0.0553319425136477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,39657,0.00611726475737415,0.00319291787346861,-0.000140854274624322,0.0123753837893726,0.0554054427294664
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.0145031610527832,0.00757234176948761,-0.000338628815412545,0.0293449509209789,0.0554824854596312
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.012277376996647,0.00641138360132877,-0.000288934861957364,0.0248436888552514,0.0555260535546689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0174379696118631,0.00911028630651905,-0.0352941307726404,0.000418191548914287,0.0556295544225724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,-0.00715407362636118,0.00373932468179174,-0.014483150002673,0.000175002749950643,0.055747631562546
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,39657,0.0112733845790794,0.00589502966882825,-0.000280873571823936,0.0228276427299828,0.0558565931416983
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,39657,0.00551132277447232,0.00288494607061341,-0.000143171523929962,0.0111658170728746,0.0561110585264848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.0205481363435192,0.0107681509074086,-0.000557439435001653,0.0416537121220401,0.0563864021073074
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,42047,0.0146862109288441,0.00770677125232964,-0.000419060725722037,0.0297914825834102,0.0567202652299045
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,39575,-0.0158873982159478,0.00834288852645476,-0.0322394597277992,0.0004646632959035,0.0568966908779739
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,-0.0141839388900824,0.00745829907310508,-0.0288022050733683,0.0004343272932036,0.0572230015304583
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00668414622903876,0.00351986737712011,-0.000214793830116667,0.0135830862881942,0.0575937349713102
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.0101053780722165,0.00533126865527191,-0.000343908492116416,0.0205546646365495,0.0580526433534722
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,42166,0.0177248449925324,0.00937271318711435,-0.000645672854211767,0.0360953628392765,0.0586307571952617
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,39649,0.00819580275237591,0.00433602284181738,-0.000302802017586153,0.016694407522338,0.058761916209444
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,39929,0.0110420320490244,0.00584692941338825,-0.000417949601216563,0.0225020136992654,0.0589819537119896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,0.0081036769528258,0.00429105203221289,-0.00030678503031146,0.0165141389359631,0.0589835833562733
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.00836409249264048,0.00443022489100891,-0.000319148293736972,0.0170473332790179,0.0590525612159672
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,42137,0.00915905994084799,0.00485318791777324,-0.000353188377987566,0.0186713082596836,0.0591513786809251
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.0109942013667694,0.00583083341092258,-0.000434232118638815,0.0224226348521777,0.0593804243910867
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REN,Renin,42145,0.0164363176722384,0.00873936810242127,-0.000692843808507256,0.0335654791529841,0.060031246248854
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0136084900110867,0.00724073348896256,-0.000583347627279943,0.0278003276494533,0.0602113778691821
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,0.00785707732730112,0.00419484252136798,-0.000364814014580116,0.0160789686691824,0.061085895545422
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.0128816603404996,0.00688744021099029,-0.000617722473041354,0.0263810431540406,0.0614624648718984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,0.0086249407424728,0.00461247578010167,-0.000415511786526481,0.0176653932714721,0.061522131320168
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,39624,0.0135249894377462,0.00723890547944341,-0.000663265301962901,0.0277132441774553,0.0617363348119765
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,41780,0.00611366803355759,0.00327665388362125,-0.000308573578340053,0.0125359096454552,0.0620878238086323
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,42258,0.00537682585710078,0.0028824109861926,-0.000272699675836718,0.0110263513900383,0.062147928600887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,39958,0.0130278600048106,0.0069932539930614,-0.000678917821589749,0.0267346378312109,0.0624995732107154
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.00570727972489086,0.00306514167413967,-0.0117149574062046,0.000300397956422887,0.0626295256066903
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.011900713640042,0.00639539645545209,-0.00063426341264409,0.0244356906927281,0.062790922490564
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,42181,0.0112246600890871,0.00603216329141048,-0.000598379962077497,0.0230477001402516,0.0627937712736551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,0.00619644619495774,0.00333070654685943,-0.000331738636886755,0.0127246310268022,0.0628503618086238
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIT,Vitrin,39958,-0.0077025050355819,0.00414367550163683,-0.0158241090187901,0.000419098947626284,0.0630730914332158
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.0112023954832682,0.0060345038045032,-0.0230300229400945,0.000625231973558056,0.0634246990222512
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,42016,0.0208721046368108,0.0112588570669957,-0.00119525521450081,0.0429394644881224,0.0637841781963112
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,42264,0.00409912769844015,0.00221557603291431,-0.000243401326071901,0.0084416567229522,0.0643148273330629
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.020665619843809,0.0112017336118369,-0.00128977803539145,0.0426210177230094,0.0650847883962808
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,42194,-0.0061314518404206,0.00333318113090426,-0.012664486856993,0.000401583176151761,0.0658605981654301
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,0.014603258773325,0.00795902305516978,-0.000996426414807806,0.0302029439614577,0.0665615463168014
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,0.00968406368841464,0.00528786675718261,-0.000680155155663274,0.0200482825324926,0.0670671420999152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,0.00750029007874141,0.00412705606389645,-0.000588739806495642,0.0155893199639785,0.0691867001979839
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,0.0122142938354802,0.00673334415927761,-0.000983060716703916,0.0254116483876643,0.0697039844879264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.00595477013100208,0.00328344947811166,-0.0123903311081009,0.000480790846096772,0.0697705889225832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.0059349665384528,0.00327787910335218,-0.00048967650411746,0.0123596095810231,0.0702283377116732
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,39929,0.00953766398379439,0.00526913869185829,-0.000789847852247854,0.0198651758198366,0.0703068829078387
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,41647,-0.0119789439588824,0.0066201381187293,-0.0249544146715918,0.000996526753827023,0.0704009586309597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,39649,0.0113010782577583,0.00624713510110252,-0.000943306540402656,0.0235454630559192,0.0704779020216022
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0101297773352898,0.00560698776168605,-0.00085991867761486,0.0211194733481945,0.0708458382766188
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,0.0160694445411813,0.00889674679437966,-0.00136817917580285,0.0335070682581654,0.0709110989979787
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,39958,0.010394704790482,0.00576304328558414,-0.00090086004926291,0.0216902696302269,0.0713074594442506
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,39919,0.0162990506484604,0.0090513452258504,-0.00144158599420638,0.0340396872911272,0.0717716767466656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,0.008598405145314,0.00478843741436294,-0.000786932186837366,0.0179837424774654,0.0725761177260924
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,39649,0.0130255481396525,0.00725392973094119,-0.00119215413299219,0.0272432504122973,0.0725768713053931
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,-0.00530239283585325,0.00295382266835561,-0.0110918852658303,0.000487099594123751,0.0726658265809926
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,0.0124413970489529,0.00693766453662773,-0.00115642544283748,0.0260392195407432,0.0729503687989732
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.00745687684752208,0.00415925412165667,-0.000695261230924984,0.0156090149259692,0.0730260513471847
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,42124,0.0111039738593632,0.00619478300854086,-0.00103780083737685,0.0232457485561033,0.0730797647632152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,42262,0.0105196888243408,0.00586903185729367,-0.000983613615954788,0.0220229912646364,0.0730900469969644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,41900,0.0207652605784545,0.0115865919977842,-0.0019444597372026,0.0434749808941116,0.0731268291895544
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.00718330136760748,0.00400842721731827,-0.00067321597833632,0.0150398187135513,0.0731525183460687
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,39649,0.0117297509125265,0.00655465735833073,-0.00111737750980177,0.0245768793348547,0.0735570029745257
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,-0.0204401087476544,0.0114347497867206,-0.0428522183296267,0.00197200083431804,0.0738721358179955
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,-0.00542299297159521,0.00304622073907028,-0.011393585620173,0.000547599676982541,0.0750647572088839
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.0132636674201875,0.00746635337224979,-0.0278977200297971,0.00137038518942211,0.0756848554651495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.00867318277201251,0.00488369993738978,-0.00089886910527147,0.0182452346492965,0.0757694686577063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,-0.00524642825908342,0.00295421171176291,-0.0110366832141387,0.000543826695971871,0.0757737991250941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,41774,0.0121588803505099,0.00684981893331407,-0.00126676475878566,0.0255845254598055,0.0759100827131314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,42310,0.0110353031642614,0.00622163088816674,-0.00115909337654537,0.0232296997050683,0.0761350732298975
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,0.00575037774762347,0.00324791542605138,-0.000615536487437234,0.0121162919826842,0.0766738926100371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,42137,0.0106072713606136,0.00599350427481611,-0.00113999701802596,0.0223545397392532,0.076783874693273
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,0.011702144325016,0.00661581332948298,-0.00126484980077065,0.0246691384508026,0.0769472009002668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,0.00983159324266309,0.00556163054093257,-0.00106920261756475,0.0207323891028909,0.0771297021132447
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00698835088096437,0.00396401399642708,-0.0147578183139615,0.000781116552032706,0.0779368860322872
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,42296,-0.00708172582106561,0.00401804390397618,-0.0149570918728589,0.000793640230727695,0.078010374382998
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,39657,0.00490268741205136,0.00278187632015657,-0.000549790175455521,0.0103551649995582,0.078034912255004
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,0.0151214982983187,0.00859053998793766,-0.00171596007803915,0.0319589566746765,0.0783933116686956
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.013267484955943,0.00753874911950686,-0.00150846331829042,0.0280434332301765,0.0784461529122401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,39736,-0.00726972320890336,0.00413532421086143,-0.0153749586621918,0.00083551224438505,0.0787822518618781
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.0136795216367752,0.00778792343663601,-0.00158480829903142,0.0289438515725817,0.0790293624107048
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,0.00534991978999338,0.00305060304052194,-0.00062926216942963,0.0113291017494164,0.0795002136475665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.00975228533367206,0.00556209078618664,-0.00114941260725376,0.0206539832745979,0.0795698572651447
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.00496962850506085,0.00283515561082263,-0.000587276492151504,0.0105265335022732,0.0796541028164357
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,-0.00510404301517303,0.00292548216559099,-0.0108379880597314,0.000629902029385318,0.0810667961151003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.00603821452161895,0.00346189044874033,-0.000747090757912104,0.01282351980115,0.081147529917278
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,0.015899465490249,0.00913043244420447,-0.00199618210039175,0.0337951130808898,0.0816414892841167
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,39586,0.00877918027179535,0.00504148979277921,-0.00110213972205191,0.0186605002656426,0.0816439132960391
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.0122041618177906,0.00701157992759592,-0.00153853484029741,0.0259468584758786,0.0817818024632465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.0162919692213784,0.00936769894431458,-0.034652659152235,0.00206872070947814,0.0820329979659124
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.00911545853998756,0.00524268396323558,-0.00116020202795417,0.0193911191079293,0.082110653364632
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,0.00829029748617859,0.00477364700096836,-0.00106605063571939,0.0176466456080766,0.0824664103156232
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,0.0134061968930685,0.0077286333022544,-0.00174192437935014,0.0285543181654871,0.0828367844691665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00724355917938388,0.00418115586166542,-0.000951506309480338,0.0154386246682481,0.0832251524792691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00766968211735553,0.00443166939613989,-0.00101638989907865,0.0163557541337897,0.0835413147984222
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,39900,0.00848312598055686,0.00490352804589953,-0.00112778898940621,0.0180940409505199,0.0836567614157903
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,41538,-0.00527897858181926,0.00305635197658823,-0.0112694284559322,0.000711471292293672,0.0841528303345156
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,42145,-0.0117184274804065,0.00679085026313593,-0.0250284939961529,0.00159163903533995,0.0844385941310945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.0113875167464487,0.00660089545836958,-0.00155023835195569,0.0243252718448531,0.0845286288867759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.0204695341824522,0.0119098244316782,-0.0438127900685415,0.00287372170363699,0.0856900430421144
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,0.0110561016437363,0.00643390482814488,-0.00155435181942768,0.0236665551069002,0.0857443216527641
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,0.00539825668398571,0.00314330745488542,-0.000762625927589715,0.0115591392955611,0.0859330224370732
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,39657,0.00614867795651019,0.00358992535302281,-0.000887575735414525,0.0131849316484349,0.0867848702928356
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,42070,0.00278558069235955,0.00162778698827263,-0.000404881804654804,0.00597604318937391,0.0870545700109595
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,0.0157504378871948,0.00922332542691856,-0.0023272799495656,0.0338281557239551,0.0877250715568701
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.00759652032734103,0.00445080758474567,-0.00112706253876047,0.0163201031934425,0.0878915684984534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,39990,0.00419212676964204,0.0024608888110788,-0.000631215300072412,0.0090154688393565,0.0885016136249322
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,0.00742121501353317,0.004360543841379,-0.00112545091556967,0.015967880942636,0.0887970916685728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,39560,0.0102039842902429,0.00600590990858193,-0.00156759913057771,0.0219755677110635,0.0893493408449217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.0194746699779257,0.0114798837537402,-0.00302590217940513,0.0419752421352566,0.0898300418911778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.00746893601985421,0.0044054688699811,-0.00116578296530874,0.0161036550050172,0.0900268040743434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,39930,-0.0105549626288646,0.00623304980239033,-0.0227717402415496,0.00166181498382046,0.0904094045366169
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.00431859614336064,0.00255050138683673,-0.000680386574839349,0.00931757886156063,0.0904337189375742
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0104083800938905,0.00615516758165199,-0.00165574836614744,0.0224725085539283,0.0908649900447493
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,-0.00600053500232336,0.0035511032938405,-0.0129606974582507,0.000959627453604009,0.0911000486089561
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0089457001769488,0.00529797186314044,-0.00143832467480646,0.0193297250287041,0.0913406414563697
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0122373546711206,0.00725304770480334,-0.001978618830294,0.0264533281725351,0.091592985108598
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,0.00523382464329292,0.00310314085794757,-0.00084833143828433,0.0113159807248702,0.0916993704358315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.012453560655317,0.00738800855990691,-0.00202693612210057,0.0269340574327345,0.091892134087766
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,42119,-0.00623075301463632,0.00370100726204335,-0.0134847272482413,0.00102322121896865,0.0922958201886784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,39586,0.00759853630996049,0.004515405401622,-0.00125165827721863,0.0164487308971396,0.0924417115378749
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,-0.0100210749949865,0.00595544665718018,-0.0216937504430596,0.00165160045308669,0.0924656920206695
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0120568940304873,0.00717009570936006,-0.026110281620833,0.00199649355985843,0.0926830176183644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.012341944770247,0.00736530871584358,-0.00209406031280644,0.0267779498533004,0.0938277322991137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.00550274221956431,0.00328915513441286,-0.000944001843884908,0.0119494862830135,0.0943510867864226
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,41843,0.0102446980904597,0.00613350508071318,-0.00177697186773812,0.0222663680486575,0.0948867322600715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,0.0110818503495099,0.00663525057172315,-0.00192324077106746,0.0240869414700873,0.0949185763585142
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.00603039129715808,0.00361090504134588,-0.00104698258387985,0.013107765178196,0.094937133475778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,41900,-0.00970729102877179,0.00581704173217062,-0.0211086928238262,0.00169411076628262,0.0951869745286271
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00528658738829667,0.00317297477654494,-0.000932443173731413,0.0115056179503248,0.0957111406918214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,39930,0.00555378692371436,0.00333363364514101,-0.00098013502076202,0.0120877088681907,0.0957438503482686
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,39990,-0.00521002085941676,0.00312879639900343,-0.0113424618014635,0.000922420082629976,0.095903608199049
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,39929,0.00685538295616846,0.00411725706727798,-0.00121444089569638,0.0149252068080333,0.095933141708026
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00697902496197883,0.00419197096300883,-0.00123723812551847,0.0151952880494761,0.095970177413893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,-0.0130968565425542,0.007871163979274,-0.0285243379419312,0.00233062485682289,0.0961553942035726
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,0.00664789796170427,0.0039962198231819,-0.00118469289173225,0.0144804888151408,0.0962264744684088
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.00652277306036935,0.00392116898736404,-0.00116271815486418,0.0142082642756029,0.0962447709369433
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.00395471117099518,0.00238166311592933,-0.000713348536226294,0.00862277087821666,0.0968408928938971
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,42262,0.00566738508794625,0.00341524229029053,-0.00102648980102319,0.0123612599769157,0.0970503836433852
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0063006233176865,0.00380679380329025,-0.0011606925367624,0.0137619391721354,0.0979275597722137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.00674112768842594,0.00407566215149384,-0.0147294255053539,0.00124717012850198,0.0981568199544007
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.00635189843972796,0.00384283066902524,-0.0138838465510174,0.00118004967156151,0.0983703900667062
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,39721,-0.0103403775614773,0.00625773640104724,-0.0226055409075298,0.00192478578457533,0.0984782069626609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0065816126402954,0.00398581137200478,-0.00123057764883397,0.0143938029294248,0.0987085881807954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,39575,0.0103353742958708,0.00626416079662901,-0.00194238086552206,0.0226131294572636,0.0989875854978651
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,0.00583668940220841,0.00353759768466873,-0.00109700205974231,0.0127703808641591,0.0989916033204235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_A,,39934,0.00582728885545231,0.00354095056327551,-0.00111297424856769,0.0127675519594723,0.0998563784000039
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00690935375880924,0.00420429722106145,-0.0151497763120897,0.00133106879447121,0.10032830826459
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,39575,0.00812081951120172,0.00494195560502793,-0.00156541347465303,0.0178070524970565,0.10036191612891
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,41913,0.0129248605665279,0.00788986396455928,-0.0025392728040083,0.0283889939370641,0.101411926345495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.00473514093247186,0.00289243152496428,-0.000934024856458136,0.0104043067214019,0.101642319105161
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,-0.00443836000639078,0.00271372315428857,-0.00975725738879638,0.000880537376014819,0.101962277229743
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.0064940761807852,0.00397964983893942,-0.0142941898651065,0.00130603750353606,0.102740851755621
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,41913,-0.00560516174966308,0.00343803847054632,-0.0123437171519339,0.0011333936526077,0.10305392184404
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00449401739433412,0.00276221950509266,-0.00990796762431573,0.000919932835647486,0.103774387134911
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,41839,0.00926487289238734,0.00569747304113797,-0.00190217426824307,0.0204319200530178,0.103944271321614
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,-0.0205940478621132,0.0126720323527353,-0.0454312312734744,0.00424313554924806,0.10415769779298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,-0.00588421330918002,0.00362733818332987,-0.0129937961485066,0.00122536953014654,0.10479229012513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.00518556507795118,0.00320056551411519,-0.0010875433297146,0.011458673485617,0.105212538352102
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,42262,0.00515094393767561,0.00318023535758688,-0.00108231736319467,0.0113842052385459,0.105325444305898
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.0131991347367806,0.0081514638774287,-0.00277773446297963,0.0291760039365409,0.105424592642802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.00753196924395381,0.00465881984920207,-0.00159931766048224,0.0166632561483899,0.105969071742782
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00867339961188745,0.00536894849954901,-0.0191965386710035,0.00184973944722861,0.106236713358212
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.00845675163051348,0.0052387742326271,-0.00181124586543564,0.0187247491264626,0.10649443607611
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.00629566240622459,0.00390151498969768,-0.013942631786032,0.00135130697358286,0.106633074174409
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00511745178253443,0.00317308207569643,-0.00110178908583058,0.0113366926508994,0.106823010650462
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00715153924819283,0.00443512747320746,-0.00154131059929379,0.0158443890956794,0.106887116080694
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0113403246708189,0.00703290247655639,-0.00244416418323167,0.0251248135248694,0.106888187322619
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.00653547892248836,0.00405633889190837,-0.00141494530565203,0.0144859031506288,0.107169959380751
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.00924335515284189,0.00574866146445534,-0.00202402131749059,0.0205107316231744,0.107881833210288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,39958,-0.00471109788875374,0.00293215130476567,-0.0104581144460944,0.00103591866858697,0.108147213834649
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,0.00708094040889331,0.0044171294089277,-0.00157663323260498,0.0157385140503916,0.10894374458318
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,39638,0.00706754229137256,0.00442378436653776,-0.00160307506704145,0.0157381596497866,0.110155395898887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,0.00837651818709953,0.00525018514886189,-0.00191384470466977,0.0186668810788688,0.110630221547145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.00627272908453749,0.0039322002296499,-0.00143438336557632,0.0139798415346513,0.110690678109345
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,-0.00298513658189637,0.00187143981867433,-0.00665315862649806,0.000682885462705325,0.110712934004019
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00854111026341548,0.00535833062492542,-0.00196121776143835,0.0190434382882693,0.110967704584837
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,39757,-0.0092646684395499,0.00581885217653829,-0.0206696187055649,0.00214028182646514,0.111372271568601
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,41846,-0.00962110603635211,0.00604594375512154,-0.0214711557963903,0.00222894372368611,0.111558657357743
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,0.00624351248579207,0.00392893009921476,-0.00145719050866886,0.013944215480253,0.112058528080946
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,0.00532917198206608,0.00335444988855998,-0.00124554979951149,0.0119038937636436,0.112154168220883
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,0.00413909883413074,0.00260588202450032,-0.000968429933889885,0.00924662760215136,0.112231110577287
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,0.00706170413506416,0.00444791992877185,-0.00165621892532867,0.015779627195457,0.112395975870535
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,0.00448529122490483,0.00283226362062414,-0.00106594547151848,0.0100365279213281,0.113303439016889
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.00748763896998966,0.00473589243084909,-0.00179471019447456,0.0167699881344539,0.11389757421785
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.00618611627367812,0.00391318415714945,-0.0014837246743348,0.013855957221691,0.113943332516581
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,39638,0.00665640417931142,0.00421355356449059,-0.00160216080709013,0.014914969165713,0.114190449353068
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRNN,Cornulin,41749,0.0114372010151664,0.00724584311388176,-0.00276465148804184,0.0256390535183746,0.114486322585484
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.0127201524196607,0.00805871468175042,-0.00307492835657015,0.0285152331958915,0.114494639987176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,0.0201610563233943,0.0128097426000853,-0.00494603917277294,0.0452681518195615,0.115542047540354
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0134865499839716,0.00857588534389118,-0.00332218529005509,0.0302952852579983,0.115837055789678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.0154829047416181,0.00984612788665071,-0.00381550591621727,0.0347813153994535,0.115861132305846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.00663510237424848,0.00422375868829756,-0.00164346465481474,0.0149136694033117,0.116234714039092
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,41900,0.00753977812743861,0.00480936438707965,-0.00188657607123751,0.0169661323261147,0.116968272551043
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.00912697345562616,0.00582471588414408,-0.00228946967729624,0.0205434165885486,0.117157351587305
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,0.00795375995468877,0.00507914013917546,-0.00200135471809514,0.0179088746274727,0.117384544310646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,-0.00579116751660536,0.00370003048632771,-0.0130432272698077,0.00146089223659696,0.117566921783143
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.00473593114060127,0.00302800696263712,-0.00119896250616748,0.01067082478737,0.117831113360351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00702563034032432,0.00449472499501027,-0.00178403064989581,0.0158352913305444,0.118056864804615
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,39934,-0.00884391934084509,0.00565914823278639,-0.0199358498771064,0.00224801119541623,0.118135775409212
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,41839,0.00646125469051812,0.00414785887327354,-0.00166854870109802,0.0145910580821343,0.119320569151116
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALB1,Calbindin,42070,0.0075794733766835,0.00486699620123062,-0.00195983917772852,0.0171187859310955,0.119417883346783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,0.00594062353616228,0.00381669760614821,-0.0015401037718882,0.0134213508442128,0.119616746417513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.0111049292370799,0.00713953612929528,-0.00288856157633884,0.0250984200504987,0.119871571754633
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,-0.0130130399073306,0.00838554783078654,-0.0294487136556722,0.00342263384101101,0.120728118679727
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,39757,-0.00561439765220236,0.00362133288992863,-0.0127122101164625,0.00148341481205775,0.121081642881532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,0.00485252866028277,0.00313103193406897,-0.00128429393049241,0.0109893512510579,0.121209184332843
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,42103,0.0110415371802669,0.00713729651071727,-0.00294756398073892,0.0250306383412728,0.121881968496638
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,42137,0.014837934978709,0.00959897041088468,-0.00397604702662493,0.033651916984043,0.122180115762803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,0.00473063943476121,0.00306174067043403,-0.0012703722792895,0.0107316511488119,0.122349690236836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.0179825810598313,0.0116425148868203,-0.00483674811833643,0.040801910237999,0.122480303928742
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,-0.0140791750437435,0.00911950851463729,-0.0319534117324326,0.00379506164494555,0.122647501721838
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.00993253775303251,0.00643645615818494,-0.00268291631700998,0.022547991823075,0.122818485206095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.00560921147535453,0.00363759845601347,-0.0127389044491409,0.00152048149843186,0.123095179009151
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,39657,0.00470631848918127,0.00306024443638507,-0.00129176060613347,0.010704397584496,0.124104193200201
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.00573392505428982,0.00373056875251132,-0.00157798970063237,0.013045839809212,0.124313805704414
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.00667893708125762,0.00434966888286603,-0.0018464139291598,0.015204288091675,0.124683663481816
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.0139764716469712,0.00910432485008232,-0.00386800505919012,0.0318209483531326,0.124771187877705
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,0.00572044564661809,0.00373429402637404,-0.00159877064507502,0.0130396619383112,0.125583612184226
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,0.00602739144673387,0.00394428635568008,-0.00170340981039909,0.0137581927038668,0.126503084623881
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,0.00929244713810308,0.00608644682976041,-0.00263698864822732,0.0212218829244335,0.126854791333419
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,0.01015934751704,0.00665583434408867,-0.00288608779737374,0.0232047828314538,0.126938053753458
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,0.00591939640558032,0.00388368814484173,-0.00169263235830948,0.0135314251694701,0.127490421565512
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,42181,0.00890060757366383,0.005840440421128,-0.00254665565174705,0.0203478707990747,0.127541560515083
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.00387759526201965,0.00254633775503967,-0.00886841726189741,0.00111322673785811,0.127834239068625
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,39657,0.00699019317860517,0.00459276294333481,-0.00201162219033106,0.0159920085475414,0.128037241698386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,39929,0.00635954227455182,0.00418076392542087,-0.00183475501927309,0.0145538395683767,0.128251714486479
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.00520300225890262,0.00342137302135363,-0.0015028888629505,0.0119088933807557,0.128355090043158
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0119844372607851,0.00788202188271868,-0.0274332001509138,0.00346432562934347,0.128414383751921
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,-0.00773164974183398,0.0050874639888007,-0.0177030791598834,0.0022397796762154,0.128598596413329
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.0112523982218123,0.00740607944271833,-0.00326351748591564,0.0257683139295402,0.128704032537464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,39657,-0.00885559399409303,0.0058365228998058,-0.0202951788777124,0.00258399088952634,0.129226560329041
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,0.00588860717228331,0.0038839944779999,-0.00172402200459649,0.0135012363491631,0.129516544234643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,0.0435348518827114,0.028747175527061,-0.0128096121503281,0.0998793159157508,0.129951912145614
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0087672136280169,0.00578986260353089,-0.00258091707490364,0.0201153443309374,0.129989942166038
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,42181,-0.00625021634985124,0.00413822841826195,-0.0143611440496447,0.00186071134994218,0.130974750971132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,39657,-0.0076784177841384,0.0050865672694682,-0.0176480896322961,0.00229125406401926,0.131187355438431
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,41913,0.00766410487261839,0.00507798752780415,-0.00228875068187774,0.0176169604271145,0.131250982021668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,39930,0.00566977088686565,0.00376366188455718,-0.00170700640686643,0.0130465481805977,0.131979405744049
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,-0.0234760251104584,0.0155924776533789,-0.054037281311081,0.00708523109016424,0.132193181295454
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,42275,0.0110197906838649,0.00732025472354909,-0.00332790857429134,0.0253674899420211,0.132248604556574
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,0.00709165440974699,0.00471318095691489,-0.00214618026580621,0.0163294890853002,0.132444486093646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.00638420454754476,0.00424990450158392,-0.0147140173706492,0.00194560827555972,0.133068942448259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,0.00862441793407065,0.00575610739472382,-0.00265755255958804,0.0199063884277293,0.134081278278219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.00404121017860745,0.00271492757847016,-0.00128004787519407,0.00936246823240897,0.136638433668842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.0125481323442022,0.008458015672694,-0.004029578374278,0.0291258430626825,0.137948577330163
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.010205067739783,0.00688096035079022,-0.0236917500273318,0.00328161454776587,0.138078925450731
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.00503002025573979,0.00339380499814899,-0.00162183754063223,0.0116818780521118,0.138337386043641
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,0.00846145470655653,0.00571658436678561,-0.00274305065234326,0.0196659600654563,0.138859317142841
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.00768085856205769,0.00518929869546425,-0.0178518840051676,0.00249016688105223,0.138866174873039
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.00800786892965028,0.00542326426907457,-0.00262172903773588,0.0186374668970364,0.139812764129707
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,39930,0.0113608889927225,0.00770307441154111,-0.00373713685389811,0.026458914839343,0.140280322642231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,39560,0.00543390636582448,0.00368482590877605,-0.00178835241537658,0.0126561651470255,0.14032970608303
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,-0.00405900599109778,0.00276079075082302,-0.0094701558627109,0.00135214388051535,0.141521857527667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,39919,0.00524534499002589,0.00356856259365828,-0.00174903769354433,0.0122397276735961,0.141623098342804
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,39586,0.00759074584132574,0.00517086702359946,-0.00254415352492921,0.0177256452075807,0.142137419268742
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,42084,0.00516197978324516,0.00351647622210763,-0.00173031361208579,0.0120542731785761,0.142143562503666
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,0.00789542267450972,0.00539053927152317,-0.00267003429767569,0.0184608796466951,0.143036473355594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,41877,0.00675136066904051,0.00461405675642999,-0.00229219057356228,0.0157949119116433,0.143432015564323
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.00988351415183803,0.0067556038011948,-0.00335746929850378,0.0231244976021798,0.143487917185671
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,39919,-0.0122329898498641,0.00836923130089471,-0.0286366831996177,0.00417070349988958,0.14386153410351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00603060119897204,0.00412903406427128,-0.00206230556699967,0.0141235079649437,0.144170750791326
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,0.0101241112822247,0.00694041509212299,-0.00347910229833635,0.0237273248627858,0.144671282665566
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.00886670368668659,0.0060801329540033,-0.00305035690315987,0.020783764276533,0.1447835135845
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DMD,Dystrophin,39638,0.00809144191657156,0.00554993261348745,-0.00278642600586385,0.018969309839007,0.144886865207404
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,39586,0.00760202585764856,0.00522411736273926,-0.0026372441733204,0.0178412958886175,0.145648286259733
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,39560,0.0117693701052806,0.00808856263731883,-0.00408421266386432,0.0276229528744255,0.145680395846565
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,-0.00901960519654835,0.00620405083302581,-0.0211795448292789,0.00314033443618223,0.14602321706646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,42247,-0.018770160906744,0.0129137997435061,-0.0440812084040159,0.00654088659052791,0.146108984401012
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,-0.00642139043113351,0.0044290192194962,-0.0151022681013461,0.00225948723907904,0.14712996834851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,0.00302549901949933,0.0020871370126448,-0.00106528952528449,0.00711628756428315,0.147199632855443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,39649,0.0128536472897639,0.00887288140137918,-0.00453720025693933,0.0302444948364671,0.147465376325964
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00976068065489759,0.0067795668364315,-0.00352727034450814,0.0230486316543033,0.149975042132716
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00462853077781168,0.00322027315784889,-0.00168320461157215,0.0109402661671955,0.150658228761908
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,0.00618307851132565,0.00430397342984139,-0.00225270941116348,0.0146188664338148,0.150860339926524
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.012934962540735,0.00900704097429074,-0.0305887628503448,0.00471883776887489,0.150999191020539
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C7,Complement component C7,39722,0.00516278933657497,0.00359776781865824,-0.00188883558799517,0.0122144142611451,0.151315809077522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,0.00327468579906529,0.00228368446841598,-0.00120133575903002,0.0077507073571606,0.151609882865692
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.0093592586038933,0.0065333892280928,-0.00344618428316858,0.0221647014909552,0.152021415967655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,0.010186193572853,0.00712575543171956,-0.00378028707331739,0.0241526742190233,0.15289111197621
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,42310,-0.00953884063264238,0.0066734439911699,-0.0226187908553354,0.00354110959005063,0.152919840243642
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,-0.00685568248717894,0.00479814625822917,-0.0162600491533081,0.00254868417895024,0.153084696966097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,41900,0.0112110992676086,0.00784798763103193,-0.00417095648921401,0.0265931550244312,0.153162354315168
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,0.00882847361892393,0.00620525429622612,-0.00333382480167926,0.0209907720395271,0.154834621900071
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.00612556535124335,0.0043142064099869,-0.0145814099148177,0.00233027921233097,0.155676910393783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,-0.00721460546505441,0.00508560010696365,-0.0171823816747032,0.00275317074459434,0.156033939711864
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,39649,0.00901222502342784,0.00636097540492308,-0.0034552867702214,0.0214797368170771,0.156569830075153
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,0.00701774509347301,0.00495715819148979,-0.00269828496184698,0.016733775148793,0.156892481756684
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,42296,-0.00464502899896588,0.00328976986442107,-0.0110929779332312,0.00180291993529941,0.157983962274816
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00753628838872528,0.00533746735994131,-0.00292514763675969,0.0179977244142102,0.157990202470765
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00551654989299192,0.00390935755323261,-0.00214579091134401,0.0131788906973278,0.158239104251082
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,-0.00943692200019519,0.00669313090031471,-0.022555458564812,0.00368161456442163,0.158579966779599
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,0.00665363061924617,0.00472122969844899,-0.00259997958971385,0.0159072408282062,0.158773823820098
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,0.00515082955671783,0.00366939092175903,-0.00204117664992987,0.0123428357633655,0.160427929772228
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,0.00567175174001583,0.00404098129627881,-0.00224857160069065,0.0135920750807223,0.160478384583882
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,39736,0.00427962161826845,0.00305211020551674,-0.00170251438454436,0.0102617576210813,0.160888033288473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,-0.0153773964060658,0.0109703871981909,-0.03687935531452,0.00612456250238846,0.161027569488069
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00547251515554453,0.00391110476404805,-0.00219325018198965,0.0131382804930787,0.161773625075589
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRTN,Neurturin,41913,0.00743444401830055,0.00532743202721964,-0.00300732275504995,0.017876210791651,0.162887675797706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,39586,0.0100403326332114,0.00719509480072369,-0.00406205317620706,0.0241427184426298,0.162911000978183
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.0072346390643838,0.0051866243626654,-0.00293114468644039,0.017400422815208,0.163084882159371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,-0.0146104757146346,0.0105070125170387,-0.0352042202480305,0.00598326881876121,0.164386359655872
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.00830683014593091,0.00597716199485022,-0.00340840736397551,0.0200220676558373,0.164629265916403
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,39649,0.0098164462536097,0.00706677925975613,-0.00403444109551232,0.0236673336027317,0.164831062362687
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.00979661304951699,0.0070564438564823,-0.00403401690918832,0.0236272430082223,0.16506733165267
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,41843,0.00467315607348456,0.00337030504501368,-0.00193264181474226,0.0112789539617114,0.165596967483431
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.0051276173810279,0.00372131217002551,-0.00216615447222211,0.0124213892342779,0.168260461344013
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,0.0123895040164861,0.00900413324026331,-0.00525859713443002,0.0300376051674021,0.168855133641948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,0.00401631457629128,0.00292139810552406,-0.00170962571053588,0.00974225486311844,0.169223223423841
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,-0.0113758566619096,0.00829218296500406,-0.0276285352733176,0.00487682194949836,0.170124911635296
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,0.00629577613724417,0.0045901185921242,-0.00270085630331926,0.0152924085778076,0.170218104117806
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.0103090224977533,0.00751842191891526,-0.00442708446332059,0.0250451294588272,0.17034558064382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,39649,0.00408965084603021,0.00298439474263086,-0.00175976284952627,0.0099390645415867,0.170607027310644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.00412976872773798,0.00301715643393086,-0.0100433953382425,0.0017838578827665,0.171101525237083
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAT,Catalase,39827,0.00772692643613423,0.00564648558069336,-0.00334018530202476,0.0187940381742932,0.171199019677014
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,39930,-0.0177919151557795,0.0130092411443948,-0.0432900277987932,0.00770619748723427,0.171452961045885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,42296,0.00698115978043995,0.00511912082595403,-0.00305231703842995,0.0170146365993098,0.172671211192401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,39347,-0.0181592119583224,0.013374093182071,-0.0443724345951816,0.00805401067853686,0.17455878902866
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,42123,-0.00524105006120003,0.00386024666946344,-0.0128071335333484,0.00232503341094832,0.174582113941057
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,0.0112634996085838,0.0083132798058023,-0.0050305288107887,0.0275575280279563,0.175483159534703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,0.00950392614986096,0.00702348250836476,-0.00426209956653397,0.0232699518662559,0.176026130309608
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,0.00940519432047165,0.00695242920244417,-0.00422156691631891,0.0230319555572622,0.176149579485523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.00503253208103485,0.00372274140910316,-0.00226404108080734,0.012329105242877,0.176455939919373
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.00442199988668001,0.00328214442167401,-0.00201100317980105,0.0108550029531611,0.177909292647213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,0.0049584948537477,0.00368229901217115,-0.00225881121010775,0.0121758009176031,0.178139539281056
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,0.0118273024427533,0.00878472760727978,-0.00539076366751506,0.0290453685530217,0.178218082508286
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,39586,0.00849722746526564,0.00631261092715886,-0.00387548995196572,0.020869944882497,0.178307141304706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,42105,0.00720459201349621,0.00535885980205094,-0.00329877319852363,0.0177079572255161,0.178833157403166
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,-0.0278029946213599,0.0206872063250403,-0.0683499190184389,0.0127439297757191,0.178980543574599
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.00576806471929788,0.0043054720025164,-0.00267066040563426,0.01420678984423,0.180368674399786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,-0.00573324702006228,0.004284139657613,-0.0141301607489838,0.0026636667088592,0.180837650896761
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,39958,0.00431992454840515,0.00324240992458144,-0.00203519890377447,0.0106750480005848,0.182782095977786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.00493808241467149,0.00370953456483633,-0.00233260533240773,0.0122087701617507,0.183155296069673
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.008029067311046,0.00605215584252237,-0.00383315814029784,0.0198912927623899,0.184653470585478
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,39560,0.00753618267811778,0.00568148192774565,-0.0035995219002637,0.0186718872564993,0.184719433222738
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0131450988530346,0.00991319553196495,-0.00628476438961672,0.0325749620956859,0.184860530373359
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,0.00950949905824195,0.00717279684743308,-0.00454918276272689,0.0235681808792108,0.184942553898745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.00842991756850024,0.00636164057735798,-0.0040388979631214,0.0208987331001219,0.185155268007642
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.00296194373078479,0.00223537142759969,-0.00734327172888018,0.0014193842673106,0.185182263519434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,39586,0.0139390748793657,0.0105210488205207,-0.00668218080885481,0.0345603305675862,0.185240159737208
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.00667520394222108,0.00504083416170161,-0.00320483101471407,0.0165552388991562,0.185455593994823
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,0.00841491222946374,0.00635588531190948,-0.00404262298187884,0.0208724474408063,0.185545245596279
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TF,Serotransferrin,39979,0.00305661873189071,0.00231015793301752,-0.00147129081682362,0.00758452828060504,0.185821691037063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,41900,0.00762794455828838,0.00576593371712974,-0.0036732855272859,0.0189291746438627,0.18588037147402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00308292520419665,0.0023314257621605,-0.00148666928963793,0.00765251969803123,0.18608411887432
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.00361670800296176,0.00273536657115261,-0.00897802648242089,0.00174461047649736,0.186128383885664
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,0.00407664971540493,0.00308386677803813,-0.00196772916954981,0.0101210286003597,0.18621439961482
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,39649,0.00708807032624812,0.00537812287401341,-0.00345305050681816,0.0176291911593144,0.187549372705885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,39757,0.00328883860789144,0.00249803130148055,-0.00160730274301044,0.00818497995879333,0.188009100707561
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,0.00430273222348588,0.00326846669523241,-0.00210346249916965,0.0107089269461414,0.188054696161531
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,39575,0.00479022026123743,0.0036413948911345,-0.00234691372538619,0.0119273542478611,0.188372599809945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,39930,0.00883496750198317,0.00672607836091877,-0.00434814608541762,0.022018081089384,0.189027923230854
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.00593559997114059,0.00451925233838022,-0.0147933345543658,0.00292213461208464,0.189074411065193
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.00755914337648394,0.0057697485686436,-0.00374956381805752,0.0188678505710254,0.190172558231351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.00531069218646782,0.00405459801552932,-0.00263631992396965,0.0132577042969053,0.190287820014572
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.00661531044994222,0.00505456028023419,-0.0032916276993168,0.0165222485992012,0.190631390223106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.00517516130563406,0.00395904250721535,-0.00258456200850803,0.0129348846197761,0.19117523610411
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,41830,-0.0120367883350416,0.00921242497579151,-0.0300931412875929,0.0060195646175098,0.191377436850778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,-0.0045878435516417,0.00352191462096646,-0.011490796208736,0.00231510910545255,0.192714077326632
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,0.00676192267736838,0.00519249385928377,-0.0034153652868278,0.0169392106415646,0.192857561464819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,0.00653340713728357,0.00502242875883002,-0.00331055323002327,0.0163773675045904,0.193338431298382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,0.00833336328567387,0.00641772563256879,-0.00424537895416095,0.0209121055255087,0.194145692207725
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.00871228450399745,0.00671146637421736,-0.0218667585974635,0.00444218958946857,0.194269239398271
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,39649,0.00440153010409815,0.00339744637503557,-0.00225746479097157,0.0110605249991679,0.195160830876901
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEB,Nebulin,39575,0.00554439259100407,0.00429299280791333,-0.00286987331250604,0.0139586584945142,0.19655816873098
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,39560,0.00555261742669143,0.00430137939604381,-0.00287808618955444,0.0139833210429373,0.196768263353446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.00872587084237184,0.00676451784371625,-0.004532584131312,0.0219843258160557,0.197096171028643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,0.00554490771755461,0.00430222395744729,-0.00288745123904207,0.0139772666741513,0.197478544122678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,0.0167411457707679,0.013006891613624,-0.00875236179193522,0.0422346533334709,0.198087234015775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,39979,0.00572166759424298,0.00444683626299431,-0.00299413148122587,0.0144374666697118,0.198231056893272
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,39560,0.00858196258914386,0.00668241112350554,-0.00451556321292701,0.0216794883912147,0.199077657630321
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.00380673054359699,0.00297124271860443,-0.0020169051848677,0.00963036627206168,0.200148792688365
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEO1,Neogenin,39934,0.0031210241943054,0.00243746549980048,-0.00165640818530353,0.00789845657391434,0.200417232468657
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00625685923359436,0.00488661250182702,-0.0158346197371753,0.00332090126998661,0.200428607192384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,0.0148216550799552,0.011575774333932,-0.00786686261455148,0.0375101727744618,0.200429620288093
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,39560,0.00899801682540566,0.00703549413039907,-0.00479155167017652,0.0227875853209878,0.200943163103345
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,0.0171376441373875,0.0134022821808804,-0.00913082893713807,0.043406117211913,0.201025922550547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NBN,Nibrin,41913,0.00746983526964682,0.00584263455043099,-0.00398172844919793,0.0189213989884916,0.201093844266502
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00626667472555046,0.00490633870122015,-0.015883098579942,0.00334974912884103,0.201536981282106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,-0.00549024365551915,0.00429849532094612,-0.0139152944845735,0.00293480717353525,0.201540977427849
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,0.00665327045700253,0.00521710261542457,-0.00357225066922963,0.0168787915832347,0.202236888059532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.00693320361700368,0.00544593564737414,-0.017607237485857,0.00374083025184963,0.203010455114117
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,41843,0.022181694610301,0.0174250600105936,-0.0119714230104623,0.0563348122310644,0.203048672108909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,0.00637422494303666,0.00501081999271877,-0.00344698224269212,0.0161954321287654,0.20336732069211
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,0.00584092502980146,0.00459583633501103,-0.00316691418682016,0.0148487642464231,0.203785230823944
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,41913,0.00698731683550801,0.00549893398469446,-0.00379059377449313,0.0177652274455091,0.203869157239587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.0066421124790307,0.00523070815246366,-0.00361007549979806,0.0168943004578595,0.204171927958881
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,39657,0.00534572944326312,0.00421219605821557,-0.0029101748308394,0.0136016337173656,0.204429453303034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00532508564936022,0.00419792688413462,-0.00290285104354363,0.0135530223422641,0.204640439239402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,39575,0.0061110270360284,0.00482270656172678,-0.00334147782495609,0.0155635318970129,0.205133408772967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,41843,-0.00874711895226031,0.00691239202373722,-0.0222954073187853,0.00480116941426465,0.205741008176272
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.00837887948943162,0.00663827989170244,-0.00463214909830517,0.0213899080771684,0.206901340545512
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.0144958759259247,0.0114943804978587,-0.00803310984987846,0.0370248617017278,0.207288978459678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,41997,0.00939982043248484,0.00746469841925957,-0.00523098846926391,0.0240306293342336,0.207966874143298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0076286719834461,0.0060670248733496,-0.0195200407352113,0.00426269676831912,0.208635709373449
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.00696049719190565,0.00555007999356415,-0.00391765959548008,0.0178386539792914,0.209822244099287
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,39638,0.00600479322694054,0.00479169437254103,-0.00338692774323988,0.015396514197121,0.210171484317887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.0128099985777627,0.0102452511193402,-0.0328906907716695,0.00727069361614418,0.211203802460901
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,0.00855817945646219,0.00685316113753547,-0.00487401637310733,0.0219903752860317,0.211766597980292
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,-0.0131117603165902,0.0105068685734642,-0.03370522272058,0.00748170208739974,0.212081412993446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,39575,0.00656107102424302,0.00526992314874807,-0.00376797834730321,0.0168901203957892,0.21315716760811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,41225,-0.0055470663526236,0.0044579381898354,-0.014284625204701,0.00319049249945379,0.213407825766695
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.00278869818429785,0.0022455833498524,-0.00161264518141285,0.00719004155000855,0.21431507942223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,0.00716633599111909,0.00579237895435819,-0.00418672675942297,0.0185193987416612,0.216038203166665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,41742,0.012196035987479,0.00986321354270896,-0.00713586255623057,0.0315279345311885,0.216288368503165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.00420096115101261,0.0034121752537888,-0.00248690234641345,0.0108888246484387,0.218286250041737
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00631542634468192,0.00513054246407203,-0.0163712895742631,0.00374043688489925,0.218368853811475
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.0100770519942034,0.00818791811562169,-0.00597126751241511,0.0261253715008219,0.218448574412045
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,0.00876012071533885,0.00712267544919423,-0.00520032316508185,0.0227205645957595,0.218763762073957
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,0.00971868213903318,0.0079029091602263,-0.00577101981501037,0.0252083840930767,0.218812895248686
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.00674591180597779,0.00548596897571565,-0.0174984109983805,0.00400658738642488,0.218843800005193
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.00475528384634675,0.00387071846482683,-0.0123418920374073,0.00283132434471384,0.219275201572124
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,39930,0.00900274174454473,0.00732989795142494,-0.00536385824024814,0.0233693417293376,0.219389164372886
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,0.00290484184715096,0.00236992445620057,-0.00174021008700216,0.00754989378130407,0.220333654777259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,41890,0.00743026105457754,0.00606307236819639,-0.00445336078708739,0.0193138828962425,0.220410726746014
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,0.0100951126341388,0.00823883733112073,-0.00605300853485789,0.0262432338031354,0.220480562675857
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.00671399441989884,0.00549201968717846,-0.00405036416697094,0.0174783530067686,0.221540342787832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.00587655149841809,0.00481399138519762,-0.00355887161656924,0.0153119746134054,0.222212061158778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,41839,0.00509905193101125,0.00418620769825255,-0.00310591515756375,0.0133040190195862,0.223222899857939
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,39560,0.0121460662780099,0.00997389149999215,-0.00740276106197474,0.0316948936179945,0.223331490324894
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,-0.00481113795214551,0.00395728745546482,-0.0125674213648566,0.00294514546056554,0.224095148210549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.00403166097775746,0.00331894754076401,-0.00247347620213999,0.0105367981576549,0.224491317729477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,39575,0.00762216195613825,0.00628743823580969,-0.00470121698604875,0.0199455408983253,0.225429710531105
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,39638,0.0114382557933476,0.00944971884879253,-0.00708319315028577,0.0299597047369809,0.226138531218549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.00682118566413153,0.00568546514988461,-0.0043223260296423,0.0179646973579054,0.230254580005897
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,0.00738323576397124,0.00616284321676154,-0.00469593694088138,0.0194624084688239,0.230933412642003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,-0.00808007687281915,0.00675726545011108,-0.0213243171550369,0.00516416340939857,0.231815571577391
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.00650700616328466,0.00544276594440658,-0.00416081508775223,0.0171748274143215,0.231904320318662
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCIN,Adseverin,39586,0.00948813940643425,0.00795775858769221,-0.00610906742544248,0.025085346238311,0.233164272608982
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,42310,-0.00828919825002461,0.00695920864581265,-0.0219292471958174,0.00535085069576817,0.233630165606432
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.00799199000844386,0.00671773567070555,-0.0211587519230267,0.00517477190613902,0.234195956313085
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,0.00441023914349373,0.00370814724461396,-0.00285772945594963,0.0116782077429371,0.234332134290569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00489243722270149,0.0041216308482679,-0.0129708336853066,0.00318595923990359,0.235247435912254
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.00629366646020597,0.00530384523822153,-0.00410187020670823,0.0166892031271202,0.235397518810671
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,0.00504085404958288,0.00424844694008621,-0.0032861019529861,0.0133678100521519,0.235443919275631
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,42123,0.0164076789193468,0.0138523733501001,-0.0107429728468495,0.043558330685543,0.236249074203026
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,0.00676751681228654,0.00571458501538725,-0.00443306981787247,0.0179681034424455,0.236333366403388
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.00708361998981263,0.00598350503324413,-0.00464404987534587,0.0188112898549711,0.236494520459967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.00763581773295769,0.00647451127882031,-0.00505422437353013,0.0203258598394455,0.238273003420165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,39652,0.00900490479383213,0.00765706815353793,-0.00600294878710221,0.0240127583747665,0.239610153557418
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,0.00551557308622943,0.00469384274260406,-0.00368435868927454,0.0147155048617334,0.239993823453025
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.0110642275589892,0.00941951261727506,-0.00739801717086988,0.0295264722888483,0.240177187987958
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,39919,0.00511215137529838,0.00436524320640806,-0.00344372530926141,0.0136680280598582,0.241581850268198
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,39649,0.00510866746025399,0.00436966351298233,-0.00345587302519138,0.0136732079456994,0.242379913421199
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.0034217701322165,0.00292745010235621,-0.00231603206840168,0.00915957233283467,0.242485890155477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,39750,0.0124927507998277,0.0106940374963656,-0.00846756269304893,0.0334530642927044,0.242751975509824
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,42145,0.0144173425154178,0.0123436868169478,-0.0097762836457999,0.0386109686766356,0.242830057800924
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,39934,-0.00530034444089861,0.00454484253262239,-0.0142082358048385,0.00360754692304128,0.243544872942258
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00770965727211135,0.00662493218802264,-0.00527520981641303,0.0206945243606357,0.244556451736099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.00825363857902643,0.00709316474575231,-0.022156241480701,0.0056489643226481,0.244604853987852
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,0.00713042834245893,0.006130259677677,-0.004884880625788,0.0191457373107059,0.244788384767584
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,42137,0.00249270009769334,0.00214438756043303,-0.00171029952075539,0.00669569971614208,0.2450813989721
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,41843,0.0110573943273362,0.00955560756233784,-0.00767159649484595,0.0297863851495184,0.247226693276701
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.00700485040048071,0.00605492127347934,-0.0048627952955388,0.0188724960965002,0.247343816872718
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,39638,-0.00290010357257165,0.00250729703622047,-0.00781440576356377,0.00201419861842047,0.24743414843815
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.0131694179543304,0.0113869013290238,-0.00914890865055628,0.035487744559217,0.247484712601659
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,0.0136997401795186,0.0118674278995605,-0.00956041850361993,0.0369598988626572,0.248361237360578
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.00323846056164227,0.00280729572631658,-0.00874076018522277,0.00226383906193823,0.248694583032689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,0.0112343057077609,0.00974459006759169,-0.00786509082471879,0.0303337022402406,0.248982021740901
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,0.00439478111301835,0.00381585138941435,-0.00308428761023378,0.0118738498362705,0.249462451030206
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,41843,0.00762725679152463,0.00662653706615109,-0.0053607558581315,0.0206152694411808,0.249746024618833
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00466702382820494,0.00406559178603226,-0.0126355837288282,0.0033015360724183,0.251021598559822
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,42016,0.00404723608502105,0.00352929096142859,-0.00287017419937898,0.0109646463694211,0.251502871583827
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,42287,0.00724955198218629,0.00632396390372446,-0.00514541726911364,0.0196445212334862,0.251665434915679
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,39586,0.010125680742809,0.00884061711127958,-0.00720192879529897,0.027453290280917,0.252085407401961
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,0.00725360381013359,0.00634243451555162,-0.00517756784034759,0.0196847754606148,0.252788436299207
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,39586,0.00702786489903891,0.0061458595789509,-0.00501801987570486,0.0190737496737827,0.252850943283998
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,39757,0.00355745380987845,0.00311673268318512,-0.00255134224916438,0.00966624986892127,0.253725983445757
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTN,Titin,39575,-0.00851228086348682,0.00746936840163605,-0.0231522429306935,0.00612768120371985,0.254467330736484
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,0.00685441995573775,0.00601951802548497,-0.00494383537421279,0.0186526752856883,0.254853494183896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,0.00430186049233236,0.00377801512767725,-0.00310304915791505,0.0117067701425798,0.2548713910138
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,39657,0.00321608565926667,0.00282466066751743,-0.0023202492490675,0.00875242056760084,0.254905477223051
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,41839,0.00621394987334631,0.00546495562554466,-0.00449736315272122,0.0169252628994139,0.255536274763953
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,-0.00506055631080844,0.00445142835611266,-0.0137853558887893,0.00366424326717238,0.255625918353623
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,41843,0.0117228695326728,0.0103273208142794,-0.00851867926331472,0.0319644183286604,0.256340673200987
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,41900,0.00690236832973366,0.00608593752230776,-0.00502606921398954,0.0188308058734569,0.256751916751181
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,39958,0.00660257093842382,0.00582801452535876,-0.00482033753127935,0.018025479408127,0.25727920690103
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,-0.00457605199406482,0.00404694050429545,-0.0125080553824839,0.00335595139435426,0.258187649892128
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,39929,0.0132268751607385,0.0116999136535583,-0.0097049556002357,0.0361587059217127,0.258285111888083
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,-0.00928895069845676,0.00823378632006263,-0.0254271718857795,0.00684927048886599,0.259280641347322
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.00909351468670107,0.00806864888675532,-0.00672103713133936,0.0249080665047415,0.259758566832187
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,42082,0.0106262211959928,0.00943779325499312,-0.00787185358379369,0.0291242959757794,0.260218482077428
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,0.00839609954280648,0.00747539308170837,-0.00625567089734191,0.0230478699829549,0.261391986550214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,42310,0.00525685140593298,0.00468295227710965,-0.00392173505720194,0.0144354378690679,0.261648017000799
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,39649,0.00459473711909635,0.00409526891988477,-0.00343198996387779,0.0126214642020705,0.261902873596971
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,39699,0.00537464493325603,0.00479687583173624,-0.004027231696947,0.0147765215634591,0.26254758729333
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,42262,0.00490200228568632,0.00437742880591232,-0.00367775817390183,0.0134817627452745,0.262803349053972
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,42077,0.00277421446924012,0.00247890729332099,-0.00208444382566903,0.00763287276414927,0.263105497601026
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00764735062284366,0.0068342799689413,-0.00574783811628129,0.0210425393619686,0.263177254655569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,39586,-0.00470809729534888,0.00421081626065489,-0.0129612971662325,0.0035451025755347,0.263550394812434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,0.0116954743424261,0.010461005813533,-0.00880809705209864,0.0321990457369508,0.263588431843624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,39657,0.00668276268482891,0.00599357721392695,-0.00506464865446792,0.0184301740241257,0.264880082368851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.00401162398144429,0.0035981589155246,-0.00304076749298392,0.0110640154558725,0.264913362890886
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.00688525259553151,0.00618365478571159,-0.00523471078446321,0.0190052159755262,0.265534882592043
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,0.00426449577148842,0.00383634649658667,-0.00325474336182145,0.0117837349047983,0.266332324330046
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00579824154485379,0.00521732194072646,-0.00442770945897008,0.0160241925486777,0.266444478047501
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,0.00882984527115209,0.0079474222903399,-0.00674710241791412,0.0244067929602183,0.266578258338559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.00666315250537417,0.00599999285832648,-0.00509683349694573,0.0184231385076941,0.26679568157384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00642168878281069,0.0057860143637184,-0.0177622769356988,0.00491889937007737,0.26708194766649
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.00341186158473886,0.00308693310413341,-0.00263852729936263,0.00946225046884035,0.269071443665002
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,0.00615807024548582,0.00560136320563778,-0.00482060163756422,0.0171367421285359,0.271618300843734
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,-0.00743655540836561,0.00677339404964121,-0.0207124077456624,0.00583929692893115,0.272264835166355
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,39638,0.00820612481245608,0.00749064200180092,-0.00647553351107372,0.0228877831359859,0.273314153505816
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.00804539969694171,0.00735951879630004,-0.00637925714380637,0.0224700565376898,0.274331556982876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.00719935370586015,0.00659292057244474,-0.00572277061613154,0.0201214780278518,0.274860265116093
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.0081480689912198,0.00746714625206144,-0.00648753766282062,0.0227836756452602,0.275213223934338
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0045513191431135,0.00417378876897003,-0.00362930684406777,0.0127319451302948,0.275532971707921
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,41839,-0.00484496688003888,0.00446025519567562,-0.0135870670635631,0.00389713330348533,0.277386723930213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,0.00769574875122139,0.00709143408099648,-0.00620346204753172,0.0215949595499745,0.277848758891603
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,0.00908385587628065,0.0083838376454641,-0.00734846590882899,0.0255161776613903,0.278611303908689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,39897,0.0107915848842705,0.00998942310773733,-0.00878768440689469,0.0303708541754357,0.280031177127702
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,42016,-0.00616469934900515,0.0057187935333055,-0.0173735346742839,0.00504413597627364,0.28106562968959
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,42070,0.00378019461695082,0.00352073036319262,-0.00312043689490671,0.0106808261288084,0.282978123567659
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,39757,0.00410057362525525,0.00382935386605161,-0.00340495995220591,0.0116061072027164,0.284270609737668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.003610726639514,0.00337881624043447,-0.0102332064707656,0.00301175319173756,0.285252833734002
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00744099771049417,0.00701009469033359,-0.00629878788255967,0.021180783303548,0.288500179321267
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,0.0087338859350307,0.00826426408080421,-0.00746407166334555,0.0249318435334069,0.290610031579719
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.00384249884387925,0.00364294606464458,-0.00329767544282413,0.0109826731305826,0.291549427541132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,0.00609892535482626,0.00578820597976109,-0.00524595836550548,0.017443809075158,0.292052050544498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,39560,0.00414570535758866,0.00393512869030752,-0.00356714687541407,0.0118585575905914,0.292129614985201
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,0.00704531300480952,0.00669299207641826,-0.00607295146497027,0.0201635774745893,0.292528744225722
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.00706720122903394,0.00671601470912589,-0.0060961876008528,0.0202305900589207,0.292689096674488
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,41913,0.00356153781948481,0.00339164835767432,-0.00308609296155686,0.0102091686005265,0.29369555380174
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,39638,0.0067071702012456,0.00641754686639282,-0.00587122165688433,0.0192855620593755,0.295985817103362
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,39934,-0.00287495044667404,0.002751245759481,-0.0082673921352568,0.00251749124190871,0.296062284867599
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.00467741510379415,0.00447948638348311,-0.00410237820783275,0.013457208415421,0.296418600962472
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,-0.00704929644498195,0.00676837981023397,-0.0203153208730405,0.00621672798307664,0.297664385427188
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,41839,0.00661001563877518,0.00634888833581089,-0.00583380549941417,0.0190538367769645,0.297834410930989
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,-0.00362660283953991,0.00348553322693104,-0.0104582479643247,0.00320504228524491,0.298143369739728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.00774904373370234,0.00744850801293987,-0.0223481194390645,0.0068500319716598,0.298200245720423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,39690,-0.00955882692950452,0.00920677736940211,-0.0276041105735327,0.00848645671452362,0.299181860436541
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,39929,-0.00242676839996296,0.00235658534743258,-0.00704567568093081,0.00219213888100489,0.303134490415942
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,0.0085551969585773,0.00831295759930909,-0.00773819993606852,0.0248485938532231,0.303436659078332
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,42119,0.00889148274164563,0.00865035123068263,-0.00806320567049232,0.0258461711537836,0.304026859184331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,0.00656458687139209,0.00639561647924311,-0.00597082142792441,0.0190999951707086,0.304715701625654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00608346605017642,0.00593570743864074,-0.00555052052955943,0.0177174526299123,0.305436160795521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,0.00324996367761854,0.00317229068739057,-0.00296772606966699,0.00946765342490406,0.305628890954673
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,42224,-0.0053484964797502,0.00523437908869515,-0.0156078794935927,0.00491088653409229,0.30689299561918
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSC1,Hamartin,39657,0.00814168897624151,0.00797749478562352,-0.00749420080358059,0.0237775787560636,0.307474767405284
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,0.00321284307065449,0.00315213595094699,-0.0029653433932016,0.00939102953451058,0.308102145548418
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,41960,0.00443157320230717,0.00435083377082683,-0.00409606098851341,0.0129592073931277,0.308431661179205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,42211,0.00668435170465009,0.00656405229122376,-0.00618119078614847,0.0195498941954487,0.308540679302353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.00551307538391084,0.00541422791541246,-0.00509881133029757,0.0161249620981193,0.308577587935883
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,42137,0.00286166949962971,0.00281268065308364,-0.00265118458041422,0.00837452357967364,0.308973215674417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,0.00441363420091138,0.00434115219728064,-0.00409502410575867,0.0129222925075814,0.309319882409135
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,0.00739445274110486,0.00727766998756765,-0.00686978043452774,0.0216586859167375,0.309628980249277
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,0.0040425226113053,0.00398097769545077,-0.0037601936717782,0.0118452388943888,0.309904963034494
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.00340778649006517,0.0033575306811917,-0.00998854662520091,0.00317297364507057,0.310143445524152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,41900,-0.00254171385884777,0.00250525456238707,-0.00745201280112642,0.00236858508343087,0.310337346615452
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,39657,0.00508736029491083,0.00502087160442901,-0.00475354804977002,0.0149282686395917,0.310966535360691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLGN,Calmegin,39649,-0.0049978803323688,0.00493332219109859,-0.014667191826922,0.00467143116218443,0.311041202206577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,0.00573320086224011,0.00566732634211581,-0.00537475876830687,0.0168411604927871,0.31174001349223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,39560,0.00719511858628561,0.00714249082253232,-0.00680416342587773,0.0211944005984489,0.313780075088408
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.00805848990525889,0.00800914013555622,-0.0076394247604313,0.0237564045709491,0.31435985728528
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,39915,0.00266405113713484,0.00264915283816677,-0.00252828842567202,0.0078563906999417,0.314618076367123
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,39934,-0.00657949478882443,0.0065437911785611,-0.0194053254988042,0.00624633592115533,0.314698740614274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00541386657231181,0.00539966839426992,-0.00516948348045724,0.0159972166250809,0.316061761924706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,39757,0.0041683099648141,0.00416253924241768,-0.00399026695032455,0.0123268868799528,0.316661779659648
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,-0.00346504811990206,0.00346320833579637,-0.0102529364580629,0.00332284021825882,0.317071339552307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,0.00557072151085236,0.00557481914049947,-0.00535592400452659,0.0164973670262313,0.317688378231811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,0.00861469901672219,0.00864116653105648,-0.00832198738414851,0.0255513854175929,0.318816690184072
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,0.00925947050078172,0.00930000373810076,-0.00896853682589577,0.0274874778274592,0.319445912514253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.00382017803552196,0.00383883235602481,-0.00370393338228666,0.0113442894533306,0.319686056156759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,41913,0.00518692323186553,0.00522480433329087,-0.00505369326138457,0.0154275397251156,0.320849963263813
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.00585161282731445,0.00590062571131001,-0.00571361356685317,0.0174168392214821,0.321368724573154
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00300090031538706,0.00302625923148811,-0.00893236840910376,0.00293056777832963,0.321403924371115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,0.00503701987244854,0.00509229755712281,-0.00494388333951216,0.0150179230844092,0.322613730365905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,42016,0.00935273955878824,0.0094631665738892,-0.0091950669260346,0.0279005460436111,0.323008460457089
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,0.00293912991656007,0.00297768842601403,-0.00289713939842743,0.00877539923154757,0.323638915755618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,42137,0.00300319084687658,0.00304810929187859,-0.00297110336520546,0.00897748505895862,0.324512262853541
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,39966,0.00983646587609893,0.0099993177238036,-0.00976219686255612,0.029435128614754,0.325277238881531
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,39638,0.00453306404190192,0.00463171453784435,-0.004545096452273,0.0136112245360768,0.327749145405321
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,41913,-0.0032323113571602,0.00330322847754267,-0.00970663917314385,0.00324201645882344,0.32782956398682
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.00803065553517123,0.00821456188486132,-0.00806988575915696,0.0241311968294994,0.328287005440226
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,39966,0.0088642499653382,0.00907836698531533,-0.00892934932587984,0.0266578492565562,0.328879835634414
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.00500680513052065,0.00513200493478111,-0.0150655348026916,0.00505192454165032,0.329277945847095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,0.00797189869216386,0.0081903219105275,-0.00808113225247004,0.0240249296367978,0.330410029271223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.00783929274505031,0.00806896910519392,-0.00797588670112977,0.0236544721912304,0.331302921443316
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,41839,-0.00337290910707019,0.00347973611394609,-0.0101931918904045,0.00344737367626415,0.332413108886652
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.00461073267779857,0.00476268120260783,-0.00472412247931277,0.0139455878349099,0.333017754319448
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,0.00546588868878041,0.00564816259518078,-0.00560450999777391,0.0165362873753347,0.333197584824146
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,0.00493903024096473,0.0051074833926138,-0.00507163720855833,0.0149496976904878,0.333552517320558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,0.00442043768640548,0.00457715273984734,-0.0045507816836953,0.0133916570565063,0.334184840238078
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,39649,0.00477642712366292,0.00494794995183743,-0.00492155478193844,0.0144744090292643,0.334398391119148
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,39638,-0.00654915198984646,0.00680079961741755,-0.0198787192399849,0.00678041526029193,0.335569950312581
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.00750916928658565,0.00781929342435284,-0.0228349843983172,0.00781664582514592,0.336902136858021
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.010941366064319,0.0114279788167358,-0.0114574724164832,0.0333402045451212,0.338376812634624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,42075,0.00604346571575889,0.00633386832380646,-0.00637091619890177,0.0184578476304196,0.340024415582346
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,0.00433032422374997,0.00454252928956868,-0.00457303318380465,0.0132336816313046,0.340462800917312
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,42084,0.00820863608519803,0.00866082204844966,-0.0087665751297633,0.0251838473001594,0.343253618696963
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,-0.00352817883293849,0.0037265476398141,-0.0108322122069741,0.00377585454109714,0.343777454915947
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.00705750265881769,0.00745572156997264,-0.0075557116183287,0.0216707169359641,0.343869030411854
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.0045097884821067,0.00476706695104376,-0.00483366274193907,0.0138532397061525,0.344150440331298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.00424630803733941,0.00449116667522248,-0.00455637864609665,0.0130489947207755,0.344434677767735
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,39649,0.00502679990250142,0.00532755878438536,-0.00541521531489389,0.0154688151198967,0.345422029302902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,0.00759740248164943,0.00805983478405749,-0.00819987369510325,0.0233946786584021,0.345893450695591
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,39575,0.00767404260923373,0.00818011277250885,-0.00835897842488361,0.0237070636433511,0.348196151680978
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,42262,0.00392649699402622,0.00420914280922399,-0.0043234229120528,0.0121764169001052,0.350914136589806
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,41913,0.00473203191303852,0.00510012816093096,-0.00526421928238616,0.0147282831084632,0.353514614658991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,-0.0103576098271777,0.0111872611240197,-0.0322846416302563,0.0115694219759009,0.354545849253103
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,-0.00487111296189488,0.00527766517197382,-0.0152153366989636,0.00547311077517381,0.356043861753848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,-0.00390062572524989,0.0042291072622431,-0.0121896759592464,0.00438842450874658,0.356373733845175
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,42262,-0.00370451118973143,0.00401816272103481,-0.0115801101229597,0.0041710877434968,0.35657534184464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,39919,-0.00396048931178232,0.00429667161058957,-0.0123819656685379,0.00446098704497323,0.356674722650105
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,-0.00398394123426553,0.00432511427317778,-0.012461165209694,0.00449328274116292,0.357008311907226
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00580337056192209,0.00632819060180218,-0.00659988301761018,0.0182066241414544,0.359128059456326
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00360639328581477,0.00394889878896099,-0.0113462349121783,0.00413344834054877,0.361122815124606
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,39586,0.00399400358694804,0.00437677857927538,-0.0045844824284317,0.0125724896023278,0.361502375884177
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,0.00578149607947455,0.00633706258432137,-0.00663914658579533,0.0182021387447444,0.36161132567084
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,39919,0.00512346121453343,0.00562190140104692,-0.00589546553151853,0.0161423879605854,0.362135890026095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,39757,0.00568547069563229,0.00624240524203695,-0.00654964357876013,0.0179205849700247,0.362429894135582
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,42166,-0.00570266381611883,0.00627819720783838,-0.0180079303434821,0.0066026027112444,0.363720962377583
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0056018271035475,0.00616846854647795,-0.0176920254546443,0.00648837124754927,0.36382122099816
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,0.0111051519901215,0.0122734995160051,-0.0129509070612486,0.0351612110414916,0.3655836646877
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,0.00344551794737106,0.00380911436924942,-0.0040203462163578,0.0109113821110999,0.365722583424539
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,0.00462117322749317,0.00511023237334839,-0.00539488222426968,0.014637228679256,0.365857223638234
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00654165413623555,0.00723874663609358,-0.020729597542979,0.00764628927050786,0.366174421820287
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,39757,0.00419563418399022,0.0046689722525472,-0.0049555514310023,0.0133468197989827,0.368874227568715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,41913,0.00398750372886626,0.00444077171617484,-0.00471640883483642,0.0126914162925689,0.369238918089315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,42119,0.00835351759412855,0.00931671056410542,-0.00990723511151808,0.0266142702997752,0.369939488578409
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,39575,0.00382236182950622,0.00426852661803877,-0.00454395034184977,0.0121886740008622,0.370552493027666
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.00212845376013198,0.00238067713074376,-0.00253767341612579,0.00679458093638976,0.371312355221775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.00225450092127468,0.00252330678186838,-0.00269118037118734,0.00720018221373671,0.371620936155971
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,41668,0.00352944415707981,0.00395154071447372,-0.00421557564328869,0.0112744639574483,0.371776282903153
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00570507634452902,0.00639488176216285,-0.00682889190931016,0.0182390445983682,0.372341343190651
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,42085,0.00800249243860128,0.00897093968310518,-0.00958054934028487,0.0255855342174874,0.372384099626739
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,39657,0.0118210939892099,0.0132527197529032,-0.0141542367264805,0.0377964247049002,0.372425771710855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.00683648271226832,0.00766528191730316,-0.00818746984564587,0.0218604352701825,0.37247823726229
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.00384779575173615,0.00431631882110995,-0.00461218913763935,0.0123077806411117,0.372702342905681
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,0.00558105668688169,0.00626678830469194,-0.00670184839031451,0.0178639617640779,0.373175717163621
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,42057,0.00531931919399676,0.00598867608683682,-0.00641848593620341,0.0170571243241969,0.37443315063259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,39575,0.00397922077627666,0.0045036328879294,-0.00484789968406497,0.0128063412366183,0.376954224567683
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,0.0049893115991016,0.00564778504575019,-0.00608034709056878,0.016058970288772,0.37703032541831
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,41913,-0.00672951261275406,0.0076213902945549,-0.0216674375900817,0.00820841236457355,0.37726462243656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,41913,0.00405231766923714,0.00459839750435633,-0.00496054143930127,0.0130651767777755,0.378200800282999
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,39657,-0.00431660261356234,0.0048995360516479,-0.0139196932747922,0.00528648804766755,0.378324668816361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.00320476167499365,0.00364423202704694,-0.00393793309801836,0.0103474564480057,0.379196608865144
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,41900,0.00258644500322561,0.00294135403432061,-0.00317860890404279,0.00835149891049401,0.379233808755643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.00422492647087177,0.00482916489752861,-0.0052402367282843,0.0136900896700278,0.381659265730138
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,0.00245534253918896,0.0028070338953374,-0.00304644389567234,0.00795712897405026,0.381749827658778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,39560,0.00564876620257483,0.00646063314993554,-0.00701407477129884,0.0183116071764485,0.381954284389191
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,0.00454918601091706,0.00520458831947667,-0.00565180709525722,0.0147501791170913,0.382098115692269
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,39586,0.0057755239098492,0.00663160620791904,-0.00722242425767211,0.0187734720773705,0.383823005804674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCN,Decorin,41900,0.00215539133359903,0.00247879272039874,-0.0027030423983825,0.00701382506558056,0.384571520615915
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,39736,0.00324157718347465,0.00373512860311934,-0.00407927487863926,0.0105624292455886,0.385488437852026
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.0085642596601091,0.00987933364640392,-0.0107992342868426,0.0279277536070608,0.386019912482331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,0.0101248344850292,0.0117177658011696,-0.0128419864852631,0.0330916554553216,0.387574650331852
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.00360688843263512,0.00418104923807353,-0.004587968073989,0.0118017449392592,0.388334689497306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00417272797731563,0.00483898643292517,-0.00531168543121771,0.013657141385849,0.388530116394942
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,39919,-0.00416161048985369,0.00483959233787747,-0.0136472114720935,0.00532399049238615,0.389857250180417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.00225685508739964,0.00262554774158165,-0.0028892184861004,0.00740292866089967,0.390038647696427
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,-0.00273529249650682,0.00318821892399742,-0.00898420158754176,0.00351361659452811,0.390945749776483
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.00389271025614841,0.00454326986076153,-0.00501209867094419,0.012797519183241,0.391566012809987
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.00490771113053801,0.00574389869652437,-0.00635033031464975,0.0161657525757258,0.392886625738421
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELN,Elastin,39958,-0.00319639750555611,0.00374484465048107,-0.010536293020499,0.00414349800938679,0.393374540442202
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,42137,0.00456028720622069,0.00534630103408561,-0.00591846282058711,0.0150390372330285,0.3936855543323
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.00276463295611769,0.00324477113484365,-0.00359511846817586,0.00912438438041125,0.394214257091006
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,42137,0.00215287938735621,0.00252875945639281,-0.0028034891471737,0.00710924792188612,0.394585619934365
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,39575,0.0035716191903459,0.00419744467494273,-0.00465537237254186,0.0117986107532337,0.394841679893924
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.00638911929173825,0.0075323649247949,-0.00837431596085975,0.0211525545443363,0.396332145967119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,0.00286791165140892,0.00338185377426301,-0.00376052174614657,0.00949634504896442,0.396439930818703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,0.00918974648294737,0.0108412860860919,-0.0120591742457927,0.0304386672116875,0.396644417587079
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.0272716626459863,0.0321843619210728,-0.0358096867193164,0.090353012011289,0.396810844042967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.00332591842275485,0.00393079328789456,-0.00437843642151849,0.0110302732670282,0.397504875542061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.00460670642360407,0.00545446809566862,-0.00608405104390642,0.0152974638911146,0.398366557784371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,42207,0.0141843827171745,0.0168487950249882,-0.0188392555318024,0.0472080209661513,0.3998792526341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.003295658415448,0.00391610757271878,-0.00437991242708081,0.0109712292579768,0.400049781048866
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00435455469029433,0.00517899486368557,-0.0145053846231181,0.0057962752425294,0.400471968292607
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.004449029506023,0.00529389398301785,-0.00592700270069198,0.014825061712738,0.400697980160933
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,39978,0.00504322970709824,0.0060197047263693,-0.0067553915565856,0.0168418509707821,0.402168000219197
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,39586,0.00389096026031949,0.00464444124207968,-0.00521214457415668,0.0129940650947957,0.402179721934007
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,-0.00397551264649575,0.00481050249169964,-0.013404097530227,0.00545307223723554,0.408581253649555
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.00156034938608429,0.00189003298341375,-0.00526481403357524,0.00214411526140666,0.409064143228409
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,-0.00378034993436258,0.00458170341327677,-0.0127604886243851,0.00519978875565989,0.409331282570814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,0.00691252661406275,0.00838476839810653,-0.00952161944622606,0.0233466726743516,0.409718490274894
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,0.00373947040414629,0.0045379814568894,-0.00515497325135693,0.0126339140596495,0.409932282330681
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.0101024016509728,0.0123165147478261,-0.0140379672547663,0.034242770556712,0.412101287448948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,39649,0.00606536464621552,0.00740193145522984,-0.00844242100603496,0.020573150298466,0.412558802768413
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,-0.0108697515056268,0.0132985873296344,-0.0369349826717103,0.0151954796604567,0.413736200560468
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,-0.00401553766706468,0.00492482749354633,-0.0136681995544155,0.00563712422028612,0.41487704905194
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,0.00724802295152767,0.00889497916673794,-0.0101861362152787,0.024682182118334,0.415179162348163
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,39929,0.0120552436404378,0.0148032152457523,-0.0169590582412366,0.0410695455221122,0.415452100422759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.00337130603352186,0.00414084831838699,-0.00474475667051664,0.0114873687375604,0.415571382222798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,41997,0.00400510675245864,0.00493651216689432,-0.00567045709465423,0.0136806705995715,0.417194515025495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,38503,-0.00932485360142834,0.0115025411429033,-0.0318698342415187,0.0132201270386621,0.417570263976223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,0.00424752237537153,0.00524340677582281,-0.00602955490524117,0.0145245996559842,0.417917371504376
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,42168,0.00280001621703075,0.00346813371965216,-0.00399752587348748,0.00959755830754897,0.419475952270746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.00486371308921965,0.00602507619644304,-0.00694543625580871,0.016672862434248,0.419542777265325
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,39819,-0.00525158004850813,0.00652018975624592,-0.0180311519707501,0.00752799187373387,0.420586566255629
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,-0.00351629289354945,0.00436915211407471,-0.0120798310371359,0.00504724525003697,0.420952514664721
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.00457993753308781,0.00574299014687408,-0.00667632315478538,0.015836198220961,0.425187248060536
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,39575,0.00339469799343624,0.00425759355048565,-0.00495018536551563,0.0117395813523881,0.42527788793527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,41693,0.00771647151498055,0.0096878875348018,-0.011271788053231,0.0267047310831921,0.425751773755879
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.0052773500947843,0.00663318055983424,-0.0182783839920594,0.00772368380249081,0.426279484025933
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,0.00527416950532056,0.00663527530567858,-0.00773097009380946,0.0182793091044506,0.426707371323076
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,0.00743151322986785,0.00935164858150197,-0.010897717989876,0.0257607444496117,0.426817006117375
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,39475,0.00338529093032738,0.00427957502616462,-0.00500267612095528,0.01177325798161,0.428941186745319
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,0.00727947403387317,0.00920260384193715,-0.0107576294963236,0.02531657756407,0.42894736327386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.00527721387664661,0.00667581432185206,-0.00780738219418343,0.0183618099474766,0.429254321893094
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.00650346034922004,0.008230660179194,-0.0096286336020002,0.0226355543004403,0.429456667150752
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,39802,0.00199336885284054,0.00252498831857601,-0.00295560825156844,0.00694234595724951,0.429861858252094
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,39560,0.0025720302437029,0.00327734495901228,-0.00385156587596118,0.00899562636336697,0.432593184722869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00381933205863606,0.00486893965361898,-0.00572378966245714,0.0133624537797293,0.432805883430495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,42145,-0.00385005668217026,0.00492203051011748,-0.0134972364820005,0.00579712311765999,0.434105415462075
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,39560,0.00653141270818894,0.00836682607083024,-0.00986756639063833,0.0229303918070162,0.435035786799145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,0.00574962610332674,0.0073691128333873,-0.00869383505011237,0.0201930872567659,0.43526720927549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,39560,0.00257120355066019,0.00330012986556878,-0.00389705098585462,0.009039458087175,0.435924714807658
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,39919,0.0047672700495784,0.00617045199053429,-0.00732681585186882,0.0168613559510256,0.439777306144106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,39649,0.00400283827338421,0.00518122487435087,-0.0061523624803435,0.0141580390271119,0.43979578683756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,0.004185752253363,0.00542345336332848,-0.00644421633876082,0.0148157208454868,0.440257073909481
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,0.00321230635969166,0.00416931749942764,-0.00495955593918652,0.0113841686585698,0.441041149064391
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.00247135956988877,0.00320854884176694,-0.00381739615997443,0.00876011529975197,0.441172283006178
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.00225583556725569,0.00293337501931489,-0.00349357947060149,0.00800525060511287,0.441895087894095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,39586,0.00280413774884782,0.00364724914862277,-0.0043444705824528,0.00995274608014845,0.442006990178882
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PXN,Paxillin,41839,0.00424589055699089,0.00552669445558272,-0.00658643057595125,0.015078211689933,0.442351565922389
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,39919,0.00353023363062463,0.00460346193812996,-0.00549255176811009,0.0125530190293593,0.44317780598995
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,41839,0.00672835034217305,0.00881650688712666,-0.0105520031565952,0.0240087038409413,0.445385302511005
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00417493826355468,0.0054775345917131,-0.006561029536203,0.0149109060633124,0.445961231014254
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,0.0053716916231884,0.00704970652898494,-0.00844573317362209,0.0191891164199989,0.446091752486805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,41913,-0.00394997201650754,0.00518449127981758,-0.01411157492495,0.00621163089193491,0.446143765747794
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,42262,-0.00378067171418975,0.00496479196669461,-0.0135116639689112,0.00595032054053169,0.446373711724356
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,0.00561290396424523,0.00737971344727715,-0.00885133439241799,0.0200771423209084,0.446917873332427
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00246180896219112,0.00324484895670465,-0.00882171291733224,0.00389809499295,0.448058464039259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,0.00744873950262224,0.00983142883667897,-0.0118208610172685,0.026718340022513,0.448676216604263
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,42255,0.00198895561232927,0.00263149433059989,-0.00316877327564651,0.00714668450030505,0.449765702858972
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,41913,0.00658303301225691,0.00873121539621632,-0.0105301491643271,0.0236962151888409,0.450883421992884
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.00575260055071803,0.00765345619290475,-0.00924817358737529,0.0207533746888114,0.452286836459631
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,41900,-0.00394257381115432,0.00524671700486735,-0.0142261391406943,0.00634099151838568,0.452403396686084
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,-0.00350779269274312,0.00469712420696577,-0.012714156138396,0.00569857075290979,0.455202842487303
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRL,Prolactin,42249,-0.00591217224891154,0.00792232263718722,-0.0214399246177985,0.00961558011997541,0.45551866679821
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F3,Tissue factor,42174,-0.00208911832519735,0.00281268840147234,-0.00760198759208313,0.00342375094168843,0.457647193829641
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.00687500045735712,0.00929956299779776,-0.0113521430183265,0.0251021439330407,0.459751579693525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,0.005250944694339,0.00711585278879388,-0.00869612677169701,0.019198016160375,0.460577594644783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,-0.00256102774706331,0.00347252363355486,-0.00936717406883083,0.00424511857470421,0.460826605586205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,39657,0.00342607026982106,0.00465293498628983,-0.00569368230330701,0.0125458228429491,0.461548828811558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,0.00595073267506114,0.00808238977419936,-0.00989075128236962,0.0217922166324919,0.461588566237392
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,39586,0.00388344516002978,0.00528142898588735,-0.00646815565230944,0.014235045972369,0.462171302639466
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,39560,0.00369961283281994,0.00503550635327344,-0.00616997961959601,0.0135692052852359,0.462534755859821
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,39586,0.00594486721486098,0.00809739934550017,-0.00992603550231935,0.0218157699320413,0.462860838303643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,39657,0.00358528168339976,0.00488763228717901,-0.00599447759947111,0.0131650409662706,0.463243708041371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.00597422395643504,0.00815922090628207,-0.0100178490198778,0.0219662969327479,0.46405629399635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.00681057329144638,0.00931593231478757,-0.0114486540455373,0.02506980062843,0.464753550613728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,0.00208114909742206,0.0028489561232189,-0.00350280490408699,0.00766510309893111,0.465103069335186
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.00286575115885431,0.00393158653300663,-0.00484015844583868,0.0105716607635473,0.466075513459542
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,0.0026375377300253,0.00362595991557561,-0.0044693437045029,0.0097444191645535,0.46699122356094
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.0076641506319557,0.0105618349665628,-0.0283653471664187,0.0130370459025073,0.468068529425734
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.0045988981854664,0.00634685883582367,-0.007840945132748,0.0170387415036808,0.468716359874439
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,-0.00263140354116577,0.0036391435146466,-0.0097641248298731,0.00450131774754157,0.469641313295069
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,39990,-0.00210626108028774,0.00291615172796047,-0.00782191846709026,0.00360939630651477,0.470140756248455
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,39966,0.00884553816402717,0.0122496474786189,-0.0151637708940659,0.0328548472221203,0.470244455207272
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,0.00494166019102413,0.00685472878947236,-0.0084936082363417,0.01837692861839,0.470975675310457
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,-0.00272889511087223,0.00379585558988695,-0.0101687720670506,0.0047109818453062,0.472206369480617
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00285936141201266,0.00397954960679183,-0.0106592786413247,0.00494055581729934,0.472455264815613
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,-0.00378698910715655,0.00528508384216478,-0.0141457534377995,0.00657177522348643,0.473671457604635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.00344818680846033,0.00481877032755738,-0.00599660303355214,0.0128929766504728,0.474269536289889
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,39979,-0.00530877611809806,0.00742542489326219,-0.019862608908892,0.00924505667269584,0.474657220899495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,39657,0.00441255988767046,0.00620096113160365,-0.0077413239302727,0.0165664437056136,0.476731919671814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,39560,0.00356785459522916,0.00504055165318566,-0.00631162664501474,0.0134473358354731,0.479065772340675
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,39649,0.00456923665695577,0.00648842514640141,-0.00814807662999099,0.0172865499439025,0.481314659220309
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.00219728202167826,0.00312208154929505,-0.00392199781494005,0.00831656185829657,0.481579585814791
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,41839,0.00505478528726456,0.00719608478115633,-0.00904954088380184,0.019159111458331,0.482419973433807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,0.00431556639843639,0.00614611411523654,-0.00773081726742722,0.0163619500643,0.482590556390931
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,0.00297368663228853,0.00424520189691904,-0.0053469090856728,0.0112942823502499,0.483640810528788
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,39649,0.0055705998627109,0.00796267483746381,-0.0100362428187182,0.02117744254414,0.484198731108195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,0.00408585059520461,0.00586185253735344,-0.00740338037800814,0.0155750815684174,0.485802512477253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0044664723956476,0.00641486013884696,-0.0170395982677877,0.00810665347649244,0.486272134373622
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,39586,0.00695053589326866,0.00999257374565595,-0.012634908648217,0.0265359804347543,0.486712785938072
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,39649,0.00366336089485804,0.00533846073813154,-0.00680002215187977,0.0141267439415959,0.492588507423432
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00383606129475986,0.00561088946172477,-0.00716128205022069,0.0148334046397404,0.494190764664243
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,39575,0.00234658924381445,0.00345108463474378,-0.00441753664028336,0.00911071512791227,0.496546013751918
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.00626158105224677,0.009251988803227,-0.0243954791065717,0.0118723170020782,0.498558340829596
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,-0.00338196171164029,0.00499986379379116,-0.013181694747471,0.00641777132419039,0.498794136362195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,0.00386938459740373,0.00572398283386271,-0.00734962175696718,0.0150883909517746,0.499057740120941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,42145,0.00282912435454217,0.00419181268624782,-0.00538682851050356,0.0110450772195879,0.499740214314898
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00228521348284855,0.00338861579576877,-0.00892690044255533,0.00435647347685823,0.500084095839871
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,39649,0.00353995636381975,0.0052540208048907,-0.00675792441376603,0.0138378371414055,0.500477118828639
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,0.00379307576407837,0.00563518251514477,-0.00725188196560537,0.0148380334937621,0.500893947684633
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,42145,-0.00226892101220592,0.00338482774671277,-0.00890318339576295,0.00436534137135111,0.502664631364527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,0.00197022607572358,0.00295168566357844,-0.00381507782489015,0.00775552997633732,0.504471829854948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.00268389436292498,0.00402699258139979,-0.0105767998224686,0.00520901109661861,0.505118200006476
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,39575,0.00474629327566105,0.0071268883237666,-0.00922240783892148,0.0187149943902436,0.505444321580498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,0.00435537971731656,0.00655499287778805,-0.00849240632314801,0.0172031657577811,0.506424117367634
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.00473718920645394,0.00713905548518469,-0.00925535954450804,0.0187297379574159,0.506985895873983
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,39657,0.00410593019781242,0.00619314257732747,-0.00803262925374941,0.0162444896493743,0.507357128489376
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.00330104122446092,0.00497979022744337,-0.0130614300702499,0.00645934762132809,0.507416461022945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,-0.00462001240619538,0.00699821606437069,-0.0183365158923619,0.00909649107997116,0.509156213676901
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FURIN,Furin,42181,-0.00233894943051253,0.00355703922097297,-0.00931074630361956,0.0046328474425945,0.510835171111341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.00616688308022745,0.00941610458910804,-0.0122886819144243,0.0246224480748792,0.512526980276063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.00223539379973597,0.00341529385184996,-0.00445858214988995,0.00892936974936189,0.512784929201814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,39560,0.00818072565954969,0.0125944419464573,-0.0165043805555065,0.0328658318746059,0.515996249194483
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNST,Consortin,42145,-0.00760488165581965,0.0117243579424472,-0.0305846232230161,0.0153748599113768,0.516582415193513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,0.00435282728310404,0.00671635060433558,-0.00881121990139369,0.0175168744676018,0.516937548995088
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0024053637470944,0.00373497332630724,-0.00491518397246779,0.00972591146665659,0.519581377698176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.00233826981211377,0.00363743108360971,-0.0094676347359888,0.00479109511176125,0.520344201021221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,0.00187239478129712,0.00294023290263948,-0.00389046170787626,0.00763525127047049,0.52425591910838
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,39990,-0.00149587407451906,0.00235016857810814,-0.00610220448761102,0.00311045633857289,0.524465652005353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.00401894376848731,0.00634463392083643,-0.0164544262533267,0.0084165387163521,0.526459654719145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,-0.00779477898880902,0.0123073698304623,-0.0319172238565152,0.0163276658788972,0.526522808643197
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,0.00244783457876506,0.00386939366169643,-0.00513617699815994,0.0100318461556901,0.526998175183513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,0.00345597850040567,0.00547843380548262,-0.00728175175834026,0.0141937087591516,0.528162572650836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,41843,0.00595364867377606,0.00951149061271075,-0.012688872927137,0.0245961702746891,0.531363274725679
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.00364171032730593,0.005840834645938,-0.00780632557873255,0.0150897462333444,0.532974495264417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,39649,-0.00559700414651635,0.00899938183213688,-0.0232357925375046,0.0120417842444719,0.533999370800365
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.00312107727570759,0.00502819459978771,-0.0129763386912915,0.00673418413987633,0.534799856065022
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,-0.00592889733001213,0.00955892386258928,-0.0246643881006871,0.0128065934406629,0.535107725439717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,39757,0.00222579652157593,0.00360402066145728,-0.00483808397488035,0.0092896770180322,0.536860181584502
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,0.00586217272618499,0.00953055290428183,-0.0128177109662074,0.0245420564185774,0.538505912074188
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.00726257644505117,0.0118229709793008,-0.0159104466743784,0.0304355995644808,0.539042739175218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.00297024691504099,0.00487058046703772,-0.0125165846304349,0.00657609080035293,0.54198401272185
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,42070,0.00461609589066426,0.00764020783811,-0.0103587114720313,0.0195909032533599,0.545731096106963
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,42007,-0.00320596765171805,0.00530789723572715,-0.0136094462337433,0.00719751093030716,0.545854147209136
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,0.00382111689221435,0.00632774001247262,-0.00858125353223199,0.0162234873166607,0.545942047691802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,-0.0029932910638879,0.004993699722493,-0.0127809425199742,0.00679436039219838,0.548909545415531
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,0.00258388429665794,0.00431218975226945,-0.00586800761779018,0.0110357762111061,0.549048785123819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,0.00374222114692784,0.00625353544453582,-0.00851470832436237,0.015999150618218,0.549571869758889
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,0.00539736957345763,0.00904765128793478,-0.0123360269508945,0.0231307660978098,0.550818517546755
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00347195972707519,0.00583183010921932,-0.00795842728699468,0.0149023467411451,0.551624161898377
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,-0.0018010209087261,0.00304213532443197,-0.00776360614461276,0.00416156432716056,0.553843480854724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,39575,-0.00412216125701197,0.00696843877334003,-0.0177803012527584,0.00953597873873448,0.55416594522537
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOC,Myocilin,42137,0.00282622539823923,0.00481204254564324,-0.00660537799122153,0.0122578287877,0.556996294682985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,0.00426570822232449,0.00727813263878673,-0.00999943174969751,0.0185308481943465,0.55781857320568
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,42137,-0.00367482891909943,0.00628406779385057,-0.0159916017950465,0.00864194395684768,0.558702001964507
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,0.00365352641780132,0.00625420500009057,-0.00860471538237619,0.0159117682179788,0.55911508854611
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00485215858408446,0.00830645318491179,-0.0211328068265116,0.0114284896583426,0.5591359589476
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,39757,0.00261230047039141,0.00447243844904184,-0.0061536788897306,0.0113782798305134,0.559172489181592
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.00185800042660124,0.00318556687436311,-0.00438571064715045,0.00810171150035294,0.55973299320464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.00450266886067727,0.00772560265705991,-0.0106395123471601,0.0196448500685147,0.560023203830516
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,0.0051391627389246,0.00883739264370183,-0.012182126842731,0.0224604523205802,0.560898576156855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,39560,0.00326744286261389,0.00562146044139553,-0.00775061960252135,0.0142855053277491,0.56108764472791
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,0.00187737137644731,0.0032384083445754,-0.00446990897892047,0.00822465173181509,0.562114707942699
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,0.00277789761575381,0.00481497069177233,-0.00665944494011996,0.0122152401716276,0.563998864249665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,39757,-0.00536639635601116,0.0093252818752505,-0.0236439488315021,0.0129111561194798,0.564986791334678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIM,Vimentin,41900,0.0071080436608865,0.0123749701796814,-0.0171468978912891,0.0313629852130621,0.565714477962787
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,0.00535711367073079,0.0093341607971959,-0.0129378414917732,0.0236520688332347,0.566029549360846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,39919,0.00382647135733813,0.00671905942881817,-0.00934288512314549,0.0169958278378218,0.569031502734925
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,-0.00650256896108869,0.0114594507918536,-0.0289630925131217,0.0159579545909444,0.570425721486742
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.00396698182428609,0.00699401102445703,-0.0176752434322219,0.00974127978364969,0.570591892923404
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.004384130511162,0.00780406858938733,-0.0196801049463612,0.0109118439240372,0.574280797920432
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,-0.00184076408261158,0.0032808456237682,-0.00827122150519726,0.0045896933399741,0.574763461042256
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.00293637031705862,0.00523892777249907,-0.00733192811703957,0.0132046687511568,0.575156062155673
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,41992,0.00197456178752718,0.00354699394422176,-0.00497754634314746,0.00892666991820182,0.577751302066245
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,-0.00189628386419834,0.00342132364457183,-0.00860207820755912,0.00480951047916245,0.579416010026686
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,39934,-0.00217369206194285,0.0039455673407642,-0.00990700404984069,0.00555961992595499,0.581699357714134
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,0.00198994825482958,0.00361582970162384,-0.00509707796035314,0.00907697447001229,0.582094638713759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.00272109924841183,0.00497694966029148,-0.00703372208575947,0.0124759205825831,0.584567899584168
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,42070,0.00111511831635403,0.00205675703791112,-0.00291612547795176,0.00514636211065983,0.587708240990786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,39757,0.00409855438664084,0.00758396406619618,-0.0107660151831037,0.0189631239563853,0.588915612346825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,-0.00664411418248891,0.0123155702411153,-0.0307826318550749,0.0174944034900971,0.589560124396286
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.00214447814699984,0.00400739001691577,-0.00571000628615507,0.00999896258015474,0.59257002302372
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,41839,0.0025651628614724,0.00482039000228226,-0.00688280154300082,0.0120131272659456,0.594632142793337
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,0.00156777620651121,0.00296030906636227,-0.00423442956355884,0.00736998197658126,0.596398765212914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00343573774277811,0.0065117597626358,-0.00932731139198807,0.0161987868775443,0.597771624916964
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,-0.00246328081021634,0.00467379678534078,-0.0116239225094843,0.00669736088905159,0.598174200799874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,42262,0.00361871161375139,0.00687404844314335,-0.00985442333480958,0.0170918465623124,0.598597386320643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,39657,0.00350105708278181,0.00665066523507541,-0.00953424677796599,0.0165363609435296,0.598605531000714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,-0.00174183123090245,0.00332400351265017,-0.00825687811569679,0.00477321565389189,0.600277797044443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,0.00203067722605306,0.00388261389743677,-0.005579246012923,0.00964060046502913,0.600970382918928
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,42250,0.00284080653146692,0.00543767246473884,-0.00781703149942121,0.0134986445623551,0.601379027903002
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.00295182808257723,0.00565829228618741,-0.00813842479835009,0.0140420809635046,0.601900628422118
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,0.00320689508775018,0.00615597477311728,-0.00885881546755968,0.01527260564306,0.602418821557869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.00548051944051886,0.0105352531461811,-0.0151685767259961,0.0261296156070339,0.602929336369445
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,0.00340134107984993,0.00654929770193184,-0.00943528241593648,0.0162379645756363,0.603529276197927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00391659152415737,0.00754584897596905,-0.010873272468742,0.0187064555170567,0.603743791123745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,39757,0.00289307482725546,0.00557405540792907,-0.00803207377228551,0.0138182234267964,0.603753512381492
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,42310,-0.00232279482747878,0.0044936797930207,-0.0111304072217993,0.00648481756684179,0.605232481529762
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.00431857397013741,0.00836309877186736,-0.0207102475629974,0.0120730996227226,0.605596274248379
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,41839,0.00287249166636221,0.00556866715677868,-0.008042095960924,0.0137870792936484,0.605980998251868
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.00236955600280437,0.00460256657207235,-0.00665147447845744,0.0113905864840662,0.606679581811328
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.00217461345997851,0.00422716712160126,-0.00611063409835996,0.010459861018317,0.606956148567623
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,0.00311608989148209,0.00607798954621305,-0.00879676961909549,0.0150289494020597,0.608180715948795
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.00521860977803463,0.0101882486376382,-0.0147503575517363,0.0251875771078056,0.608508054028487
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,0.00217768198565627,0.00425946927312661,-0.00617087778967188,0.0105262417609844,0.609181641262902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,39757,0.00307961709524525,0.00606051562105194,-0.00879899352201654,0.014958227712507,0.611362123228004
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00222228454439135,0.00440586347698727,-0.00641320787050371,0.0108577769592864,0.613995637396264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,0.00795906003253266,0.0157955720806108,-0.0230002612454645,0.0389183813105298,0.614356404293545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,39575,0.00187922206696106,0.00373593480919775,-0.00544321015906653,0.00920165429298865,0.61496554792235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,0.00572219662566146,0.0113985963879202,-0.0166190522946621,0.028063445545985,0.615671276770676
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,39934,0.00359355029013747,0.00716134036621384,-0.0104426768276417,0.0176297774079166,0.615818972665034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.00344242487155227,0.00687029031160223,-0.0100233441391881,0.0169081938822926,0.616337467033883
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,42129,0.00163968376294843,0.00327386090221592,-0.00477708360539476,0.00805645113129163,0.61649117707412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,0.00423615361873263,0.00850001812201223,-0.0124238819004113,0.0208961891378766,0.618233241886769
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,39657,0.00537466974280637,0.0108044730374398,-0.0158020974105757,0.0265514368961884,0.618882648537169
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.00917771479362571,0.0185623082990335,-0.0272044094724799,0.0455598390597313,0.621013916653273
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,42262,0.0031903747675584,0.00646200466286841,-0.00947515437166368,0.0158559039067805,0.621516922360331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,42204,-0.00364371547277257,0.00739473524063022,-0.0181373965444078,0.0108499655988627,0.622201049188209
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.0029760124029891,0.00604542798537419,-0.0148250512543225,0.00887302644834431,0.622534888122761
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,39586,0.0027676083443227,0.00566707339879128,-0.0083398555173082,0.0138750722059536,0.625300070486951
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,-0.00304709032322073,0.00625209226213592,-0.0153011911570071,0.00920701051056566,0.626004668012128
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,0.002189563924912,0.00449311492357115,-0.00661694132528746,0.0109960691751115,0.626042753977665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,39657,-0.00230016504309729,0.00472462885327091,-0.0115604375955083,0.00696010750931369,0.626377361617087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00229381762859812,0.00471291821535311,-0.0115311373306902,0.00694350207349397,0.626474589053385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,41756,0.00385105944958241,0.00792339298823834,-0.0116787908073647,0.0193809097065296,0.626949270356061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.0033684647599377,0.00693245481338195,-0.0169560761941663,0.0102191466742909,0.627048972955321
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00156525348138189,0.00323053839323824,-0.00789710873212884,0.00476660176936507,0.628026147349311
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00323974159000368,0.00675001756128357,-0.00999029283011212,0.0164697760101195,0.631264996958602
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,42189,-0.00233966484120234,0.00488533225116097,-0.0119149160534778,0.00723558637107316,0.632005939354122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,39990,-0.00253929237988138,0.00533186698919438,-0.0129897516787024,0.00791116691893961,0.633906656039397
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.00329971184157079,0.00693977859479151,-0.0103022542042206,0.0169016778873622,0.63445417618247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.00352083325202685,0.00746487799637263,-0.0111103276208635,0.0181519941249172,0.637183693057317
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,0.00270309140707496,0.00573296182510403,-0.00853351377012894,0.0139396965842789,0.637291498750625
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,0.00315641164398432,0.00669537736264026,-0.00996652798679058,0.0162793512747592,0.637341719892871
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,-0.00207958359424879,0.00442761326753661,-0.0107577055986205,0.00659853841012296,0.638589273535497
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,39934,0.00224116850228911,0.00478191281445293,-0.00713138061403864,0.0116137176186169,0.639310148599748
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.003162380800554,0.00680562918909616,-0.0101766524100745,0.0165014140111825,0.642175906623684
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.00230999028620872,0.00498866948842112,-0.00746780191109667,0.0120877824835141,0.643339526451944
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,0.00201192250258654,0.00438795751506714,-0.00658847422694506,0.0106123192321181,0.64659507463919
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.0019543378347283,0.00428004587858436,-0.00643455208729704,0.0103432277567536,0.647955770387473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NENF,Neudesin,39919,0.00553361296856222,0.0121211272985813,-0.0182237965366572,0.0292910224737816,0.648020348203599
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,0.00317459362348944,0.00695772688529334,-0.0104625510716855,0.0168117383186644,0.648205672469417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,0.00264769101079942,0.00580543922267568,-0.00873096986564492,0.0140263518872438,0.648348119155443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,0.0026784639793453,0.00592514301527493,-0.00893481633059356,0.0142917442892842,0.651241534278881
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,39560,0.0029737151311819,0.00659305409593447,-0.00994867089684967,0.0158961011592135,0.651971391086969
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.00290437047520833,0.0064506833303219,-0.00973896885222259,0.0155477098026392,0.6525430503584
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.00570447365525069,0.0127219025273897,-0.0306394026089345,0.0192304552984332,0.653874669605883
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,39990,-0.00361429021177478,0.00809079817402141,-0.0194722546328567,0.0122436742093072,0.655088512696044
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,42296,-0.00246864817396495,0.00554856211468047,-0.0133438299187387,0.00840653357080877,0.656386954823553
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,42119,0.00383745906028333,0.00867828183229011,-0.0131719733310053,0.0208468914515719,0.658357993577753
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,-0.00146722327065982,0.00332300039678649,-0.00798030404836134,0.0050458575070417,0.658832401186513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,0.00246920174281915,0.00560209580537517,-0.00851090603571618,0.0134493095213545,0.659390875975674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.00421974499365666,0.00958410042713005,-0.0145650918435182,0.0230045818308316,0.659737152947893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,42196,-0.00165720020349525,0.00377941009371939,-0.00906484398718524,0.00575044358019475,0.661044475698684
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,-0.00322217543693934,0.00743158217990151,-0.0177880765095463,0.0113437256356676,0.664602899328902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0015753815634544,0.00364818481224213,-0.00872582379544898,0.00557506066854018,0.66587619983225
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,-0.00168802878245546,0.00391535951969804,-0.00936213344106362,0.00598607587615269,0.666382358433577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,39929,0.00283460843683579,0.00658513427103793,-0.0100722547343986,0.0157414716080701,0.666872389598862
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.00264685157115159,0.0061812967079703,-0.0147621931187734,0.00946848997647019,0.66851153729047
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,-0.00335787284400201,0.0078761931016984,-0.0187952113233309,0.0120794656353269,0.669872917104739
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,39560,0.00229297355187014,0.00538000927311583,-0.00825184462343688,0.0128377917271772,0.669968645664703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,42015,-0.00230856096613609,0.00543921796147505,-0.0129694281706272,0.008352306238355,0.67125989833654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTTG1,Securin,39757,0.00189870623711331,0.00449172418549026,-0.00690507316644761,0.0107024856406742,0.672513460738382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,39919,-0.00320051846376123,0.00759256991139395,-0.0180819554900934,0.0116809185625709,0.673373953595875
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,39575,0.00509275227463867,0.0120827157093699,-0.0185893705157264,0.0287748750650038,0.673405057117571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.00286232496334319,0.00679288988389617,-0.0161763891357797,0.0104517392090933,0.673492383975939
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,39649,0.00414112880936872,0.00985556078750959,-0.0151757703341501,0.0234580279528875,0.674360706048851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,-0.00329845626593155,0.00785181329992866,-0.0186880103337917,0.0120910978019286,0.674429038083287
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,39575,0.00159792798048092,0.00380596828243819,-0.00586176985309794,0.00905762581405978,0.674604752251725
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,39649,-0.00352113458897363,0.00839201480609198,-0.0199694836089139,0.0129272144309667,0.67479932573897
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.00133573890968949,0.00319735054416971,-0.00493106815688315,0.00760254597626212,0.676126059903659
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,-0.00333223416263214,0.00797917441405373,-0.0189714160141775,0.0123069476889132,0.676234368220658
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,39649,0.00275669598977395,0.00665222210065418,-0.0102816593275082,0.0157950513070561,0.678587565886985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,41751,0.00334097441795551,0.00809106111297765,-0.0125175053634807,0.0191994541993917,0.679670740040368
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,-0.00146931381319027,0.00356677344864632,-0.00846018977253705,0.00552156214615652,0.680386514018065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,0.00174821373251102,0.00425311892377033,-0.00658789935807882,0.0100843268231009,0.681049076639597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,-0.003351300630979,0.00817887272388839,-0.0193818911698002,0.0126792899078422,0.681995141907014
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.00368250544582851,0.00901479781393027,-0.0213515091611318,0.0139864982694748,0.682917824249851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,0.00362043961123542,0.00887503782770165,-0.0137746345310598,0.0210155137535306,0.683329258433712
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.00355371065188675,0.0087436188166453,-0.013583782228738,0.0206912035325115,0.684431052336124
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,0.00228684278953261,0.00562811463752529,-0.00874426190001696,0.0133179474790822,0.68451172808279
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,0.00184315017033328,0.00453787453559802,-0.00705108391943884,0.0107373842601054,0.684625290826968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.00251075198105282,0.00618385282273736,-0.00960959955151242,0.0146311035136181,0.684737715124766
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.0048622571123853,0.0121180888359649,-0.0286137112308765,0.0188891970061059,0.688250118676969
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,0.00118670167631216,0.0029605327058232,-0.00461594242710131,0.00698934577972563,0.688543738986577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,0.00206627971049776,0.00520129875076325,-0.00812826584099821,0.0122608252619937,0.691181556543063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.00203954779570831,0.00519498095732316,-0.0122217104720617,0.00814261488064508,0.694622570811261
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.00148631065207554,0.00378686993056452,-0.00593595441183092,0.00890857571598199,0.694701902074468
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,0.00203177005361819,0.00519092305922703,-0.0081424391424668,0.0122059792497032,0.695502870995772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00208801541309084,0.00535484391261248,-0.00840747865562962,0.0125835094818113,0.696595664630805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,-0.00126429166172456,0.00325349755994318,-0.00764114687921319,0.00511256355576407,0.69758353156745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,-0.00258479160992894,0.00669174624050237,-0.0157006142413136,0.0105310310214557,0.699306121490947
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.0031217199384137,0.00813510944961594,-0.0128230945828335,0.0190665344596609,0.701181508347236
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,42200,-0.00164948590648529,0.0043093360139385,-0.0100957844938048,0.00679681268083416,0.701896054885841
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,41843,-0.00548796270603032,0.0143415962692262,-0.0335974913937136,0.022621565981653,0.701977630992373
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.00135685310548926,0.00355370269806016,-0.00832211039368718,0.00560840418270865,0.702605426741115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,41843,-0.0032090110578955,0.00841857571064862,-0.0197094194507668,0.0132913973349758,0.703074184537801
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,42217,-0.00233726784916101,0.00614312509296025,-0.0143777930313631,0.00970325733304108,0.703603336547616
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,0.00208720496429647,0.00548707765052863,-0.00866746723073964,0.0128418771593326,0.703666563104904
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,-0.00238700107278384,0.00630632825559601,-0.014747404453752,0.00997340230818435,0.705059707946247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,39657,0.00189421861992129,0.00505715753266297,-0.00801781014409814,0.0118062473839407,0.707993483339559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.00177423388386772,0.00475272917901039,-0.00754111530699265,0.0110895830747281,0.70892589142127
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,0.00165451704098718,0.00445985333305534,-0.00708679549180129,0.0103958295737756,0.710659426637833
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.0026890826457835,0.00727356628734888,-0.0115671072774203,0.0169452725689873,0.711608487582961
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.002126287461422,0.00580402656084452,-0.00924960459783325,0.0135021795206773,0.714113142229015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,41913,-0.0013242910391781,0.00366549925048617,-0.00850866957013099,0.00586008749177479,0.717891905903095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,42296,-0.00189268837551888,0.00528171610615701,-0.0122448519435866,0.00845947519254886,0.720088994609348
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,0.00272176774141069,0.0076468108273104,-0.0122659814801177,0.0177095169629391,0.721896065477543
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,42137,-0.00120700414655708,0.00339794141515566,-0.00786696932026217,0.00545296102714801,0.72243309525852
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,0.0016892476740313,0.00475620164841324,-0.00763290755685864,0.0110114029049212,0.722470818982352
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,41830,0.0018876840131479,0.00531889662264067,-0.0085373533672278,0.0123127213935236,0.722669094837055
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.00150079509538627,0.00424285118115037,-0.00681519321966845,0.00981678341044099,0.723553048193062
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,0.00297858617928972,0.00842590319434169,-0.01353618408162,0.0194933564401994,0.723717812620914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,-0.00314114071418277,0.00900271610549515,-0.0207864642809533,0.0145041828525877,0.727162020814371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.00164180960848761,0.00472135474890236,-0.00761204569936102,0.0108956649163362,0.728041005304051
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00240204645809559,0.00691100881127784,-0.0159476237282002,0.011143530812009,0.728171213154615
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,39713,-0.00144980690714242,0.00423001450925373,-0.00974063534527972,0.00684102153099489,0.73179846305765
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.00150656493131324,0.00439761854711505,-0.0101258972836587,0.00711276742103227,0.731916039983333
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.00241422412875151,0.00714282581366711,-0.011585714466036,0.016414162723539,0.735374827960898
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.00196189507405479,0.0058424485709643,-0.0134130942731448,0.00948930412503523,0.737027957247667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,39638,-0.00266523391590226,0.00799029732942565,-0.0183262166815765,0.012995748849772,0.738718854938593
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,0.00296426671389361,0.00894208729686697,-0.0145622243879657,0.0204907578157529,0.740274962769918
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.00354828358728109,0.0108131519457743,-0.0176454942264366,0.0247420614009987,0.742807971785744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,41814,-0.00128978796726113,0.00393841686677377,-0.00900908502613773,0.00642950909161546,0.743303294293149
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.00289995714237171,0.0088692641856427,-0.014483800661488,0.0202837149462314,0.743699001040122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.00197794031821041,0.00607297162887183,-0.00992508407437839,0.0138809647107992,0.744660671634492
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.00301581935090181,0.00927087611019955,-0.0211867365268929,0.0151550978250893,0.744959912225795
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,39539,-0.00126306064156712,0.00388611019087106,-0.00887983661567441,0.00635371533254016,0.745172713864382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.00506841914246106,0.0160405513252207,-0.0263710614549714,0.0365078997398936,0.752026183975107
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,39638,-0.00175404427901035,0.00557921527027458,-0.0126893062087485,0.00918121765072784,0.753231501253996
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.000987387477625683,0.00315314565836433,-0.0051927780127684,0.00716755296801977,0.754177341505778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,39586,0.00307036286277677,0.0098354155509262,-0.0162070516170386,0.0223477773425921,0.75491407216089
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,0.00113525406218462,0.00364874603318283,-0.00601628816285373,0.00828679628722298,0.755703564756259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.00182030759287926,0.00590216474373033,-0.0133885504905907,0.0097479353048322,0.757772544319923
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,0.00132403465138729,0.00429338375841059,-0.00709099751509746,0.00973906681787204,0.757791799588193
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,39638,0.00292876863344575,0.00951083156803593,-0.0157124612399047,0.0215699985067962,0.758133545662575
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.00196734033733512,0.00640550805135022,-0.0145221361179816,0.0105874554433113,0.758748280638678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,-0.000865800500591625,0.00283515422120328,-0.00642270277415005,0.0046911017729668,0.760082255073788
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.00123103005912435,0.00406927334381857,-0.00674474569476006,0.00920680581300875,0.762261563519194
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,41913,-0.00188095157697644,0.00622182892834075,-0.0140757362765243,0.0103138331225714,0.762416745259386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,39560,0.00237729125884331,0.00786915845687202,-0.0130462593166259,0.0178008418343125,0.762579773718038
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.0020890153668075,0.00696788876852564,-0.0157460773531177,0.0115680466195027,0.764329651665099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFM,Afamin,39979,-0.000650422619389279,0.0021798957431479,-0.00492301827595916,0.0036221730371806,0.765423736517521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,-0.002175347689634,0.00729204205355556,-0.0164677501146029,0.0121170547353349,0.765466084631823
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,42137,-0.00203326167229495,0.00685513220319618,-0.0154693207905595,0.0114027974459696,0.766773179779842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.00219847028968329,0.00748777475766541,-0.0124775682353409,0.0168745088147075,0.769062032342904
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.000953511610108207,0.00325211071568237,-0.00732764861284565,0.00542062539262924,0.769375482708802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.001415020588689,0.00483687480247096,-0.00806525402415408,0.0108952952015321,0.769871770124402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.00215742326978474,0.00738392147482988,-0.0166299093604513,0.0123150628208818,0.770154631595209
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,39510,-0.00107807334424994,0.00369934508393871,-0.00832878970876981,0.00617264302026992,0.7707335520437
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,41913,0.00123363507939311,0.00424111275151295,-0.00707894591357226,0.00954621607235849,0.771151199369219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.00132999063016122,0.00460442566150649,-0.0103546649267139,0.0076946836663915,0.772701244474662
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,42199,0.000568581992565929,0.00197131296974207,-0.00329519142812853,0.00443235541326039,0.773023480431018
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,39560,0.00132205051417542,0.00458755128151414,-0.00766954999759229,0.0103136510259431,0.773212740599165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,0.00136890113883459,0.00479277689141622,-0.00802494156834121,0.0107627438460104,0.775176371133997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00140736104332319,0.00494574219088258,-0.0111010157374531,0.00828629365080667,0.775986489073863
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,39966,0.00132623850282457,0.00467906672372195,-0.00784473227567045,0.0104972092813196,0.776844104256893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,39575,-0.0011998338362021,0.00424131266910749,-0.00951280666765277,0.00711313899524858,0.777264887875078
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.00134359879900111,0.00477799656078343,-0.0080212744601344,0.0107084720581366,0.778558066430195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.000718714139285475,0.00258105193331197,-0.00434014765000599,0.00577757592857694,0.780665156546972
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,-0.00133362854224189,0.00479447760084599,-0.0107308046399,0.00806354755541624,0.780894328773308
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,39990,0.000718364476249972,0.00260568587813541,-0.00438877984489544,0.00582550879739538,0.782790312597663
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.000962317520525837,0.0034969244033645,-0.00589165431006859,0.00781628935112027,0.783175687504635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,0.00304853767524776,0.0112818891814514,-0.0190639651203969,0.0251610404708924,0.786999760872185
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,0.00141561910325523,0.00525155539432464,-0.00887742946962107,0.0117086676761315,0.78750159351675
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,0.00191799883803344,0.00722411303865538,-0.0122412627177311,0.016077260393798,0.790629641734898
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KAZN,Kazrin,39930,0.00298125902235262,0.0113152552066434,-0.0191966411826684,0.0251591592273737,0.792191177791046
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,39929,0.00197708981754462,0.00753949537947601,-0.0128003211262284,0.0167545007613176,0.793148081268347
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.00140029427454898,0.00536288085457799,-0.0119115407495218,0.00911095220042389,0.794012826651504
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,42262,-0.00131541523814867,0.00507183037251304,-0.0112562027682742,0.0086253722919769,0.795363631228294
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,-0.00170021725595115,0.00655808951276189,-0.0145540727009645,0.0111536381890622,0.795443388168826
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,39757,0.00111688167047894,0.0043140332385172,-0.00733862347701477,0.00957238681797264,0.795721025910069
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00115110276644159,0.00446009654529081,-0.00759068646232839,0.00989289199521157,0.796342897931176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,0.000833679932372416,0.00326176490840359,-0.00555937928809863,0.00722673915284346,0.798270778008909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,39657,0.000896327400838282,0.00355807887465652,-0.00607750719348849,0.00787016199516505,0.801112758974635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,0.00166276083394611,0.00662628306465341,-0.0113247539727746,0.0146502756406668,0.801869627387844
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.00141480708405275,0.00564754849568239,-0.0124840021355902,0.00965438796748473,0.802192082199832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,41913,0.00163305577694566,0.00655006706276055,-0.011205075666065,0.0144711872199563,0.803117928153674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPGN,Epigen,39919,-0.00123398000235758,0.00499407579640413,-0.0110223685633097,0.00855440855859451,0.804844012561567
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,0.00186977778934341,0.00758892549021648,-0.0130045161714809,0.0167440717501677,0.805390825350922
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,-0.00174945358249501,0.00711714384234077,-0.0156990555134829,0.0122001483484929,0.805835012942857
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.00232800302848883,0.00948949058678093,-0.0209274045785794,0.0162713985216018,0.806209866555571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,39575,-0.00125903113834528,0.00513395235639471,-0.0113215777568789,0.00880351548018835,0.806278107797784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,-0.00110012496682734,0.00449379762275801,-0.00990796830743305,0.00770771837377836,0.806608263180483
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,39657,-0.00121640150429894,0.00501364773699967,-0.0110431510688183,0.0086103480602204,0.808305786777777
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAG,S-arrestin,39586,-0.00136427908473974,0.00563917626854867,-0.0124170645710951,0.00968850640161565,0.808839857964238
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,41300,0.00130053692466151,0.00537919454639254,-0.00924268438626786,0.0118437582355909,0.808960984401615
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,39657,0.0014802396985601,0.00616192065848171,-0.0105971247920641,0.0135576041891843,0.810161254835421
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,42262,-0.00112472861259573,0.00473687217005152,-0.0104089980658967,0.00815954084070525,0.812318090769319
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,0.00258893331793792,0.0109159316966009,-0.0188062928073998,0.0239841594432757,0.812529207923076
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,41843,0.00250459352748109,0.010639489145966,-0.0183488051986123,0.0233579922535745,0.813897711173875
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00100990551553357,0.00434441164809498,-0.00750514131473259,0.00952495234579972,0.816184441224262
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,0.00208859760807512,0.00905669519797934,-0.0156625249799644,0.0198397201961146,0.817618518419029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,42081,0.000771887310704405,0.00337688917725925,-0.00584681547672373,0.00739059009813254,0.819199302196934
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,42137,-0.000838385233575931,0.00367125883360073,-0.00803405254743337,0.00635728208028151,0.819366324878089
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,42119,-0.00235570880975785,0.0103778276968095,-0.0226962510955045,0.0179848334759888,0.820431526038551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.00167181807119326,0.00744332871742158,-0.0162607423573396,0.012917106214953,0.822289723734099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.00134801498772566,0.00602546317013478,-0.0104618928257385,0.0131579228011898,0.822978826248989
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,39657,-0.000798304302366211,0.00357841677495301,-0.0078120011812741,0.00621539257654168,0.823470603412125
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00129420037343935,0.00580516907980595,-0.012672331769859,0.0100839310229803,0.823586897904895
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,-0.00143265425476638,0.00644293452813286,-0.0140608059299068,0.011195497420374,0.82403667405785
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,39934,0.000701037262819947,0.00315860430747398,-0.00548982717982906,0.00689190170546895,0.824360493313948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.000553890157603957,0.00251147903942474,-0.00436860875966854,0.00547638907487646,0.825451250287057
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPHS2,Podocin,39657,0.00239883333993021,0.0109853748756527,-0.019132501416349,0.0239301680962094,0.827147915540463
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,39919,-0.000509856310293966,0.00239173604964743,-0.00519765896760292,0.00417794634701499,0.831194965763261
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.00153611727368111,0.00723995467132789,-0.0157264284294838,0.0126541938821216,0.831976622085872
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,39560,0.00162443623128009,0.0076638167277635,-0.0133966445551364,0.0166455170176965,0.832140793762961
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,0.0011715171569433,0.00553051161116396,-0.00966828560093806,0.0120113199148247,0.83224513842299
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,0.000654088148941458,0.00315260555234287,-0.00552501873365058,0.00683319503153349,0.835641699876781
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,42132,0.00425132381491112,0.0206791859021668,-0.0362798805533358,0.0447825281831581,0.837118438015003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,42310,0.00113376370539382,0.00551655746441141,-0.00967868892485254,0.0119462163356402,0.837168809719739
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,-0.00183548579914996,0.00894846734378322,-0.0193744817929651,0.0157035101946651,0.837483524833865
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.00127500353977696,0.00638401058172038,-0.011237657200395,0.0137876642799489,0.841704625475165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,41827,-0.00125785875381514,0.00636586387163704,-0.0137349519422237,0.0112192344345935,0.84336548954922
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.000796812379925112,0.00403287728870671,-0.00710762710594004,0.00870125186579026,0.84337799784029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,39657,-0.00127606075025567,0.00649113607149517,-0.0139986874503862,0.0114465659498749,0.84415583047696
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,-0.000714813840635855,0.00367079544433218,-0.00790957291152692,0.00647994523025521,0.845607938445588
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,41843,0.00205760283510047,0.0105931324995766,-0.0187049368640697,0.0228201425342707,0.845991476891942
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.00113803976959658,0.00592202445344297,-0.0127452076983448,0.0104691281591516,0.847612023516306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,0.00115074479468851,0.00600395527207416,-0.0106170075385769,0.0129184971279539,0.848008486592247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,-0.00128082675221824,0.00681740219876905,-0.0146429350618056,0.0120812815573691,0.850977273429515
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,-0.00104625647689617,0.00558001053374777,-0.0119830771230418,0.00989056416924946,0.851270806325411
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,39657,-0.000741115036240194,0.00396465980884464,-0.0085118482615757,0.00702961818909531,0.851718713789231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,39638,-0.000626513021032229,0.00338643894349816,-0.00726393335028861,0.00601090730822416,0.853227381602391
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.00166811759512903,0.00905765312263395,-0.0160848825252335,0.0194211177154916,0.853885544445866
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.000738004244084882,0.00403913641055354,-0.00865471160876982,0.00717870312060006,0.855026292463568
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,0.00164922176621455,0.00904866385065509,-0.0160861593810694,0.0193846029134985,0.85538098501081
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,39649,0.000707886514808716,0.00388404825740161,-0.00690484806969844,0.00832062109931588,0.855386097009418
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,-0.00072128662653928,0.003963829536396,-0.00849039251787545,0.00704781926479688,0.855611871264871
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.00117733041254128,0.00661447942126517,-0.0117870492531385,0.014141710078221,0.858731234466218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,0.00129701885956429,0.00729112433196056,-0.0129935848310784,0.015587622550207,0.858811953627315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,0.000800843259795186,0.00452700415885073,-0.00807208489155225,0.00967377141114262,0.859587392318938
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.00107485533289741,0.00608620199843651,-0.0108541005840381,0.013003811249833,0.859821156734428
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.00139053072792542,0.00787533939537029,-0.0140451344870003,0.0168261959428512,0.859851186826069
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,-0.000880148783511848,0.00502451027259923,-0.0107281889178063,0.00896789135078265,0.860948452771377
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,-0.00122859650529815,0.00709094138279556,-0.0151268416155774,0.0126696486049812,0.862447495278532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,0.00155416858999452,0.00901884788597163,-0.0161227732665099,0.0192311104464989,0.863185482563418
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,0.00103681263461496,0.00610452368958463,-0.0109280537969709,0.0130016790662008,0.865136456362091
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,-0.00139108941648598,0.00833824338178271,-0.0177340464447801,0.0149518676118081,0.867504952659534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,0.000908653930541496,0.00548241464194844,-0.00983687876767745,0.0116541866287604,0.868364251034472
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,39930,0.000774444425810605,0.004717749663131,-0.00847234491392615,0.0100212337655474,0.86961168136554
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.000941436178446053,0.00576828621492356,-0.0122472771596962,0.0103644048028041,0.870356334997483
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,42296,0.00106133344488531,0.00657398467052816,-0.0118236765093499,0.0139463433991205,0.871745728479461
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.00115808537820429,0.00730097384852914,-0.0131518233649128,0.0154679941213214,0.87397011477291
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,-0.00047127023596606,0.0029915406194992,-0.00633468985018449,0.00539214937825237,0.874826159050628
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,39575,-0.00105606848890993,0.00680486522532591,-0.0143936043305487,0.0122814673527288,0.876671900107148
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,-0.000624721549979257,0.00402952215213563,-0.00852258496816509,0.00727314186820658,0.876795658083611
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,-0.000538908121526413,0.00349468841451036,-0.00738849741396673,0.0063106811709139,0.877448727085561
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,39966,-0.00140497598895503,0.00916574423892976,-0.0193698346972574,0.0165598827193473,0.878175830170897
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.00134574747983115,0.00900823393234458,-0.0190018859872265,0.0163103910275642,0.881247911932485
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.000403956449732582,0.00273349497205362,-0.00576160659495769,0.00495369369549252,0.882518861128267
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,0.00064583085525372,0.00440212249728795,-0.00798232923943066,0.0092739909499381,0.883364340517219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.000914815515785853,0.00628535295626862,-0.0114044762785006,0.0132341073100723,0.884281058894981
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,0.00116466486522666,0.00813142711385982,-0.0147729322779386,0.0171022620083919,0.886111109990055
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.000530502174095962,0.00378216748569338,-0.00688254609786307,0.00794355044605499,0.888453420683023
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,39575,0.000712207325137647,0.00513265728688657,-0.00934780095716003,0.0107722156074353,0.889642380160972
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,39919,-0.00149946914699062,0.0108432045641737,-0.022752150092771,0.0197532117987898,0.890016429652519
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,39649,0.000333848118261307,0.00241450548223996,-0.00439858262692902,0.00506627886345163,0.890031372090657
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BSND,Barttin,39560,-0.000489727691649924,0.00361234157806533,-0.00756991718465796,0.00659046180135811,0.892163155940186
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,0.000830635468367348,0.00617841004515874,-0.0112790482201438,0.0129403191568785,0.893055752807556
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,0.00239366692883408,0.0179111344720371,-0.0327121566363587,0.0374994904940269,0.893688614139703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,39575,0.00117983571181817,0.00890112231927923,-0.0162663640339691,0.0186260354576055,0.894552422957534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.000373605694125981,0.00287116863350521,-0.00525388482754423,0.00600109621579619,0.8964713311571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.000643186313492437,0.00497712899670403,-0.0103983591470323,0.00911198652004747,0.897178903618814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,42119,0.00126730631775394,0.00992832484311502,-0.0181922103747515,0.0207268230102594,0.898431394142537
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,39560,0.000586238640807537,0.00461734259904954,-0.00846375285332956,0.00963623013494463,0.898970817173055
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,39934,-0.00211267056999236,0.0168527230960068,-0.0351440078381656,0.0309186666981809,0.900240156818758
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,0.00111928475544514,0.00903724055939417,-0.0165937067409674,0.0188322762518577,0.901434337944668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,39649,-0.00085019571322744,0.00700392755164638,-0.0145778937144543,0.0128775022879995,0.903385594385811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.00036164901432591,0.00307710611166855,-0.00639277699319627,0.00566947896454445,0.906442985814802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,-0.000354104026860156,0.00303861443593105,-0.00630978832128502,0.00560158026756471,0.907230917699326
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,39813,0.0013550118140322,0.0118901938022768,-0.0219497680384304,0.0246597916664948,0.909271187232705
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,39468,0.000519116577253092,0.00457720802518566,-0.0084522111521108,0.00949044430661698,0.909704936941448
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,-0.000482446117334201,0.00438957983847637,-0.00908602260074789,0.00812113036607949,0.912485024758003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,-0.00049766186330495,0.00455260952917001,-0.00942077654047817,0.00842545281386827,0.912955773604182
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,-0.000261384329600228,0.00240493373455318,-0.00497505444932447,0.00445228579012401,0.913452585089097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.000537056443936287,0.00502698343348769,-0.00931583108569958,0.0103899439735722,0.914921660602279
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.000590281014447492,0.00557835229758526,-0.0103432894888196,0.0115238515177146,0.915729647633783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,39575,-0.000634585352741818,0.00606559057343653,-0.0125231428766774,0.0112539721711938,0.916678828475938
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,0.000625173681500903,0.00597571018145262,-0.0110872182741462,0.012337565637148,0.916679935438509
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,0.000367516269395194,0.00351536035468633,-0.00652259002579001,0.0072576225645804,0.916737783382858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,39757,0.000657109748698171,0.00629697102874803,-0.011684953467648,0.0129991729650443,0.916890851941597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.000540187379466678,0.00517671915242189,-0.00960618215928022,0.0106865569182136,0.916893680778382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,41913,0.00152988696153618,0.0148527540587082,-0.0275815109935319,0.0306412849166043,0.917961674623406
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,39930,-0.00284659403984213,0.0280236459424249,-0.0577729400869948,0.0520797520073106,0.919093209694208
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,39958,-0.000327264465569586,0.00327844637312657,-0.00675301935689766,0.00609849042575848,0.920486582221174
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.0004572902422381,0.0046036289534716,-0.00948040299104243,0.00856582250656623,0.920875690517666
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,42016,-0.00136504438219987,0.0137678985820201,-0.0283501256029592,0.0256200368385595,0.921023120712727
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,0.000444456790444498,0.00451387635568788,-0.00840274086670374,0.00929165444759274,0.921565208687309
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,39649,0.000360368839787735,0.00370117386712558,-0.00689393193977841,0.00761466961935388,0.922437436478888
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,39946,0.000499218411497514,0.00513842456151827,-0.0095720937290783,0.0105705305520733,0.922605827525259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,39575,-0.000526183013388841,0.00542456209958132,-0.0111583247285682,0.0101059587017905,0.922728093951995
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,0.000941391413558902,0.00987621191544582,-0.0184159839407149,0.0202987667678327,0.924063116943153
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTD,Biotinidase,39979,-0.000210683564052505,0.00221163727236447,-0.00454549261788687,0.00412412548978186,0.924108914416135
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCLN,Nicalin,41913,-0.000513557008461642,0.00550600091994732,-0.0113053188115584,0.0102782047946351,0.925688693177035
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,41900,0.000698477561480413,0.0075737624435435,-0.0141460968278648,0.0155430519508257,0.926521994677198
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,41913,0.000761473823280304,0.00826875141396041,-0.0154452789480821,0.0169682265946427,0.926627486224443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,39757,-0.000272676176235402,0.00297524102551659,-0.00610414858624793,0.00555879623377712,0.926979015152506
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.000559546134607485,0.00619376185292104,-0.0115802270971178,0.0126993193663327,0.928018184260561
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,0.000279335231802352,0.00313490736832409,-0.00586508321011287,0.00642375367371757,0.929000252307592
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,0.000208933716846912,0.00236538068556252,-0.00442721242685563,0.00484507986054945,0.929616115902667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,-0.000485943820709464,0.00551498149262713,-0.0112953075462586,0.0103234199048397,0.929787871181804
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,0.000298468992382879,0.00340014042486656,-0.00636580624035557,0.00696274422512133,0.93005204330495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.000585434294564926,0.00683617374670127,-0.0128134662489696,0.0139843348380994,0.931755981122395
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,0.000617343379480072,0.00738644174343752,-0.0138600824376575,0.0150947691966176,0.933393528421384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,-0.000955184675611128,0.0116803342904522,-0.0238486398848974,0.0219382705336751,0.934825355962171
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,42262,-0.000224325212820125,0.00281578734001287,-0.00574326839924535,0.0052946179736051,0.936503306125744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,0.000226321679160134,0.00287210893026452,-0.00540301182415832,0.00585565518247859,0.937193269725281
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.00126212456366418,0.0161307949428074,-0.0303542335242383,0.0328784826515667,0.937635778920066
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,0.000330162468430704,0.00435497597029086,-0.00820559043333939,0.0088659153702008,0.939569497238061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,39560,0.000336784120781684,0.00450871362639416,-0.00850029458695086,0.00917386282851423,0.940457733357034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.000538134458513355,0.00720897147203304,-0.0135914496266714,0.0146677185436981,0.940496003125266
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.000462574745220881,0.00620228006140922,-0.0116938941751412,0.0126190436655829,0.940549123365717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.000236717631878571,0.00335879014293374,-0.0068199463120287,0.00634651104827156,0.943815249788214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,0.00025246727620785,0.00358630789656978,-0.00677669620106892,0.00728163075348462,0.943878525509687
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.000234263944090501,0.00338767533423973,-0.00687410759920038,0.00640557971101938,0.944869806056054
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,0.000269225836050678,0.00392783000942514,-0.00742932098242259,0.00796777265452395,0.945354523581153
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,39930,-0.000646767866889217,0.00943868314537442,-0.0191465868318231,0.0178530510980446,0.945370438155078
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRN1,Neuritin,39934,0.000256442871949775,0.00375245757345223,-0.00709837397201659,0.00761125971591614,0.945516205349106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.000234204876428188,0.00361206153224072,-0.00684543572676362,0.00731384547962,0.948302838628558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,42016,-0.000294716280853163,0.00463438703829028,-0.00937811487590211,0.00878868231419579,0.949294959956073
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.000611613752195082,0.00985353847752937,-0.0187013216637625,0.0199245491681526,0.9505078459911
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,-0.000220986679392197,0.00358186325792556,-0.00724143866492629,0.00679946530614189,0.950805832955804
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,-0.000194204809351981,0.00325018646444159,-0.0065645702796575,0.00617616066095354,0.952354138698309
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,-0.000276287721372148,0.0047159026328769,-0.00951945688181086,0.00896688143906657,0.953282616112832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,39649,-0.000349117936978081,0.00644242194036962,-0.0129762649401025,0.0122780290661464,0.956784385181904
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,39657,0.000247527161792159,0.00459932336110564,-0.0087671466259749,0.00926220094955922,0.957081006038673
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.000347800152615096,0.00656777263031991,-0.0132206345080421,0.0125250342028119,0.957768102201807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,0.000168415370260451,0.0036016400004119,-0.00689079903054687,0.00722762977106777,0.962704596676988
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.000569572774821566,0.0124524187144922,-0.0238371679055832,0.0249763134552263,0.963518222672928
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,0.000262847934211714,0.00574958321668565,-0.0110063351704922,0.0115320310389156,0.963537302179168
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,42310,-0.000259056522231146,0.00613761383246784,-0.0122887796338681,0.0117706665894058,0.966333484532969
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,39736,0.000314615640397226,0.0075257504018454,-0.0144358551472198,0.0150650864280142,0.966654724312105
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,42246,0.000187898145573786,0.00470857155550895,-0.00904090210322376,0.00941669839437133,0.96816900880543
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,39657,0.000161372720653399,0.00428842903239703,-0.00824394818284479,0.00856669362415158,0.969983528245332
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,39575,-0.000157241098535882,0.00434152206945892,-0.00866662435467537,0.0083521421576036,0.971109219308017
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,0.000168113254839829,0.00464396052373845,-0.00893404937168753,0.00927027588136718,0.971123108312038
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,39929,-0.00014807638895232,0.00411124750645207,-0.00820612150159838,0.00790996872369374,0.971269130380913
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.000221768758761933,0.00648953527297325,-0.0129412578937895,0.0124977203762656,0.972739479893395
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,-0.000191925638543079,0.00572757947528059,-0.011417981410093,0.0110341301330069,0.973269158168601
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,41843,0.000159984038325075,0.00514393991389069,-0.00992213819290067,0.0102421062695508,0.97518909449485
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,-0.000136918229055928,0.00453069743992872,-0.00901708521131622,0.00874324875320436,0.975892041414009
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,42083,-0.000101439758648394,0.00378526953324745,-0.0075205680438134,0.00731768852651662,0.978620801325416
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,39638,8.54600561998663e-05,0.00335960154210327,-0.00649935896632254,0.00667027907872227,0.979706414358352
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,0.000101807366861006,0.004014130398992,-0.00776588821516331,0.00796950294888532,0.979766397741644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.000129422784137932,0.00557897817963719,-0.010805374447951,0.0110642200162268,0.981492529401241
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,39398,-0.000152019108258073,0.0076068284595591,-0.0150614028889939,0.0147573646724778,0.984056059891864
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,-4.96213588279744e-05,0.00256808382658,-0.00508306565892478,0.00498382294126883,0.984584257111804
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.000145232422760955,0.00792481823845643,-0.0153874113246137,0.0156778761701356,0.985378834035205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,6.60915580957347e-05,0.00366607620164562,-0.00711941779712968,0.00725160091332115,0.985616934491735
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGN,Cingulin,39649,-6.66150800210437e-05,0.00404242484632384,-0.00798976777881576,0.00785653761877367,0.986852560624986
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,9.89204076563637e-05,0.00619667054145796,-0.0120465538536012,0.012244394668914,0.987263818993119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,-7.39318373981883e-05,0.00469383482105215,-0.00927384808666041,0.00912598441186403,0.987433399516146
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-4.86585506694102e-05,0.00337847805126274,-0.00667047553114438,0.00657315842980556,0.988509121826889
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.000155603392570256,0.0135754138503266,-0.0264522077540699,0.0267634145392104,0.990854902582917
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-4.24872771000826e-05,0.00396246610217038,-0.00780892083735403,0.00772394628315386,0.991445093809916
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-6.50596113813842e-05,0.00833081215748606,-0.0163934514400541,0.0162633322172913,0.993769112031468
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,2.02751778882853e-05,0.00264725101485699,-0.00516833681123142,0.00520888716700799,0.993889235519928
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-4.0204759673962e-05,0.00526281370687332,-0.0103553196251457,0.0102749101057977,0.993904835883323
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,2.43921523909554e-05,0.00327689578362828,-0.00639832358352048,0.00644710788830239,0.994060970159794
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENG,Endoglin,42310,1.214051386672e-05,0.00185900253584439,-0.00363150445638829,0.00365578548412173,0.994789419113707
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-4.3461843579726e-05,0.00669045929328695,-0.0131567620584222,0.0130698383712627,0.994817018885905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,1.50270410360303e-05,0.00429925440077756,-0.00841151158448799,0.00844156566656005,0.997211238950807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,1.4262791266765e-05,0.00995911999913067,-0.0195056124070294,0.0195341379895629,0.998857349059717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,42145,5.41401511061451e-06,0.00380533132411723,-0.00745303538015915,0.00746386341038038,0.998864835276005
